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Abstract
Polyamidoamines (PAAs) are a family o f synthetic, water-soluble, linear 
polymers that are synthesised by hydrogen-transfer polyaddition of aliphatic amines or 
Ms-secondary amines to Msacrylamides (reviewed by Ferruti et al 2002). Over the last 15 
years, PAAs been developed as drug carriers and as pH-responsive polymers for protein 
and gene delivery (Richardson et al, 2001). The latter, called endosomolytic PAAs, can 
disrupt membranes at low pH, but the delivery of genes and proteins is still poorly 
efficient. The precise mode of action is still poorly understood, therefore the main aim of 
this work was to examine the physico-chemical properties of PAAs inorder to better 
define their mechanism of membrane permeabilisation to allow design of more efficient 
chemical structures.
First PAA ISA1 (23 k g/mol) and ISA23 (52 - 67 k g/mol) were synthesised and 
were characterised using *H-NMR, GPC and acid-base titration. In agreement with past 
studies, ISA23.HC1 demonstrated a pH-dependant haemolytic activity.
The solution conformation of ISA23.HC1 was then investigated using small-angle 
neutron scattering (SANS). ISA23.HC1 possessed a Gaussian coil like-shape in solution 
at all pHs (pH 2 to 14) and polymer concentrations examined (10 mg/ml to 50 mg/ml). 
However as the pH decreased the radius of gyration increased to a maximum (Rg ~ 8  nm) 
at ~ pH = 3.
Surface tension, electron paramagnetic resonance (EPR) and SANS were then 
used to investigate the interaction o f ISA23.HC1 with simple micelles as model surfaces. 
Both pH and micelle composition played an important role in the strength of interaction 
seen. For SDS micelles, three different responses were observed, strong interaction at pH 
< 4.5, weak interaction at pH 4.5 — 6.5, and no interaction at pH > 7. However, 
ISA23.HC1 did not appear to interact with more biologically relevant lyso-PC surfactants 
at pHs 7.4 - 5.5. EPR experiments showed that micelle fluidity was effected when a 
PAA-micelle interaction occurred, and SANS reinforced this conclusion.
Finally, liposomes were used as a more complex model membrane. Liposomes 
were prepared to mimic three phospholipids composition of plasma, endosomal and 
lysosomal membranes. The liposomes were stable over 2 days at pH 7.4, 5.5 and 4, but 
not at pH 3. SANS was used to study polymer-liposomes interaction, and the Schultz 
poly disperse 3 shell sphere model was used to fit the liposomal (alone) SANS scattering 
data. The radius o f the plasma, endosome and lysosome liposomes was ~ 50 nm. When 
liposomes were incubated in the presence of ISA23.HC1, it was difficult to interpret the 
scattering data. However, it was clear that at pH 4 and 5.5 scattering of model liposomes 
alters in the presence of PAA indicating possible interaction. Using a contrast approach 
the scattering data for ISA23.HC1 in the presence of model liposomes could be extracted. 
This was again fitted using Gaussian coil model. Generally, the polymer increased in 
size in the presence of liposomes, at pHs where there was an interaction. However, these 
are only preliminary experiments, and there is a need for further mathematical 
modelling.
In conclusion, this project emphasise the importance of combining the different 
disciplines to fully understand a system that can be the first step in finding a way to cure 
devastating genetic diseases.
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Chapterl Introduction
1 General Introduction
1.1 Background
Currently, the four main causes o f m ortality worldwide are cancer, 
cardiovascular, cerebrovascular and infectious diseases (Mathers et al, 2001). Cancer 
was responsible for 7 million deaths in 2000 (Felay et al, 2000). Cardiovascular and 
cerebrovascular diseases were responsible for more than 15 million i.e. 30% of total 
global mortality (Opari, 1999). Approximately 50% of these deaths were due to 
coronary artery disease (CAD), and nearly 33% were associated with stroke (Opari, 
1999). Acquired immune deficiency syndrome (AIDS) caused by human 
immunodeficiency virus (HIV), tuberculosis (TB) and lower respiratory diseases are the 
main infectious diseases that cause mortality. Almost 38 million people are living with 
HIV, and there have been 20 million deaths since the first AIDS diagnosis in 1981 
(UNAIDS/WHO 2004). One-third o f the world’s population is currently infected with 
the TB bacillus, and it caused two million deaths in 2002.
These facts, coupled with the emergence o f multi-drug resistance diseases 
highlight the importance of developing new and improved medicines. In this context, 
there has been growing interest in the use of macromolecular drugs such as peptides, 
proteins, genes and polymer therapeutics as treatments for such life-threatening 
diseases.
Many of these macromolecular agents work at the intracellular level. So their 
ability to access the cell cytoplasm is crucial for therapeutic efficacy. Design and 
development of effective delivery vehicles that are both safe and efficient has proved a 
major challenge. For example, for gene therapy, thus far viral vectors have been the 
most widely used, but viruses have limitations such as toxicity and immunogenicity 
(reviewed in Aneed, 2004). Therefore, there is an urgent need to find safe and effective 
alternatives. In this context, many have been developing endosomolytic polymers as 
non-viral vectors for cytosolic delivery (Duncan et al, 1994; reviewed in Smith et al, 
1998; reviewed in Christie and Grainger, 2003).
Non-viral delivery systems include physical and chemical delivery methods. For 
the physical approach, naked DNA is delivered directly to the cytoplasm by-passing the 
intracellular vesicles such as endosome and the lysosome, thus degradation by the
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lysosomal enzymes can be avoided (reviewed in W olf and Wolf, 2003). Physical 
techniques for gene delivery include direct injection (Capecchi, 1980; reviewed in 
Auerbach, 2004), electroporation (reviewed in Gehl, 2003), the gene gun (Klein et al, 
1987; Williams et al, 1991; Trimble et al, 2003), laser irradiation (Kurata et al, 1986; 
Terakawa et al, 2004), sonoporation and magnetofection.
The chemical approach for non-viral delivery usually involves cationic vehicles 
such as lipids / liposomes and polymers. To be useful a non-viral delivery vehicle must 
be (Schatzlein, 2003; Roth and Sundaram, 2004; Mastrobattista et al, 2005)
>- Biocompatible, non-toxic, non-immunogenic and non-pathogenic 
>- Able to carry and protect the payload from degradation 
>■ It must be stable 
It must be able to:
- target the appropriate cell type
- avoid the accumulation in the liver
- ideally introduce the payload into the cytosol via interaction with 
endosomal membrane or the plasma membrane
- release the therapeutic agent at the target site
- direct the payload to the intracellular target (e.g. nucleous)
In addition it must be:
>■ Easy to administer 
>■ Inexpensive to synthesise and purify
Increase in interest in the use of polymers as non-viral vectors has occurred due 
to advances in polymer chemistry which are allowing the synthesis of polymers with 
specific chemical structure. These structures vary from simple linear polymers to highly 
branched dendrimers (reviewed Duncan, 2004), and they can be designed to have 
precisely defined physical and chemical properties, as well as three-dimentional 
structure in the case of dendrimers.
Over the last 15 years, Duncan and Ferruti et al (Ranucci et al, 1991) have 
started to design amphoteric polyamisoamines (PAAs) as endosomolytic polymers for 
gene and toxin delivery. Although much less toxic than polycations (Ranucci et al, 
1991; Richardson et al, 1999), and able to avoid liver capture after intravenous injection
Chapterl Introduction
(Richardson et al, 1999) (leading to tumor targeting by the enhanced permeability and 
retention effect (Richardson et al, 2001)), their ability to deliver genes (Richardson et al, 
1999) and non-permeant toxins (e.g. ricin A chain and gelonin) (Pattrick et al, 2001a) 
was still poorly efficient (Richardson et al, 1999; Pattrick et al, 2001a).
Thus the overall aim of this project was to better understand the mechanism of 
action of PAAs by defining their physico-chemical and bio-physical properties. It was 
hoped that this information would help to improve PAAs design to improve efficiency 
of transfer when used as endosomolytic polymers for intracellular delivery of genes and 
proteins. Here small-angle neutron scattering (SANS) was chosen to investigate PAA 
conformation in physiological solutions. The mechanism at which PAAs cause pH- 
dependent membrane breakage was also investigated by studying the interaction 
between PAAs and model membranes, including red blood cells, surfactant micelles and 
liposomes, with a phospholipid composition similar to that of biological membranes 
(plasma, endosomal and lysosomal membranes). Techniques used in this context 
included: surface tension measurements, to study the onset o f an interaction, SANS to 
study the effect o f PAA on the morphology o f model membranes, and electron 
paramagnetic resonance (EPR) to investigate the effect of PAA on the fluidity of model 
membranes.
To understand the rationale for this indisciplinary project it is important to have 
a background understanding of polymer therapeutics, the design and current status of 
non-viral vectors for intracytoplasmic delivery, the mechanism by cellular uptake of 
macromolecules (i.e. endocytosis) and intracellular trafficking. These topics are briefly 
reviewed in the next section. Also, it is important to introduce the physico-chemical 
techniques that have been used to characterise polymer properties. As PAAs were used 
for these studies, their evolution as biomedical polymers, and the current understanding 
of their physico-chemical properties are reviewed in detail.
1.2 Use of water-soluble polymers to promote targeting and cytosolic delivery
Over recent years the development of polymer therapeutics (reviewed in 
Duncan, 2003a) has been leading to the design of sophisticated nanosized medicines. 
Polymer therapeutics is a term used to describe polymeric drugs, polymer-drug 
conjugates (Kopecek et al, 2000; Duncan, 2003b) and polymer-protein conjugates
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(reviewed in Harris and Chess, 2003), drug entrapment in polymer micelles by 
covalent linkage and those polymeric multicomponents polyplexes used as non-viral 
vectors (Ogris and Wagner, 2002; Niidome and Huang, 2002) (Figure 1.1). Thanks to 
the successful clinical application of polymer-protein conjugates, and promising clinical 
results arising from trials with polymer-anticancer-drug conjugates (reviewed in 
Duncan, 2003a), there has been growing interest in the field o f polymer therapeutics, 
and particularly the bioresponsive polymer designed to deliver proteins and genes to the 
cytosol (Boussif et al, 1995; Li et al, 2004; Griffiths et al, 2004).
All macromolecular therapeutics and nanosized delivery systems enter the cell 
by mechanism known as endocytosis (reviewed in Jones et al, 2003). To optimise their 
design, it is therefore very important to understand the processes of endocytosis and 
intracellular trafficking. Both play a key role in determining the therapeutic efficiency, 
and they are briefly explained in the next section.
1.3 The complexity and the implications of intracellular trafficking for design of 
non-viral vector for cytosolic delivery
Macromolecular therapeutics such as, genes, peptides and proteins, normally 
require access to intracellular components to exert a therapeutic effect. At the cellular 
level there are number of barriers that such macromolecular therapeutics will encounter 
before they can reach their site of action. These include
>■ The plasma membrane, which is a physical barrier (Hawiger, 1999),
The mechanism of cellular uptake and trafficking (Wiethoff and Middaugh,
2003)
The effect o f the change in pH in the endosome and lysosome 
>■ The effect of the lysosomal enzymes, which can degrade proteins and nucleotide
(Alberts et al, 1994)
The endosomal or lysosomal membranes, which are also physical barriers
These biochemical and physical barriers will be discussed in more detail in the next 
section (Figure 1.2).
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Polymeric drugs Polymer-drug conjugates
N o n -v ira l v e c to r  
For gene delivery
Polymer-protein conjugates Drug entrapm ent in a
polymer micelle
Figure 1.1 Schematic diagram of polymer therapeutics now in, or progressing towards, 
clinical development (adapted from Duncan, 2003a).
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Exocytosis
Fluid-phase uptake
Recycling
Com partm entPlasma membrane
Sorting
earl
endosome or 
endosome 
5.9 -  6.0
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com partm ent
8 min
Late endosome 
pH 5.0 -  6.0
Lysosome 
pH 4.5 -  5.5 Endoplasmic 
reticulum (ER)
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Figure 1.2 The intracellular trafficking and the barriers that the therapeutic agent faces at 
the cellular level. The first b a rrie r tha t it will encounter is the plasm a m em brane (1). 
Following endosystosis, the therapeutic drug can either be recycled back to the cell surface 
(2) or it is carried to the late endosome. If  the therapeutic agent does not escape to the 
cytosol it will get degraded by lysosomal enzymes (S<) (3). Once the protein / DNA is 
successfully delivered into cytoplasm, here it m ust spend very little time to avoid the 
degradation by the enzymes found there (nucleases, S-c) (adapted from Ogris and W agner, 
2002; Maxfield and M cGraw, 2004)
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1.3.1 Physical and biochemical barriers that therapeutic agents face during the 
endocytic pathways
The first barrier that the macromolecular drugs encounter is plasma membrane 
(Parkes and Hart, 2000). This has a complex structure, being composed of lipids and 
proteins. Cellular entry is via endocytosis (Asokan and Cho, 2002). It involves the 
invagination (folding inward) of small portion of the plasma membrane enclosing a 
droplet of the external medium containing macromolecules, and this “buds o ff’ to form 
intracellular vesicles (Slepnev and Camilli, 1998). This mechanism of endocytosis has 
been divided into two main groups, pinocytosis (cell drinking) and phagocytosis (cell 
eating) (Aderem and Underhill, 1999; Maxfield and McGraw, 2004). The latter 
describes the uptake of large particulate (e.g. bacteria by macrophages) so it will not be 
discussed further.
1.3.1.1 Pinocytosis
The term pinocytosis is used to describe the non-specific uptake of small 
droplets o f extracellular medium (Slepnev and Camilli, 1998) (see Figure 1.3 for an 
overview of endocytosis). There are three main mechanisms of internalisation; receptor- 
mediated pinocytosis, non-specific adsorptive pinocytosis and fluid-phase pinocytosis. 
The chemical properties of macromolecules play a crucial role in determining their 
mechanism of cellular uptake. Negatively charged macromolecules (e.g. the polyanion 
DNA) and neutral macromolecules (e.g. poly(ethylene glycol) (PEG)) do not associate 
with the membrane, and cellular uptake may be by non-specific fluid-phase endocytosis 
(Figure 1.4) (Godbey et al, 1999a; Kristensen et al, 2001). In contrast, positively 
charged macromolecules, poly(ethylene imine) (PEI) and cationic polyplexes, DNA 
associated with positively charged vectors (with excess positive charge) binds by ionic 
interaction to the negatively charged membrane. Thus, they are taken up by a non­
specific adsorption process (Godbey et al, 1999a; Kristensen et al, 2001). Binding of the 
positively charged m acrom olecule to the membrane can induce membrane 
depolarization, which causes the formation of membrane invagination, which is then 
followed by budding and vacuole formation
This study largely investigates PAA polymers, so it is important to consider their 
possible mechanism of endocytic uptake. The previously described cationic PAAs (e.g. 
ISA1 and ISA4) (reviewed in Ferruti et al, 2002), are probably endocytosed by a non­
specific adsorptive process. However, the amphoteric PAAs (e.g. ISA22 and ISA23)
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Clathrin coat
Caveolin-dependent
endocytosis
50-80nm
Macropinocytosis
0.5-10 pm
Clathrin-dependent
endocytosis
(~90nm)
Dynamin
C lathrin-and caveolin- 
independent endocytosis
(~90nm) 
Caveolin coat
Figure 1.3 Mechanisms by which cells uptake large macromolecules. Summ ary of the different 
types of endocytosis (diagram adapted from Conner and Schmid, 2003)
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+ + Amphoteric polymer
Non-ionic polymer 
Anionic polymer
Amphoteric polymer
++ ±+ Cationic polymer
Non-specific fluid-phase endocytosis Non-specific adsorption endocytosis
Polyplex-Targeting motif
Receptor-mediated endocytosis
Figure 1.4 The mechanisms of cellular uptake of cationic, anionic, non-ionic, 
am photeric polymers and polyplexes. The non-ionic and anionic polymers will not 
interact with the plasma m em brane and the internalisation is relied on non-specific 
fluid-phase endocytosis. On the other hand cationic polymers are able to interact 
with the plasma m em brane and it enters the cell by adsorption mechanism. For 
am photeric polymer (e.g. ISA23) both mechanisms can be responsible for their 
cellular uptake. Finally to achieve selectivity, polyplexes are conjugated to targeting 
motifs (for tran sfe rrin  receptors as an example), this is an example of active 
targeting
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would predominantly be negatively charged at pH 7.4 (although they would carry some 
positive charge), so their mechanism of uptake might not be that straightforward. 
Attraction of the positive charges on the PAA and the negatively charged membrane 
could lead to an interaction but repulsion would also result from the negative charge on 
the PAA and the negatively charged membrane. PAA could theoretically be 
endocytosed by either fluid-phase endocytosis or by adsorptive process (or a 
combination of both, which is most likely). Although cationic PAAs and the polyplexes 
they form, would show enhanced binding to the cell membrane, they suffer from 
disadvantages of increased toxicity, non-specific interaction with RBC and plasma 
proteins leading to activation o f the complement system (Plank et al, 1996), and also 
increased uptake by the reticular endothelial system (RES) (Richardson et al, 1999). 
Hence, the move towards the amphoteric PAAs, ISA22 and ISA23, that tend to be less 
toxic than cationic PAA (ISA1 and ISA 4).
1.3.1.2 Mechanisms of Internalisation
Many different gateways have been described for endocytic uptake. The main 
mechanisms of internalisation are described below:-
>■ Invaginations can occur at a specific region o f the plasma membrane called coated 
pits with either clathrin or cavolae (reviewed in Watson et al, 2005). Alternatively, 
internalisation occurs in a region of the plasma membrane where there is no 
“coating”, known as macropinocytosis, and clathrin- and caveolin-independent 
endocytosis. The best-studied route o f cellular uptake is clathrin-mediated 
endocytosis (Schnatwinkel et al, 2004), and in all mammalian cells where it accounts 
. for receptor-mediated endocytosis (Slepnev and Camilli, 1998). Clathrin-coated 
vesicles have a morphologically characteristic bristle coat made up of a complex 
protein called clathrin (Marsh, 2001). This protein is a triskelion (a three-legged 
structure consisting of three heavy and three light chains) (reviewed in Mousavi et al, 
2004) and it forms a polygonal lattice, pentagons and hexagons (Heuser, 1980), 
which helps to deform the overlying plasma membrane into coated pit (reviewed in 
Conner and Schmid, 2003). Clathrin-mediated endocytosis is responsible for uptake 
o f many physiological ligands such as transferrin, immunoglobulins and growth 
factors (reviewed in Trowbridge, et al 1993). It also modulates signal transduction, 
and is involved in cell and serum homeostasis (reviewed in Conner and Schmid, 
2003).
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The caveolae-dependent uptake m echanism uses cavolae (flasked-shaped 
invaginations) that are present in many cell types (reviewed in Nichols and Schwartz, 
2001). These structures were first observed 50 years ago on the surface of endothelial 
cells, where they are abundant and play a role in trancytosis and endocytosis of blood 
components (reviewed in Conner and Schmid, 2003). Caveolae have a single major, 
cholesterol-binding coat protein, caveolin (reviewed in Okamoto, 1998), which is 
implicated in the formation and maintenance o f caveolae structures (reviewed in 
Nichols and Schwartz, 2001).
>■ Macropinocytosis occurs primarily at sites of membrane ruffling (reviewed in 
Swanson and Watts, 1995) and it involves the formation of large, irregular primary 
endocytic vesicles, called macropinosomes (reviewed in Nichols and Schwartz, 
2001). Macropinosomes are dynamic vesicular structures (reviewed in Johannes and 
Lamaze, 2002) and are heterogeneous in size (reviewed in Swanson and Watts, 
1995).
1.3.1.3 Intracellular Trafficking
Following endocytic internalisation, the vesicle contents are delivered to a 
number of different intracellular compartments by a series of vesicle fusion events. 
These include early and late endosomes, and lysosomes.
Early Endosome
The early endosome is the first endocytic compartment entered followng 
internalisation (Gruenberg et al, 1989; Slepnev and Camilli, 1998). Early endosomes are 
usually located in the periphery o f the cell. It has been shown that oregon green-labelled 
PAAs enter this compartment (Pattrick et al, 2001b). A decrease in pH occurs 
(acidification) in the lumen of the early endosome (pH 6.5), due to the proton pump 
located in the vesicle membrane. This change in pH is the trigger used to deliver drugs 
from pH-responsive linkers (cis-aconityl and hydrazone), and causes a change in 
conformation of pH-responsive polymers such as PAAs (reviewed in Ferruti et al,
2002). Physiologically, the acidic environment is also important for the dissociation of 
the ligand from the receptor (e.g. transferrin and iron). Subsequently the vesicle 
contents are either recycled back into the cell or carried forward into the late endosome. 
The recycling stage can be a disadvantage for therapeutic agents such as polyplexes that 
are required to access the cytosol for their activity. Inclusion of transferrin into a non-
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viral vectors is often used to enhance cellular uptake, as transferrin receptors are over 
expressed in rapidly dividing tumour cells (reviewed in Merdan et al, 2002a), and, in 
theory this could enhance cancer targeting.
Late Endosome
If the polyplex is not recycled, it will experience a further decrease in pH in the 
late endosome (pH 6-5). For the pH-responsive polymer, this effect may enhance its 
ability to cause membrane permeabilisation. However, in many cases the endosomal 
membrane remains an obstacle to cytosolic delivery. For example a polyplex must act 
quickly to cause the endosomal disruption before it is transferred to the lysosome where 
the nuclease would rapidly degrade the DNA.
Lysosome
The endosomal contents can either escape to the cytosol or be further trafficked 
to either the golgi apparatus or the lysosome. The lysosome contains more than sixty 
hydrolytic enzymes (pH 5.5-4.5) (reviewed in Blott and Griffiths, 2002), and this 
compartment is able to degrade proteins that were not recycled, DNA, RNA, glycosides 
and lipids. In fact many naturally occurring macromolecules are degraded here. Due to 
the hydrolytic capacity of the lysosomes, it is essential that the entry of degradable 
therapeutic agents such as DNA and protein is avoided.
Even if a polyplex can escape from the endosome, its journey does not end in the 
cytosol. For gene therapy, the DNA must yet reach its final destination, i.e the nucleus. 
Diffusion of the macromolecule through the cytoplasm is usually slow due to its high 
viscosity, and the presence of a cytoskeleton, which forms a mesh (Lukacs et al, 2000; 
reviewed in Merdan et al, 2001a). These factors greatly slow down the diffusion of high 
molecular weight macromolecules and in turn this also increases the chances o f the 
DNA degradation by cytoplasmic nucleases (Lechardeur et al, 1999). This itself can 
cause a dramatic decrease in DNA half-life.
For successful gene therapy the DNA must also enter the nucleus via a nuclear 
pore or during cell division. Thus it is important that the system is stable until the next 
cycle of the cell division (reviewed in Merdan et al, 2001a). Nuclear pore complexes 
(NPC) (reviewed in Pouten, 1998), present in the nuclear membrane allow small 
molecules to passively diffuse through them. However, macromolecules require a motif
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that can be recognised by the receptors found in the nuclear membrane. Only in this 
case will the pore allow their translocation o f the cargo into the nucleus (reviewed in 
Merdan et al, 2001a).
The complexity of the barriers to transfection have led many to focus on 
cytosolic delivery of protein toxins e.g. PAA delivery of ricin and gelonin (Pattrick et 
al, 2 0 0 1 a).
Endosomal escape into cytoplasm remains the main factor limiting transfection 
efficiency of non-viral vectors, and the ability of the endosomolytic polymers to deliver 
proteins. Endosomotropic delivery can be defined as delivery via the endosomal 
compartment and this concept is described in more detail here.
1.3.2 Endosomtropic Delivery
Efficient cytosolic access of macromolecules such as genes and proteins (e.g. 
toxins) is crucial for many therapeutic strategies (reviewed in Plank et al, 1998). There 
is therefore a need for efficient delivery vectors to mediate rapid and efficient 
endosomal membrane translocation, before progress into lysosome (Murthy et al, 1999). 
Endosomolytic delivery systems are usually designed to use the decrease in endosomal 
pH to trigger the release o f the therapeutic agents. The process begins with the 
endocytic uptake o f the polymer/ therapeutic conjugate/complex. In the early endosome, 
hydrogen ions will be pumped into the endosome by a proton pump decreasing the pH 
(Richardson et al, 1999). This will cause the polymer to protonate, and a change in 
conformation results. Ideally, an endosomolytic polymer will display a charge that 
changes significantly as the pH decreases from pH 7.4 (extracellular) to pH 6.5 
(endosomal). The polymer should be able to diffuse to, and rapidly interact with the 
endosomal membrane. There should be enough time to allow the escape o f the 
molecular therapeutic agent, before it reaches the lysosome (Figure 1.5). It is 
hypothesised that the polymer binds to the endosomal membrane, causing its disruption 
(loss of membrane function) (Richardson et al, 1999).
The mechanism by which the endosomolytical polymer causes endosomal 
breakage is very important for the activity of the polymer, and this will be discussed in 
the next section.
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In te rn a lis a t io n  o f a 
p o ly m e r - p r o te in  o r  
polyplex by endocytosis
Early endosome 
pH 5.9 -  6.0
P re fe ra b ly  m in im al 
t r a f f i c k i n g  t o  
lysosom es to avoid 
p ro te in  an d  DNA 
degradationLate endosome 
pH 5 .0 -6 .0
As the pH falls, the endosomolytical 
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m ight occur, the  p ro to n  sponge 
h y p o th esis , p o re  fo rm a tio n  and  
mem brane bending model
Figure 1.5 The overall scheme of endosomotropic delivery (adapted from Duncan, 2003a). For 
successful delivery it is crucial th a t the therapeutic  agent escapes from  the endosomal 
com partm ent thus it avoids the degradation by the lysosomal enzymes
Chapterl Introduction
1.3.3 Mechanisms of endosomal membrane breakage
An accurate understanding of the mechanisms by which non-viral vectors cause 
endosomal membrane breakage is crucial to help the development o f more efficient 
genes and proteins delivery systems. A number of mechanisms have been proposed to 
explain the ability of polymers to permeabilise endosomal membrane. These include:
Proton sponge hypothesis
It has been suggested that cationic polymers such as PEI produce a proton sponge effect 
that is responsible for the permeabilisation of endosomal membrane. As the pH falls, 
PEI in the early endosome becomes more protonated. In turn this causes a depletion in 
H+ that drives an increase influx of H+ followed by Cl" and water, leading to an increase 
osmotic pressure inside the endosome. And this causes a membrane destruction (Figure 
1.6). For the proton sponge mechanism to operate, it is important that the polymer 
possesses functional groups that will protonate between pH 7.4 and 5 (reviewed in 
Merdan et al, 2002a). In this case membrane breakage will be independent of membrane 
composition.
The proton sponge hypothesis was first proposed by Behr (1997) and is based on 
the perceived mechanism of action of chloroquine which is known to enhance the 
transfection activity of polylelectrolytes such as poly(L-lysine) (PLL) (reviewed in 
Pouton and Seymour, 1998). Chloroquine is a weak base. It is neutral at pH 7.4 and 
becomes positively charged at pH 5.5. Thus in the acidic environment o f the 
intracellular vesicle it is present (and trapped) in the protonated form. Chloroquine 
increases the residence time o f a polyplex in the endosome by preventing or slowing 
down the acidification process. Which leads to a decrease in vesicle-vesicle fusion. 
Consequently this increases transfection efficiency.
A growing number of studies support this theory. It has been demonstrated that 
the transfection activity o f PEI (Kichler et al, 2001) and imidazole-containing polymers 
(Benns et al, 2001) can be dramatically decreased by the inclusion of bafilomycin A l, 
which is a specific inhibitor of vacuolar-type H(+)-ATPase (Yoshimori et al, 1991), that 
prevents the acidification of endosome and lysosome. Merdan et al (2002b) used 
confocal laser scanning microscopy of live cells to show that the release of PEI polyplex 
occurs as a sudden event. They suggested that this could be due to the bursting of the 
vesicles (reviewed in Merdan et al, 2002a; 2002b). Similar results have been obtained
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The polym er protonates, and the chloride ion 
and w ater molecules diffuse in to the endosome
Hydrogen ions are pum ped 
in to the endosome
The osmotic pressure 
increases inside the endosome
The endosomal membrane is disrupted due to 
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Figure 1.6 The proton sponge hypothesis. Here the protonation of polym er causes 
influx of chloride ions and w ater, this causes the endosome to swell resulting in the 
increase of osmotic pressure and the breakage of the endosomal m em brane, thus 
allowing the therapeutic agent to escape to the cytosol (adapted from Cho et al, 2003)
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by Sonawane et al, (2003) using hamster cells incubated with buffering polymers 
(polyamines) who found that the polymer caused an increased chloride ion 
concentration leading to an increase in the volume of the endosome (Sonawane et al,
2003).
Many debate the validity of the proton sponge hypothesis. Studies have 
demonstrated that another weak base, ammonium sulphate, with similar buffering 
capacity to chloroquine at endosomal pH, does not improve transfection (reviewed in 
Pouton and Seymour, 2001). Studies conducted by Godbey et al (2001) showed that the 
lysosomal pH 5 was not altered in cells that were transfected with PEI/DNA polyplex. 
More recently Funhoff et al (2004) have demonstrated that with the newly synthesised 
polymer [poly(2 -methyl-acrylic acid 2 -[(2 -(dimethylamino)-ethyl)-methyl-amino]-ethyl 
ester (pDAMA), which has two tertiary amine groups (pKa 5 and 9) was not able to 
promote transfection. However, the addition of peptide (INF-7, a fusogenic peptide 
derived from the influenza virus (Funhoff et al, 2004)) caused an increase in the 
transfection efficiency. These findings strongly suggest that the proton sponge effect is 
not a universal mechanism, although it may be able to explain endosomal destabilisation 
caused by polymers with pKa values between 7 and 5.
Pore formation
It has also been suggested that endosomolytic polymers might permeabilise the 
endosomal membrane by forming pores in the membrane. However, the polymer must 
be an amphiphilic in nature, i.e. must carry both hydrophilic and hydrophobic groups. 
The hydrophilic (charged) part is attracted to, and interacts with the headgroups of the 
phospholipids. Thus it will be located outside the membrane. The hydrophobic section 
is then inserted in the alkyl part of the lipid bilayer forming the pore (Figure 1.7). 
Natural macromolecules known to cause pore formation include membrane-active 
peptides toxins (melittin) (Benachir and Lafleur 1995), viral fusogenic peptides (Epand 
et al, 1992) and bacterial toxins (Gazit et al, 1995; Wagner, 1999). Such agents have 
been explored as a way to develop new synthetic membrane active-polymer conjugates 
or they have been added (none covalently) to existing non-viral vectors to enhance their 
membrane disruption activity.
The N-terminal domain of hemagglutinin (reviewed in Cheung et al, 2001) from 
influenza virus has also been used to prepare the fusogenic peptide, INF (Wagner, 1999) 
and GALA-based peptides (Plank et al, 1994). These peptides contain aspartic acid and
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Figure 1.7 Pore form ation mechanism. The polymer or peptide protonates and change in 
conformation, they become more hydrophobic, and due to this region, a channel is formed 
through the bilayer.
Hydrophilic region
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glutamic acid. At neutral pH they are negatively charged, and upon acidification a 
change in peptide conformation occurs, which promotes membrane interaction and then 
pore formation. Bacterial toxins such as Listeriolysin O toxin also form membrane 
pores following activation in the acidic endosomal environment. This is the mechanism 
that allows the escape of bacterium Listeria monocytogenes.
Membrane disruption by bending
Another mechanism that has been proposed to explain membrane disruption is the 
concept o f “membrane bending” (Figure 1.8). It has been proposed that 
poly(amidoamine) (PAMAM) dendrimers destabilise anionic liposomes by this 
mechanism (Zhang and Smith, 2000). The rigid spherical poly cationic dendrimers bind 
to the membrane by electrostatic interaction causing the membrane to bend, this induces 
stress in the bilayer packing and disruption of the membrane results (Zhang and Smith, 
2000).
In the following section the different macromolecules that are used as non-viral vectors 
will be discussed.
1.4 Non-viral vectors for intracytoplasmic delivery
The use of non-viral vectors (such as cationic lipids, liposomes and polymers) 
for gene delivery have been developed by many groups, but the pioneers were Feigner, 
Behr and Huang (reviewed in Kabanov, 1999). Cationic lipids, liposomes and polymers 
form complexes with DNA by electrostatic interaction between the positive charges on 
the non-viral vectors and the negative charges on the DNA to form lipoplexes (lipids- 
DNA complex) or polyplexes (polymer-DNA complex). The major advantage o f using 
polyplexes and lipoplexes systems as an alternative to viral vectors is they are a lot safer 
(Loup et al, 1999). However, there is one major disadvantage. Non-viral vectors have 
transfection efficiencies that are much lower compared to viral vectors. Thus it is very 
important to investigate further the mechanisms that will help to design and develop 
vectors that are safe, can be used in patients and that will routinely give efficient gene 
and protein delivery.
1.4.1 Cationic lipids/liposomes
Cationic lipids were first introduced as gene carriers in 1987 (Feigner et al,
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Figure 1.8 The membrane bending mechanism. It has been reported that dendrimer 
PAMAM can cause membrane breakage by this mechanism. The rigid structure of 
the dendrimer causes stress and bending of the lipids bilayer resulting in their 
destruction
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1987). Gene transfer using cationic lipid-pDNA complexes (lipoplexes) has also been 
tested in clinical trials (reviewed in W olf and Wolf, 2003). Cationic liposomes are 
usually small unilamaller vesicles that are composed of cationic and other helper lipids 
(Fang et al, 2003). Intially most were composed of a single lipid, (e.g. l,2-dioleoyl-3- 
trim ethylam m onium -propane (DOTAP), using l,2 -d io leo y l-s« -g ly ce ro l-3 - 
phosphoethanolamine (DOPE), as a helper lipid (reviewed in Ciani et al, 2004). DOPE 
was chosen because of its ability to reduce the cytotoxicity of cationic liposomes and it 
has been shown that in the presence o f DOPE, DNA translocation and transfection 
efficiency are improved (Ciani et al, 2004; Zhdanov et al, 2002).
The second important example of non-viral vectors is polymers and this will be 
described in the next section.
1.4.2 Polymers as non-viral vectors for cytosolic delivery
The polymers here can be divided into two main groups that are separated 
according to their nature e.g. cationic and anionic polymers, there are also amphoteric 
polymers but this is very small group and will not be discussed here (Table 1.1 and 
Figure 1.9).
The anionic polymers are the smaller group of the two, and will be discussed 
first in the next section
1.4.2.1 Anionic polymers
Stayton and Hoffman have systematically developed a series of synthetic, pH- 
sensitive homo- and co-polymers of anionic carboxylated groups such as acrylic and 
methacrylic acid groups. They can interact with and disrupt biological membranes in a 
pH-dependent manner, and the interaction is governed by hydrophobic forces. It has 
been shown that changing pH, causes a change in the polymer conformation from a 
hydrophilic coil at neutral pH 7.4 to a hydrophobic globule at acidic pH 5.5 (Yessine et 
al, 2003). Such polymers display a pH-dependant red blood cell (RBC) lysis with 
increasing haemolysis at < pH 6.5 (Murthy et al, 1999; Yessine et al, 2003). It appeared 
that the haemolytic activity of these polymers increased with an increase in hydrophobic 
nature. Polymers with a high degree of hydrophobicity also showed a high degree of 
toxicity (Yessine et al, 2003).
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Table 1.1 List of endosomolytic polymers, their pK a, type of structure, m olecular weight and cu rren t status.
Mw pKa Structure Status Reference
Cationic polymers
Dash et al, 1999
Poly-L-lysine (PLL) 4 kDa - 224 kDa 9 to 10 Branched in vivo Reviewed in Smedt et al, 2000 
Kawano et al, 2004
Poly(ethyleneimine) (PEI) 22 kDa - 220 kDa 8.18 to 9.94 Linear
in vivo/
Boussif et al, 1995 
Fischer et al, 1999 
Harpe et al, 2000
0.6 kDa - 800 kDa pKa o f primary amine is 5.5 Branched
clinical Reviewed in Brown et al, 2001 
Brownlie et al, 2004 
Ohana et al, 2004
Poly(amidoamine) 
(PAMAM) dendrimer 1.4 k D a- 853 kDa 3.9 and 6.9 Hyperbranched in vivo
Malik et al, 2000 
Reviewed in Smedt et al, 2000
Cationic PAAs, ISA1 and 
ISA4 5 kDa - 13 kDa 2.1 to 9 Linear in vivo
Ferruti et al, 2002 
Wan et al, 2004
Poly[2(dimethylamino)-
ethylmethacrylate)] 22 kDa - 300 kDa 7.5 Branched in vivo
Wetering et al, 1999 and 2000
P(DMAEDMA)
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Chitosan 108 kDa - 540 kDa 6.5 Linear in vivo/ clinical
Smedt et al, 2000 
Kean et al, 2005
Diethylaminoethyl-dextran 
(DEAE dextran) 500 Da Linear in vivo
Takai and Ohmori, 1990 
Gregory et al, 2003
Poly-2-[N-(2- 
hydroxyethyl)- 
D,L-aspartamide] (PHEA)
48.3 kDa - 56.9 kDa Branched in vivo /clinical
Pitarresi et al, 2003 
Martins et al, 2003
Amphoteric polymers
PAA, ISA22 and ISA23 11 kDa - 48 kDa 2.1 to 7.5 Linear in vivo Ferruti et al, 2000 Wan et al, 2004
Polyanions
N-isopropylacrylamide 
(NIP AM) 7 to lOkDa Branched
Miura et al, 1993 
Meyer et al, 2001
Poly(ethyl acrylic acid) 
(PEAAc)
Poly(propyl acrylic acid) 
(PPAAc)
22-24 kDa Branched M urthy et al, 1999 Chapterl 
Introduction
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Figure 1.9 Structures of widely studied endosomolytic polym ers..
- 2 4 -
Chapterl Introduction
1.4.2.2 Cationic polymers
A diverse range of polymer structures have been used for gene or protein 
delivery, for example linear, branched, and hyperbranched polymers, dendritic 
architectures, and random- and block copolymers.
All posses different chemical, physical and biological properties, as they contain amine 
groups, which are primary, secondary, tertiary or quaternary amines. These amines can 
be part of an aliphatic chain, or as cyclic or aromatic systems. Therefore the pKa values 
vary widely. The amine groups are not only required for the interaction with DNA, but 
they are crucial for the polymer’s ability to cause endosomal membrane disruption. In 
addition, amine functionality can be used as a site for conjugation with other polymers, 
lipids, drug, targeting moieties and proteins such as toxins.
PLL
PLL (linear polypeptide) was the first polycation used to promote gene transfer. 
Although it has been reported that Wu and Wu (1987) were the first to use PLL in gene 
delivery, this is not true, since in 1974 Schell investigated the effect of PLL on the 
cellular uptake of polynucleotides (reviewed in Chirila et al, 2002). Many studies have 
since used PLL as a vector for gene delivery. It is clear that PLL molecular weight plays 
an important role in the DNA complex formation, their ability to transfect cells and the 
cellular toxicity (Wolfert and Seymour, 1996). Unmodified PLL is poorly efficient, but 
the addition of the lysosomotropic agent chloroquine dramatically improved the 
transfection efficiency. Other methods have been employed to improve the activity of 
PLL. These include the conjugation with poly-L-histidine, and the substitution of some 
of the L-lysine monomers with tryptophan or cysteine (McKenzie et al, 2000). The 
resultant copolymers showed better transfection efficiency compared to PLL.
PLL has a number of advantages. It is widely available, and the side-substituents 
are suitable for attachment of other molecules. It can protect an oligonucleotide or DNA 
from enzymatic attack and it possesses a high solubilising power (Ferruti et al, 1998). 
However, PLL does have two major drawbacks. It is highly toxic, and the fact that PLL- 
derived polyplexes usually interact with plasma proteins after i.v. injection leads to liver 
and lung uptake. In order to reduce its toxicity, PLL has been chemically modified by 
the addition of N,N-dimethylacrylamide to the primary amine groups (Ferruti et al, 
1998). This kind o f modification reduces toxicity, but also leads to a reduction in 
transfection efficiency too.
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PEI
PEI has been the most widely investigated as a non-viral vector. It was first 
developed by Jean-Paul Behr and colleagues and has been used to promote gene 
delivery in cell culture and in vivo (Boussif et al, 1995). PEI is made up of ethylamine 
repeating units, and it possesses a very high positive charge density when fully 
protonated in aqueous solution (Ham, 1980). This property is required for polyplex 
formation which depends on the ratio of PEI nitrogen to the phosphate of DNA. PEI are 
very effective at protecting DNA from the degradation by nucleases (Campeau et al, 
2001). Branched and linear PEIs of different molecular weight have been synthesised 
and their transfection activity evaluated in vitro and in vivo. As mentioned earlier, it was 
suggested that PEIs exert their endosomolytic activity by proton-sponge mechanism 
(see section 1.3.3) (Behr, 1997).
To minimise interaction of the PEI-polyplex with plasma proteins, the complex 
was coated with a hydrophilic polymer (e.g. hydroxypropyl methacrylic acid) (reviewed 
in Brown et al, 2001). While this prolonged the plasma circulation it also led to a 
decrease in transfection efficiency (reviewed in Oupicky et al, 2002a).
Other polycations
In the search for better polycations Hennink and collagues have developed a 
series of methacrylate/methacrylamide homo- and copolymers (Wetering et al, 1999). 
Poly[2-(dimethylamino)ethyl methacrylate)], p(DMAEDMA) contains a tertiary amine 
and an ester group. The amine can be ionised with a pKa value of 7.5. Wetering et al 
(2000) showed that the transfection efficacy of p(DMAEMA) is higher than that of 
PLL-polyplex, with a similar transfection efficacy to Lipofectin-plasmid complexes 
(Wetering et al, 2000). Although it was openly proposed that these polymers exert their 
membrane activity by proton-sponge mechanism (Pang et al, 2002), recent work by 
Jones et al (2004) has bought this theory into question. It was found that p(DMAEMA) 
was able to change the morphology o f the late endosomes and lysosomes, but the 
polymer did not physically break them. Thus another mechanism must be responsible 
for their ability to transfect cells and their high cytotoxicity.
Cationic polysaccharides have also been investigated. Chitosan and 
diethylaminoethyl-dextran (DEAE-dextran) have been widely used. Chitosan possesses 
primary amine groups, which can be used to form complexes with DNA. Studies using
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different molecular weights of chitosan showed that low molecular weight chitosan 
forms excellent polyplexes that protects DNA against nuclease degradation (Richardson 
et al, 1999), but chitosan show a molecular weight and counter ion dependent toxicity 
(Gomez and Duncan, 1997). A number o f studies have shown that chitosan can form a 
complex nanoparticle with recombinant DNA plasmids, that provide an effective mean 
for delivering genes into cells (Leong et al, 1998). Numerous studies conducted by Sato 
et al (2001), have demonstrated the effect of molecular weight, pH and serum 
concentration on the transfection efficiencies of chitosan.
DEAE-dextran was shown to transfect mammalian cells in very early studies 
(Vaheri and Pagano, 1965), and experiments with this vector continued (Mack et al,
1998). However, the transfection efficiency of DEAE-dextran is still low. The polymer 
is non-biodegradable, and it displayed high toxicity so interest in these polymers for 
drug delivery is decreasing.
The polycations described so far are either linear or branched. Cationic 
dendrimers are another important group o f polymers being explored for gene delivery. 
Dendrimers are hyperbranched structures that contain many terminal functional groups. 
There are several advantages of dendrimers compared to linear polymer. For example, 
low polydispersity, which allows predictable chemical, physical, and biological 
behaviour. PAMAM dendrimers have been most extensively studied, and are 
commercially available under the trade name 'Starburst Dendrimers' (reviewed in 
Aulenta et al, 2003). PAMAM dendrimers are capable of disrupting endosomal 
membrane and are able to promote gene transfer and this depends on its generation 
number. There are other dendrimers with different chemical composition that have been 
investigated as drug vehicles, e.g. PLL dendrimers (Niidome et al, 2000), phosphorous 
containing dendrimers (Loup et al, 1999) and low generation polypropyleneimine 
dendrimers (Zinselmeyer et al, 2002).
As this project has focused on amphoteric PAA polymers they are described in 
more detail in the next section.
1.5 PAAs
1.5.1 Historical background and the evolution of PAAs
PAAs are a unique family of synthetic, water-soluble, linear polymers that are 
synthesised by hydrogen-transfer poly addition o f aliphatic amines or 6 /5-secondary 
amines to Zu'sacrylamides (Ferutti et al, 2000). They are characterised by the presence of
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amido and tertiary amino groups that are arranged in a regular manner along the main 
backbone (reviewed in Ferruti et al, 2002), that act as a weak base in solution. A vast 
number of PAAs have been synthesised, each one has a unique chemical structure and 
properties (Table 1.2, Figure 1.10).
PAAs were first synthesised by (Ferruti et al, 1967) in the late 1960’s and early 
1970’s. Initially they were developed as new heparin complexing agents (Marchisio, 
1973). During the 1970’s, PAAs were developed further as non-thrombogenic polymers 
for material coating. New linear PAAs, graft and block polymers were prepared and 
their chemical, structural and mechanical properties were investigated. Also during this 
decade PAAs were investigated for a possible inherent antitumour activity (Ferruti et al, 
1973).
In the 1980’s, the development o f PAAs as heparin-complexing agents 
continued. Graft polymers composed o f poly (vinyl chloride) (PVC) and PAA chains 
(Ferruti et al, 1982a), and PAA-surface-grafted glass microspheres (Ferruti et al, 1983) 
were prepared. Their heparin absorbing capacity was investigated. Several studies also 
found that soluble PAAs and cross-linked resins of PAAs were able to form complexes 
with heavy-metal ions such as Co2+, Cu2+ and Ni2+ (Barbucci et al, 1981b). Those PAAs 
able to form such complexes must have aliphatic amines with no more than three 
methylene groups separating the two aminic groups (reviewed in Ferruti et al, 2002). 
Such PAAs were proposed for use in water purification (Barbucci et al, 1981b; Ferruti 
et al, 1982b). Finally in the 1980’s new PAAs were synthesised and evaluated as an 
antimicrobial agents (Ranucci et al, 1989).
1.5.2 Development of PAAs for drug delivery applications
Studies on the development of PAAs as drug carriers began in the early 1980’s 
(Ferruti et al, 1982c). First, experiments examined the cytotoxicity and degradation and 
cellular toxicity o f PAAs derived from N ,N ’-6/s(2-hydroxyethyl)ethylenediamine 
(MBI) (Figure 1.10) (Duncan et al, 1994). These PAAs were less toxic than other 
cationic polymers such as PLL (Ranucci et al, 1991). This research initiated a new 
potential application of PAAs in the field of polymer therapeutics. To explore the 
possibility of ‘hiding’ a molecule inside the pH-responsive MBI, this PAA (MBI) was 
later conjugated with triton X-100 (TX-100). The RBC lysis model was used to 
investigate the pH-dependent haemolytical activity of MBI and its TX-100 conjugate.
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Table 1.2 Summary of the different applications of PAAs.
Biomedical application References
De-heparinizer filter Marchisio et al, 1973
Cross-linked PAA resin as de-heparinizer Ferruti et al, 1983 
Barbucci et al, 1983
Heparinizable materials Tanzi et al, 1985 
Barbucci et al, 1985 
Barbucci et al, 1987 
Barbucci et al, 1990
Anticancer agents with inherent activity Ferruti et al, 1973
Antibacterial agents with inherent activity Ranucci et al, 1989
Drug carriers Ferruti et al, 1994 
Ferruti et al, 1999
As endosomolytic polymers and non-viral vectors Duncan et al, 1994
for gene and protein delivery Richardson et al, 1999; 
2 0 0 1
Ferruti et al, 2000 
Pattrick et al, 2001 
Wan et al, 2004 
Lavignac et al, 2004
Non-biomedical application
Complexing with heavy metal Barbucci et al, 1981
ions (for water treatment) Ferruti et al, 1982b
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Whereas free TX-100 displayed considerable haemolysis at all pHs (5.5, 7.4 and 8 ), 
MBI did not cause any RBC lysis at any concentration or pH examined. The PAA-TX- 
100 conjugate only caused concentration-dependent haemolysis at pH 5.5 (Duncan et al, 
1994). Although MBI-TX-100 was less toxic than TX-100, it was more toxic than MBI 
against human leukaemic cells (Duncan et al, 1994). These results were very interesting, 
as they demonstrated for the first time the potential to use PAAs as bioresponsive 
polymers that would change conformation and potentially deliver drugs within acidic 
intracellular compartments such as the endosome and lysosome (Duncan et al, 1994).
In 1999, a number of PAAs-cisplatin were prepared (Ferruti et al, 1999). The 
chemical properties, and preliminary antitumour behaviour, both in vitro and in vivo, of 
the PAA-platinates were investigated (Ferruti et al, 1999). It was found that the PAA- 
platinates were less toxic than cisplatin toward lung tumour cell lines (Ferruti et al,
1999).
The search for improved endosomolytic polymers led to the birth of a very 
important series of PAAs, ISA1, ISA4, ISA22 and ISA23 (Figure 1.11). These polymers 
were optimised to display low cellular toxicity and pH-dependant membrane activity. 
Since, further investigation has mainly conducted on these PAAs and their derivatives 
(copolymers and block copolymers), Richardson et al (1999) synthesised ISA1 and 
ISA23, and their analogues, ISA4 and ISA22, these were prepared for radiolabelling 
with 125iodine (125I). It was demonstrated by Richardson et al, (1999) that the toxicity of 
ISA1 and ISA23 was low, with IC50 values of >2 mg/ml (72h incubation). They were 
lower less toxic than PLL. 125I-labelled ISA4, was taken by the liver following i.v. 
injection, where as ISA22 was not captured and was successfully taken by the tumour 
tissue.
PAAs used for gene and toxin deliveries
For parenteral administration it is crucial that the polymer picked must be 
biocompatible (Williams, 1987), i.e. non-toxin and non-immunogenic. It was shown by 
Richardson et al (1999) that all PAAs (ISA1, ISA4, ISA22 and ISA23) displayed little 
cytotoxicity against B16F10 and Mewo cell lines. Both ISA22 and ISA23 caused 
greater haemolysis at pH 5.5 and were more effective as transfection agents compared 
to ISA1 and ISA4 (Richardson et al, 1999; 2001). However ISA1 and ISA4 were able to 
deliver non-permeant ribosome-inactivating toxins, such as ricin A chain (RAC) and
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gelonin (both can potentially be used as anticancer drugs). In contrast ISA22 and ISA23 
were not successful (Pattrick et al, 2001a). It is unclear to why this occurs. These 
experiments were carried in B 16F10 cells and the PAA and protein were added to the 
cells as a noncovalent mixture. It was mentioned that the results might be explained by 
the difference in the polymers trafficking inside the cell (Pattrick et al, 2001a).
Effect o f counterion on the properties o f PAAs
While investigating mild reaction conditions suitable for PAA-protein conjugation (to 
deliver protein, like toxin, that can be used as anti-tumour agents), different PAA salt 
forms were used. In all the earlier experiments, PAAs were in the hydrochloride salt 
form were used. Therefore, Wan et al (2004) systematically studied the effect of ISA23 
counterion (acetate, citrate, hydrochloride, lactate, phosphate and sulphate) on the pH- 
dependent haemolysis and cytotoxicity. They demonstrated that the counter ion plays a 
very important role. Whereas ISA1, ISA4, ISA22 and ISA23 chloride, phosphate and 
sulphate salt forms (the strong acids) caused significant haemolysis at pH 5.5, citrate 
and lactate salt forms (weak acids), were non-haemolytic at pH 5.5.
1.5.3 Physico-chemical properties of PAAs
Over the years there has been relatively little investigation of the physico­
chemical properties of PAAs. All PAA polymers may be classified as polyelectrolytes 
due to the presence of tert-amino group in the main chain backbone. The combination 
of high molecular weight and charge density leads to unique physicochemical properties 
that set PAAs apart from uncharged polymers and simple electrolytes (Breuer and 
Jenkins, 1972).
Techniques such as 13CNMR, potentiometric and calorimetric have been used to 
obtain the protonation constants for several PAAs (Barbucci et al, 1980). PAAs have 
both sharp thermodynamic and basicity constants. Generally, for polyelectrolytes, the 
protonation constants depend on the degree of protonation of the whole o f the 
macromolecule, and an "apparent" constant is determined. However, for some cationic 
PAA (for chemical structures of these polymers see Ferruti et al, 2002), a "real" basicity 
constant can be determined (Ferruti et al, 1981). For these PAAs, the protonation of the 
amine groups is independent of the protonation of the whole polymer, i.e. groups are 
said to behave as if belonging to a small molecule (Ferruti, 1980; reviewed in Ferruti et 
al, 2002). This unusual behaviour of PAAs, can be explained by the relatively long
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distance between the amino groups of the different repeating units, coupled with the 
high charge-sheltering effect o f the amido groups (Ferruti et al, 2000; reviewed in 
Ferruti et al, 2002). For amphoteric PAAs such as ISA23, polymer carries both carboxyl 
and amino groups on each monomer. In this case, the PAA exhibits a typical 
polyelectrolyte behaviour, although it is less pronounced when the amino and the 
carboxyl groups are attached to different monomers (Ferruti et al, 2000; reviewed in 
Ferruti et al, 2002).
1 3Potentiometric titration (Emf measurements), CNMR, viscosity measurements 
and conformational analysis have been used to examine the structure of PAAs (Barbucci 
et al, 1980; 1981a; Ferruti et al, 2000). These studies demonstrated that the PAA 
stiffness and the flexibility depend on both polymer protonation, and the aliphatic chain 
length between the aminic nitrogens of each monomer unit (Barrucci et al, 1981). The 
rigidity of PAAs increases with the increasing degree of protonation, and the length of 
aliphatic chain in the monomer. Protonation of the first amino group nitrogen causes a 
decrease in the conformational freedom due to the formation of strong hydrogen 
bonding between "onium" ion and the carbonyl group belonging to the same monomeric 
unit (Barrucci et al, 1981). Protonation of the second amino group nitrogen causes a 
further increase in rigidity due to the repulsion between the positively charged onium 
ions. As the aliphatic chain between the two aminic nitrogen increases in length 
repulsion will decrease, thus causing a decrease in rigidity (Barrucci et al, 1981).
Ferruti et al, (2000) used SEC and light scattering techniques to investigate the 
solution properties o f PAAs. They found that PAAs (e.g. ISA23) can form small 
aggregates in solution (Ferruti et al, 2000).
1.5.4 Mechanism of PAA endosomolytic activity
The mechanisms by which PAAs causes endosomal membrane breakage are still 
unknown. Both cationic and amphoteric PAAs (i.e. ISA1 and ISA23) have shown 
endosomolytic behaviour, but to improve the efficiency of PAA-mediated gene/toxin 
delivery it is essential to better understand their mechanism of action (Pattrick et al, 
2001a; Richardson et al, 2001). It is possible that ISA1 and ISA23 have different 
mechanisms, but they might act in the same way.
PAAs might theoretically cause membrane breakage by one (or a combination
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of) the following mechanisms (as described in section 1.3.3) :-
(i) Proton-sponge effect. The decrease in pH in the endosome will cause PAA 
protonation. If the proton sponge hypothesis applies, influx of hydrogen ions 
into the endosome would be accompanied by the influx of chloride ions and 
water. As discussed earlier this would cause osomotic effects leading to the 
permeabilisation of the endosomal membrane.
(ii) By causing pore formation in the membrane. PAAs could theoretically form 
membrane pores. If  polymer binds to the membrane by electrostatic 
interaction, and then the less hydrophilic part (more hydrophobic region) 
inserts it could form a ‘channel’ through the lipid bilayer.
(iii) By causing membrane stress or bending. The more simple membrane 
bending model would apply if  the protontation of PAAs promotes membrane 
interaction, this in turn would cause membrane stress and this would lead to 
membrane breakage.
All three mechanisms seem plausible. However, two of these mechanisms have 
arguments against them. If the proton-sponge hypothesis is the right mechanism then 
theoretically the polymer molecular weight should not affect PAAs activity, but this is 
not true. In addition the proton sponge hypothesis does not explain why the different 
salt forms of the same PAAs (with quite similar molecular weight) showed different 
membrane activity.
All the PAAs are not naturally amphiphilic, and this is not affected by decrease 
in pH that occurs in the endosome. Thus it is unlikely that PAAs would be able to 
penetrate pores through the lipid bilayer. It appears likely that the mechanism of PAA- 
induced membrane permeabilisation is by direct interaction with the membrane, but this 
still remains unproven.
1.6 Aims of the studies in this thesis
First it was necessary to synthesise and characterise the PAAs, ISA1 and ISA23 
to be used in these studies (Chapter 3). The effect of the reaction conditions on the 
molecular weight distribution o f ISA1 and ISA23 was investigated. PAAs were 
characterised using common methods used for synthetic polymers such as gel 
permeation chromatography (GPC), titration and NMR. To ensure that the biological 
behaviours of these polymers was consistent with previous observations (Richardson et
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al, 1999; Pattrick et al, 2001a) the pH-dependence of RBC lysis was studied, and also 
the stability was examined in physiological solution using GPC (Chapter 3).
Having verified the biological properties of the new batch o f ISA23 prepared 
here, this sample was used to study the physico-chemical behaviour o f the polymer. 
First, SANS was used to examine the solution properties of ISA23.HC1 at the pHs it 
would encounter in the endosomal/lysosomal systems (pH 7.4-5.5) (Chapter 4). First it 
was necessary to find an appropriate mathematical model that would fit the neutron 
scattering data obtained. Rod, sphere, polyelectrolytes and Gaussian coil models were 
explored. Having established the Gaussian coil model as the best fit, the effect of pH, 
polymer concentration, temperature and polymer molecular weight on the Rg of the 
polymer coil could be determined (Chapter 4).
The next step was to investigate ISA23.HCl-model membrane interaction 
(Chapter 5). Micelles were used as simple models to study interaction as a function of 
pH and also micelle composition. Initially, changes in surface tension were measured to 
study the onset of interaction. Then EPR was used to examine the effect of ISA23.HC1 
on the micelle fluidity. In addition, the effect of ISA23.HC1 on the conformation of the 
micelle was also studied using SANS.
Finally, liposomal models were prepared using phospholipid compositions 
chosen to mimic the plasma, endosomal and lysosomal membranes. Their stability at 
various pHs was assessed using photon correlation spectroscopy. This was considered a 
more realistic and more complex model to study ISA23 interaction (Chapter 6 ). SANS 
was again used to study ISA23.HCl-liposomal interaction at different pHs. In this case, 
Schultz polydisperse 3 shell sphere model was used to fit the scattering data obtained 
from the protonated- and the deuterated-liposomes (alone). However, it was not possible 
to fit the SANS data of the liposomes in the presence of ISA23.HC1, a more complex 
model will be required to fit the data of this system.
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2.1 Apparatus
2.1.1 Analytical Instruments
The GPC system used to determine the PAA molecular weight consisted of two 
ultrahydrogel columns (250 and 1000) (Waters Corporation, USA) in a series which 
provide a polymer molecular weight separation up to ~ 70,000 g/mol. A Jesco PU-980 
high performance liquid chromatography (HPLC) (Jasco UK Ltd, UK) pump, and a UV 
detector 486 (Waters Corporation, USA) together with a model 133 refractive index 
(RI) detector (Gilson, UK) were used. Polymer Laboratories (Shropshire, UK) Caliber 
GPC/SEC software version 7.04 was used to interpret all the GPC data. Fluorescence 
was detected with an Aminco-Bowman Series 2 luminescence spectrophotometer 
(Spectronic Instruments, USA) and Fluostar Optima fluorescence plate reader (BMG 
Labtechnologies, Germany). The size distribution of liposomes was measured using 
photon correlation spectroscopy (PCS), a N4 Plus submicron particle sizer (Beckman 
Coulter Ltd, UK). The ^ -N M R  of ISA1 and ISA23 was carried out on Bruker 400 
MHz spectrometer.
The surface tension of surfactants was measured using the tensiometer SITA- 
online t60 (SITA, Messtechnik GmbH, Germany) with a bubble timelife of 10 s. EPR 
spectra were measured using cw-Bruker EMX spectrometer (Bruker BioSpin, UK), 
operating at 100 kHz field modulation in a Bruker ER4102ST standard cavity (sweep 
width was 60G).
The SANS m easurements were perform ed using the D l l  and D22 
diffractometers at the Institute Laue-Langevin (ILL), Grenoble (France), or the LOQ 
diffractometer at the ISIS Spallation Neutron Source, Oxfordshire (UK). The neutron 
scattering data were analysed and fitted using Sigmaplot 2002 and FISH2.
2.1.2 PAA purification and freeze drying
PAAs were purified using a stirred ultrafiltration cell, model 8200 (Amicon, 
Bioseparation, Millipore) UK, used ultrafiltration membranes (10,000 and 50,000 g/mol 
Mw cut-off). The polymer left on the membrane was collected. The apparatus and the 
membranes used were purchased from Fisher Scientific UK Ltd (UK). The purified 
polymer was dried using Flexi-dry lyophiliser from FTS systems, USA.
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2.1.3 General equipment
The mixing and vortexing was carried using WhilrliMixer TM from Fisher 
Scientific UK Ltd. (UK), and a Sartorius BP221S analytical balance (from Fisher 
Scientific UK Ltd., UK) was used for general weighing. Filtration of the mobile phase 
was carried out using nylon membrane filters (0.2 p.m pore size, 47 mm in diameter, 
Whatman International Ltd, England). The polymer samples were filtered through 0.2 
pm Sartorius single use filter units (Minisart, Germany). A sonicator from Decon 
Laboratories Ltd (UK) was used to sonicate the samples and GPC mobile phase.
Centrifugation was carried out with a Varifuge 3.0 RS with swing out rotor 
buckets (type 8080, rmax 21.1 cm) from Heraeus Instruments (Hanau, Germany). For the 
ultracentrifugation studies, Optima LE-80K centrifuge (Beckman, USA) and a Ti 50.4 
fixed angle rotor ( rmax 9.64 cm, r mjn 6.57 cm) (Beckham, USA) were used to centrifuge 
the liposome samples that were contained in thick-walled 6.5 ml polycarbonate 
centrifugation tubes (Beckham, USA).
Eppendorfs, centrifuge tubes and non-sterile 96-well microtitre plates for general 
used were obtained from Fisher Scientific UK Ltd., (UK). The water bath was from 
Grant Instruments Ltd. (Hertfordshire, UK). Lithium/heparin tubes were purchased from 
L.I.P. Services and Equipments Ltd. (West Yorkshire, UK). A Mettler Toledo 320 pH 
meter (Mettler-Toledo Ltd. Leicester, England) was used to measure the pH of the 
samples and to conduct basic acid-base titration of the polymers to obtain their pKa 
values.
The liposome samples were extruded using an exruder supplied by Lipex 
Biomembranes Inc., Canada, and the liposome samples were put through nuclepore 
track-etch membranes (100 and 200 nm) supplied from Fisher Scientific, UK.
2.2 Materials
2.2.1 General chemicals
TX-100, dextran o f Mw 74,000 g/mol (clinical grade) [code number D4751] and 
PEI of Mw 750,000 g/mol [code number P3143], sodium chloride (NaCl), sodium 
dihydrogen orthophosphate (NaH 2 P0 4 ), disodium hydrogen orthophosphate, 
dodecahydrate (Na2 HP0 4 .1 2 H2 0 ), methanol and chloroform were all from Sigma 
(Sigma-Aldrich, UK). Phosphate buffered saline Dulbecco A BR14 tablets were from 
Oxoid, U.K. Hydrochloric acid (HC1), acetic acid and sodium hydroxide (NaOH) were
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from Fisher Scientific UK Ltd., UK. GPC standards including the polysaccharides 
pullulan (PS), and PEG were from Polymer Laboratories Inc., UK.
2.2.2 Materials used for the synthesis of ISA1 and ISA23
L ith iu m  h y d ro x id e  m o n o h y d ra te  (L iO H .tU O  ) a n d  bis- 
(hydroxyethyl)ethylenediamine (BHE) and were from Fluka, UK. 2-Methyl piperazine 
(2-MePip) was from Fluka, UK, and was recrystallised from n-heptane. Its purity was 
determined titrimetrically before use. 2,2-6zs-(acrylamido)acetic acid (BAC) and bis- 
acryloylpiperazine (BIS-PIP) were kindly donated by Professor Paolo Ferruti, Milan, 
Italy (Ferruti et al, 1985 for details of synthesis).
2.2.3 Materials for the analytical experiments
Deuterium oxide solution (D2 O) was purchased from Fluorochem Ltd., UK. 
Cetyl Trimethyl Ammonium Bromide (CTAB), sodium dodecyl sulphate (SDS), 
deuterated SDS (d-SDS), spin probe 16-doxyl stearic acid methyl ester (16-DSE) and 
tetraethyleneglycol dodecylether (Brij 35, C 12E4 ) were from Sigma-Aldrich, UK, and 
were used without further purification. Sugar surfactant dodecylmalono-6 z's(/V- 
methylglucamide) (C 12BNMG) was prepared by Dr.J. Roe (2000), School of Chemistry, 
Cardiff.
The lyso-phospholipids, 1 -palmitoyl-2-hydroxy-.szz-glycero-3-phosphocholine 
(lyso-PC) was obtained from Avanti Polar Lipids, Inc. (Alabaster, Alabama, USA). The 
lysophospholipid contained one fatty acid chain with 16 carbons, and was used without 
further purification.
2.2.4 Materials used in liposome preparation and characterisation
Calcein fluorescence dye was from Sigma, UK. The following phospholipids, 
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-dipalmitoyl-sn-glycero-3- 
[phospho-L-serine] (sodium salt) (DPPS) and l,2-dipalm itoyl-sn-glycero-3- 
phosphoethanolamine (DPPE), and the deuterated form of these phospholipids (the fatty 
chain was deuterated only) l,2-dipalmitoyl-D62-l?«-glycero-3-phosphocholine (D- 
DPPC), l,2-dipalmitoyl-D62-5«-glycero-3-phosphoethanolamine (D-DPPE) and 1,2- 
dipalmitoyl-D62-s«-glycero-3-[phospho-L-serine] (sodium salt) (D-DPPS) all were 
from Avanti Polar Lipids, Inc., (USA). All the phospholipids contained saturated fatty 
acid chains with 16 carbons in each chain, they were supplied in powder form, and were
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used without further purification.
2.3 Methods
2.3.1 Characterisation of PAAs using GPC
GPC also known as size exclusion chromatography (SEC) was used to 
characterise PAA molecular weight characteristics. This technique was developed in the 
mid 1960’s by Moore (1964), for the determination of the molar mass distribution of a 
polymer (Feng and Fan, 1990). GPC separates polymers according to their size 
(Nishikida et al, 1990). The most important information obtained from GPC is the 
average number molecular mass (Mn), average-weight molecular mass (Mw) and 
polydispersity (Zhu et al, 1990). These are calculated as follows:
m „ - 2 N,M, ! ' Z N i 
/  2  N tM ,
Polydispersity -  M w / M n
2.1
2.2
2.3
Briefly the theoretical basis of GPC is as follows. The GPC column is packed 
with a porous gel composed of beads. The pore size depends on the packing material 
used. When the polymer solution is passed through the column, small polymer 
molecules pass through the pores of the gel, travelling a longer path than bigger 
polymer molecules that are excluded by most o f the pores. Thus larger polymer 
molecules are eluted first (Figure 2.1).
A precolumn and two ultrahydrogels SEC columns (pore sizes of 250 and 1000 
A) were used here, with PBS buffer as eluent. The buffer was filtered through 0 . 2  p,m 
membrane, and sonicated for 30 min before use. To analyse the polymer molecular 
weight the PAA (ISA23.HC1 batch 1 and 2, ISA23.cit, ISA23, ISA1.HC1 and ISA1) 
solutions were prepared in PBS buffer (pH 7.4) to a concentration o f 3 mg/ml. The 
sample solution was injected (60 \x\ loop) onto the column, with an eluent flow rate of 1 
ml/min using refractive index detection.
The GPC system was calibrated using both pullulan and PEG standards (Table 
2.1), that were also prepared in PBS (pH 7.4) at a concentration of 3 mg/ml.
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Figure 2.1 A schematic showing the principle of GPC. Polym er molecules are 
separated according to their size using the GPC. The sm aller m olecular weight 
polymer molecules travel longer distance compared to that of a polymer with high 
molecular weight. Thus the smaller polymer molecules appear later
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Table 2.1 Polymer standards used for GPC calibration.*!
Polymer Mw (g/mol) Mn (g/mol) Mw/M„
PS 2 1 2 , 0 0 0 187,610 1.13
1 1 2 , 0 0 0 1 0 0 , 0 0 0 1 . 1 2
47,300 44,622 1.06
22,800 21,308 1.07
11,800 10,727 1 . 1 0
5,900 5,412 1.09
PEO 278,300 271,000 1.03
222,800 217,800 1.03
128,100 125,900 1 . 0 2
78,000 75,500 1.04
42,870 41,920 1.03
20,400 2 0 , 0 0 0 1 . 0 2
* Mw, Mn and Mw/Mn supplied by the manufacturer 
t  The GPC profiles obtained are shown in Chapter 3
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2.3.2 Evaluation of the haemolytic activity of PAAs
RBC were used as a model to study membrane activity of PAAs under different 
conditions. Freshly prepared PAAs (ISA23.HC1 batch 1 and 2, ISA23.cit, ISA23, 
ISA1.HC1 and ISA1) (1 mg/ml) in PBS (pH 7.4, 6.5 or 5.5) were plated (100 pi) into 
non-sterile 96-well microtitre plates.
To prepare RBC, a male Wistar rat (~ 250g) was killed by 4% CO2 asphyxiation 
and blood obtained by cardiac puncture (Gomez and Duncan, 1997). RBCs were 
isolated by centrifugation at 1500 x g for 10 min at 4°C (repeated 3 times). Using the 
final pellet, a 2 % w/v RBC solution was prepared with pre-chilled PBS and it was 
added ( 1 0 0  pi) to the previously prepared microtitre plates containing the test 
compounds (Wan et al, 2004). The plate was then incubated for 1 h at 37 °C before 
centrifugation at 1500 x g for 10 min at room temperature. The supernatant was then 
pipetted into another 96-well microtitre plate and the absorbance of the haemoglobin 
was measured at 550 nm (Figure 2.2) (Richardson et al, 1999). Dextran was used as a 
negative reference control, and PEI was used as the positive controls. TX-100 (2 mg/ml) 
was used to cause 100% haemolysis. The results were expressed as a percentage of the 
haemolysis caused by TX-100.
To study the concentration-dependent haemolysis of ISA23.HC1 (batch 1 and 2) 
and ISA23.cit (Table 3.2, Chapter 3), at pH 5.5, the concentrations examined varied 
from 0 to 2 mg/ml, and the method described above was used. In certain experiments 
(see Chapter 3) pH was also varied.
2.3.3 Liposome preparation and stability testing
The widely used freeze/ thaw extrusion method (Hope et al, 1985; Mayer et al, 
1986) was used to prepare large unilameller liposomes (Figure 2.3). Prior to the 
liposomes preparation, stock phospholipid solutions were prepared with protonated or 
deuterated DPPC in chloroform (10 mg/ml), protonated or deuterated DPPE in 
chloroform (4 mg/ml), and protonated or deuterated DPPS in 3:1 ratio o f 
chloroform:methanol (2 mg/ml). These stock solutions were then used to prepare the 
model liposomes (described below). It should be noted that the compositions chosen 
were to reflect plasma, endosomal, or lysosomal membranes (see Chapter 6  for more 
details).
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Figure 2.2 The schematic representation of the red blood cell lysis assay.
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Protonated plasma membrane model-liposomes
0.861 ml of DPPC stock solution 8 . 6  mg, 5.9 mM,
0.985 ml of DPPE stock solution 3.9 mg, 2.8 mM
0.97 ml of the DPPS stock solution 1.9 mg, 1.3 mM
Deuterated plasma membrane model-liposomes
0.934 ml of deuterated -DPPC (D-DPPC) stock solution 9.3 mg, 5.9 mM
1.075 ml of D-DPPE stock solution 4.3 mg, 2.8 mM,
1.053 ml of D-DPPS stock solution 2.1 mg, 1.3 mM
Protonated endosomal membrane model-liposomes 
0.986 ml of DPPC stock solution 9.8 mg, 6.7 mM
0.937 ml of DPPE stock solution 3.7 mg, 2.7 mM
0.432 ml of DPPS stock solution 0.9 mg, 0.6 mM
Deuterated endosomal membrane model-liposomes
1.070 ml of D-DPPC stock solution 10.7 mg, 6.7 mM
1.022 ml of D-DPPE stock solution 4.1 mg, 2.7 mM
0.468 ml of D-DPPS stock solution 0.9 mg, 0.6 mM
Protonated lysosomal membrane model-liposomes
0.768 ml of DPPC stock solution 7.7 mg, 5.3 mM
0.980 ml o f DPPE stock solution 3.9 mg, 2.8 mM
1.461 ml of the DPPS stock solution 2.9 mg, 1.9 mM
Deuterated lysosomal membrane model-liposomes 
0.834 ml of D-DPPC stock solution 8.3 mg, 5.3 mM
1.070 ml of D-DPPE stock solution 4.3 mg, 2.8 mM
1.58 ml of the D-DPPS stock solution 3.2 mg, 1.9 mM
To prepare the liposomes (for each sample), the required amount o f each 
phospholipid was added to a round bottomed flask, 1 ml of chloroform was added, and 
was thoroughly mixed. The chloroform was evaporated (using a rotary-evaporator), to 
give a phospholipid film. The film was left to evaporate further for 60 min, at 25 °C. 
Then 2 ml of PBS, at pH 7.4, was added, and the film left to hydrate in a hot water bath 
(70 °C) for around 50 min. The hydrated lipid film was then put through 5 freeze/thaw 
cycles (5 min freezing in liquid nitrogen, 2 min thawing in water at room temperature
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and 5 min mixing by a vortex). Subsequently, the liposome mixture was put through 10 
cycles of extrusion through 2 0 0  nm polycarbonate membrane and 2 0  cycles through 1 0 0  
nm polycarbonate membrane.
The liposomes were prepared in this way and were characterised using PCS. The 
liposomes used for stability testing were prepared in H2 O. The stability studies were 
conducted over two days, at pH 7.5, 5, 4 and 3. The liposomes used for SANS 
measurements were prepared in D2 O. PCS was also used to examine the stability of the 
liposomes, described in Chapter 6 .
2.3.4 Evaluation of ISA23.HC1 interaction with micelles and liposomes as model 
membranes
The three techniques used to investigate the interaction of ISA23.HC1 with 
liposomes and micelles were, surface tension measurements (surfactants), EPR 
(micelles) and SANS (micelles and liposomes). The experimental detail of each study is 
given in the related experimental chapters (Chapters 5 and 6 ).
The techniques mentioned above are very important for the understanding of the 
mechanism of action o f PAAs and background information on SANS and EPR are 
given in Chapter 4 and 5 respectively. Here, a brief introduction will be given on the 
theory behind the maximum bubble pressure, which was used to measure the surface 
tension.
Maximum bubble pressure was used to measure the dynamic surface tension 
(Mysels, 1990). Basically, air is blown through a narrow capillary into the sample 
solution. At the base o f the capillary a bubble is formed, as the bubble grows the 
pressure increases, and it reaches a maximum pressure when the bubble has a shape of a 
hemisphere (the radius of the bubble is equal to that of the capillary) (Kjellin et al, 
2003). Beyond this point, the size of the bubble increases exponentially with time and 
the pressure inside the bubble decreases (Buzzacchi et al, 2006). Ultimately the bubble 
is detached from the capillary and it travels to the surface. At the same point, a new 
bubble begins to form and the whole process is repeated (Buzzacchi et al, 2006) (Figure 
2.4). The maximum pressure reached is proportional to the surface tension, the pressure 
is converted into surface tension via the Laplace’s relation (Kjellin et al, 2003):
C T- — max —Ro_ R
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Figure 2.4 The schematic illustration of the changing pressure inside the bubble with 
bubble life-time (adapted from Dukhin et al, 1996).
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where a  is the surface tension, p max is the maximum pressure reached, po is the 
hydrostatic pressure at the tip o f the capillary and R is the maximum radius o f the 
bubble (Buzzacchi et al, 2006).
2.3.5 Lyophilisation and storage of polymers
The polymers to be lyophilised were dissolved in the minimal amount of double 
distilled water, this is followed by the freezing of the polymer solution in liquid 
nitrogen, they were left in liquid nitrogen for at least 10 min. Once the samples were 
frozen, then they were put into the lyophiliser for drying until a constant weight o f the 
samples was reached (approximately three days). PAAs were stored in the freezer (- 
20°C).
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ofpoly(amidoamine)s
3.1 Introduction
To begin this study it was first necessary to synthesise the PAAs ISA1 and 
ISA23 that would be used in all subsequent experiments. The synthetic method is well 
established (Richardson et al, 1999; reviewed in Franchini and Ferruti, 2004) so the 
main purpose of this study was to prepare sufficient polymer for the later studies on 
physico-chemical behaviour and to confirm the reproducibility with the earlier work.
As mentioned in Chapter 1 (section 1.5.1) PAAs are synthetic, water-soluble 
polymers prepared by stepwise polyaddition of primary or secondary aliphatic amines to 
bis(acrylamide)s (reviewed in Ferruti et al, 2002). Using different monomers, many 
diverse polymers (linear, block, cross-linked or grafted polymers) can be produced 
(Vansteenkiste et al, 1992). Thus the chemistry of polyamidoamine polymers can be 
easily tailored to suit specific application (reviewed in Ferruti et al, 2002). The 
preparation of PAAs usually involves five main steps. Polymerisation is generally 
carried out in a proton carrying solvent, e.g. alcohol or water (Ferruti, 1996), and the 
reaction mechanism is Michael addition (Ranucci et al, 1991). This involves the 
reaction of the a-P-unsaturated carbonyl group with nucleophilic group of the primary 
or secondary aliphatic amine group (Figure 3.1). Polymerisation is followed by 
acidification, and during this step the polymer salt is produced, where the counterion 
depends on the particular acid used, e.g. hydrochloric acid for the chloride salt form. 
Ultrafiltration is used as a final purification step, to remove the un-reacted monomer 
and low molecular weight polymer, and lypohilisation gives a solid PAA suitable for 
storage.
Even though the synthetic methods used to prepare both ISA1 and ISA23 are 
well documented, it was considered important to examine the effect of the reaction 
conditions (e.g. reaction temperature, the length of the reaction, the choice of solvent, 
the chemical nature, the concentration and molar ratio of monomers and the presence of 
chain terminators) to see if it was possible to alter the molecular weight average of the 
product. During polymerization PAA molecular weight usually increases with time until 
it reaches a maximum, after which the molecular weight average starts to decrease 
(reviewed in Ferruti et al, 2002). This could be due to polymer degradation. It is known 
that generally increasing the reaction temperature decreases the time taken for the 
reaction to reach completion, but the resulting overall PAA molecular weight decreases 
slightly (Danusso and Ferruti, 1970). Also the inclusion of chain terminators (e.g. 
dimethyl acrylic acid), and the use of monomers containing hindered amino groups
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Figure 3.1 The overall mechanism of Michael addition.
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can be used to cause a decrease in the molecular weight of the product (Danusso and 
Ferruti, 1970; reviewed in Franchini and Ferruti, 2004). All these factors can be 
manipulated to optimise the synthetic conditions of PAAs.
Three main physical and chemical techniques have been used to characterise 
PAAs, these are nuclear magnetic resonance (NMR spectroscopy), acid-base titration 
and GPC. NMR is commonly employed to analyse the chemical structure and molecular 
microstructure of polymers, and was used here to confirm the successful polymerisation 
of ISA1 and 23 (Ferruti et al, 2000). Acid-base titration is used to deduce the pKa of 
ISA1 and ISA23 to ensure that these polymers exhibit ionization properties similar to 
that of the previous batches (Ferruti et al, 2000). The pKa value of a polymer is 
important as it determines the average charge of the polymer at a particular pH, its 
reactivity and the pH condition required for a chemical reaction. Acid-base titration is 
also used to obtain the concentration o f acid or base in solution of unknown 
concentration. GPC can be used to obtain the Mw, the Mn and polydispersity (Mw/Mn) 
(described in Chapter 2, section 2.3.1) of a polymer (Pattrick et al, 2001). GPC does not 
give an absolute value, as polymer standards of a known molecular weight are used to 
calibrate the columns. As there are no PAA standards, to calibrate the GPC to analyse 
ISA1 and ISA23, the standards (poly(vinylpyrolidone) (PVP), PS and PEG) were used 
as reference.
In the context of the proposed use of ISA 1 and ISA23 as endosomlytic polymers 
(see Chapter 1, section 1.4.2) their ability to show a pH-dependant membrane 
permeabilisation is a key property (Richardson et al, 1999; Ferruti et al, 2000) if they 
are to show effective gene (Richardson et al, 2001) or toxin delivery (Pattrick et al, 
2001). Here isolated RBC were used as a model to study pH-dependant membrane 
breakage caused by the PAAs. The RBC model was chosen because it is a well 
established technique to evaluate the pH-dependant membrane activity of PAAs 
(Duncan et al, 1994; Richarson et al, 1999; Ferruti et al, 2000; Pattrick et al, 2001; Wan 
et al, 2004) and other polymers (Dubruel et al, 2003; Fisicaro et al, 2005). Before 
moving on to the physical-chemical studies described later in this thesis, it was 
considered important to establish the pH-dependent membrane breakage of the ISA1 
and ISA23 batches synthesised here. This also ensured that it was possible to correlate 
the biological and physico-chemical properties of these polymer batches.
An advantage of the RBC lysis model is the simplicity of the experimental
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design, and the fact that the results are reproducible. However it does have an important 
disadvantage for the assessment o f endosomolytical polymers. The membrane 
composition of the RBC (see Table 3.1) is very different from that of a “normal” cell 
plasma membrane and also the endosomal and lysosomal membranes (see Chapter 6  for 
the composition o f the plasma, endosomal and lysosomal membranes). The RBC 
membrane is composed of 49% protein, 43% lipid and 8 % carbohydrate by weight 
(Becker et al, 2000). The major proteins of the RBC membrane are actin, a-and 13- 
spectrin, ankyrin and glycophorin A, B and C, these are skeletal proteins, and are not 
present in the plasma membrane or the intracellular vesicle membranes. These skeletal 
proteins allow the RBC to withstand the mechanical stress and permit the rapid recovery 
of their shape after squeezing through the narrow passages of blood capillaries and 
vessels. Whereas most biological membranes exist in the fluid phase, RBC membrane is 
an example of a solid membrane (Nelson, 1989).
Thus, in summary the aims of these studies were:
To synthesise and characterise ISA1 and ISA23, batches that would be used in all 
subsequent experiments.
>* To study the effect of the polymerisation conditions (temperature and time) and 
the effect of varying the monomer molar ratio on molecular weight and polydispersity 
of the product.
As it had been claimed that PAAs are biodegradable in aqueous solution (Ferruti 
et al, 1994), experiments were conducted to establish the degradation behaviour of the 
PAAs prepared here, both as a function of pH and temperature.
>■ It was considered important to define PAA stability, so that future experiments 
could be carried out with intact polymer and not the degradation products.
Finally, the effect of the ISA1 and ISA23 samples prepared here on the RBC 
integrity (lh ) was investigated, as a function of pH, polymer concentration and 
molecular weight. The pH values chosen were 7.4, 6.5 and 5.5 and these values were 
selected to mimic the pH of the extracellular fluid, the endosome and the lysosome 
respectively.
3.2 Methods
3.2.1 General methods
NMR. 30 mg of ISA1 or ISA23 was dissolved in 3 ml of D2 O (10 mg/ml), 2 ml of
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Table 3.1 The lipid composition of the plasma membrane of human erythrocyte.
Lipid Human erythrocyte plasma membrane Percent of the total composition*
Phosphatidic acid 1.5
Phosphatidylcholine 19
Phosphatidylethanolamine 18
Phosphatidylglycerol 0
Phosphatidylinositol 1
Phosphatidylserine 8.5
Sphingomyelin 17.5
Glycolipids 1 0
Cholesterol 26
Cardiolipin 0
* Taken from Smith and Wood, 1996
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polymer solution was then added to NMR tube and the *H NMR was measured. 
Acid-base titrations. The pKa of ISA1.HC1 and ISA23.HC1, was determined by 
titration. Samples were made up in PBS at concentration of 1 %w/v (3 ml). The solution 
was then titrated with 0.1 M HC1, and following the addition of known amount of acid 
or base, the pH was measured.
GPC. ISA1 and ISA23 samples were prepared (3 mg/ml in PBS), and 60 \i\ was 
injected into the column (see Chapter 2, section 2.3.1 for details), PBS buffer was used 
as the eluent with a flow rate of 1 ml/min, a RI was the choice of detector (see Chapter 
2, section 2.3.1 for details).
RBC haemolyis assay. Isolated rat RBCs (2 w/v%) were incubated with ISA1 and 
ISA23 (up to 2.5 mg/ml) for 1 h, at pH 7.4, 6.5 and 5.5. The released haemoglobin was 
measured at this time as described in Chapter 2, section 2.3.2.
PAA Stability studies. GPC was also used to study polymer stability with time. An 
Ultrahydrogel column was used, with PBS as the mobile phase and polymer detected 
using a refractive index detector. The stability of ISA23.HC1 (batch 1 and 2) and 
ISA23.citrate during the incubation at room temperature was studied at pH 7.4, 6.5 and
5.5 over 2 weeks. At 37 °C the stability o f ISA23.HC1 (batch 1 and 2), at pH 7.4, 6.5 
and 5.5 was investigated over 7 days. For these experiments, stock polymer solution 
was made up in PBS at a concentration o f 3 mg/ml (total volume 10ml). The polymer 
samples were kept in a water bath at either 25 or 37 °C, and samples were taken 
overtime for GPC analysis.
As this chapter mainly deals with the synthesis of ISA 1 and ISA23, a detailed 
description of the synthetic methods used are given below.
3.2.2 Synthesis of ISA1
To synthesise ISA1, 1 g of BIS-PIP (5.15 mmol) and 402 mg of BHE were 
dissolved in 1.72 ml of double distilled water. To that, 2-MePip (266 mg, 2.58 mmol) 
was added (Figure 3.2). The amount o f water added was calculated in order to have a 3 
M solution of BIS-PIP. After ensuring all the reactants have dissolved, the reaction was 
stirred under nitrogen in a water bath at 25 °C, and stopped after 3 days by adding 
water. To purify and isolate the product (ISA1 and ISA1.HC1), the reaction mixture was 
filtered using a stirred, ultrafiltration cell (model 8200, Amicon, Bio separation, 
Millipore), with a membrane cut-off 10,000 g/mol. To prepare ISA1.HC1, before the
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Figure 3.2 Synthesis of ISA1.
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filtration step concentrated HC1 (10 M) was added dropwise to obtain pH between 3 and 
4. In both cases, the product was finally lyophilised (Richardson et al, 1999).
To investigate the effect o f time and temperature on the polymerisation, ISA1 
polymerisation was carried out using the methods described above, but on a smaller 
scale. 0.2 g of BIS-PIP (1.03 mmol) and 80.2 mg of BHE (0.52 mmol) were dissolved 
in 334 pi of double distilled water, and to that 53.2 mg of 2-MePip (0.52 mmol) was 
added. Four separate reactions mixtures were prepared, and they were subsequently 
incubated in water bath at 25, 35, 50 or 70 °C. A sample of each (~ 0.1 ml) was taken 
after 0, 5, 24, 48 and 72 h, water was added (5 ml), and the molecular weight was then 
determined using GPC as described above. GPC analysis was undertaken without 
further purification of the polymer.
3.2.3 Synthesis of ISA23
ISA23 was synthesised as previously described (Richardson et al, 1999; Ferruti 
et al, 2000). To prepare ISA23.HC1 (batch 1), 1 g BAC (5 mmol) and 0.212 g 
LiOH.H2 0  (5 mmol) were dissolved in double distilled water (1.67 ml, amount required 
to make 3 M of BAC) (Figure 3.3). To this mixture, 0.516 g 2-MePip (1% NH2 excess) 
was added. For ISA23.HC1 batch 2, briefly BAC (5 g, 25 mmol) and L iO H .^O  (1.06 g, 
25 mmol) were dissolved in double distilled water (8.35 ml, amount required to make 3 
M of BAC). This mixture was stirred for 10 min, or until all the chemicals had 
dissolved. For ISA23.citrate and ISA23, 1 g BAC (5 mmol) and 0.212 g LiOH.H2 0  (5 
mmol) were dissolved in 1.67 ml double distilled water, and 0.511 g of 2-MePip (5 
mmol) was added to the mixture. All the reaction mixtures were then stirred for 3 
days at 25 °C under a nitrogen atmosphere in the dark. The reactions were then stopped 
by adding water. Each reaction product was then filtered using stirred ultrafiltration cell 
(with membrane cut off 1 0 , 0 0 0  g/mol) and then the product was recovered by 
lyophilisation (Richardson et al, 1999). For ISA23.HC1 (batches 1 and 2), concentrated 
HC1 (10 M) was added until the pH reached 3 - 4 ,  prior to purification. To prepare 
ISA23.citrate, before the filtration step citric acid was added until the pH reached 3 - 4  
before purification.
To study the effect of time-and temperature on the polymerisation of ISA23, the 
synthesis was carried out as described above, but on a smaller scale. To a 0.2 g o f BAC
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(1 mmol) and 42.2 mg of LiOH.tkO (1 mmol) were dissolved in 334 p,l double distilled 
water and to that 0.10 g of 2-MePip (1 mmol) was added. Four separate reactions 
mixtures were prepared, and these were incubated in a water bath at 25, 35, 50 or 70 °C. 
From each reaction a sample was taken after 0, 5, 24, 48 and 72 h, and as above the 
molecular weight of the polymer characterised using GPC, without further purification 
step.
3.3 Results
Table 3.2 gives a summary of all the polymers synthesised and their codes.
3.3.1 Characterisation of ISA1 and ISA23
lU NMR was used to confirm the identity of ISA 1 and ISA23 (Figure 3.4a,b). 
For ISA1, the peaks are not well separated and this makes it difficult to assign them. 
The peak at 1.264 ppm corresponds to the three protons of the -C H 3 on the 2- 
methy lpiperazine.
For ISA23, again it is quite difficult to assign the peaks due to the poor 
separation of the peaks. The peak at 5.390 ppm is the -C H  proton on the BAC 
monomer. The peak at 1.220 ppm corresponds to the three protons of the -CH3 on the 
2-MePip. The theoretical ratio between the two integrals should be 1:3, from the spectra 
this ratio is 1:3.24 which is consistent with the experimental error of the NMR 
technique.
In solution the polymers ISA1.HC1, ISA23.HC1 (batch 1 and 2), and 
ISA23.citrate (Figure 3.5a,b), displayed an initial pH of ~ 3, indicating that they act as a 
weak acid. In contrast, ISA1 and ISA23 act as a weak base, and they have an initial 
solution pH of ~ 9. Acid-base titration of the ISA1.HC1 showed three pKa values. These 
were 3.5, 6.4 and 8 , and these values correspond to each amino group; present as part of 
the cyclic ring of the 2-MePip or in the aliphatic chain of the BHE. Previous studies 
have shown that ISA1 displayed 4 pKa values (Pattrick et al, 2001a), but here only 3 
pKa values were observed, this is due to the fact that the initial pH of the polymer 
solution was ~ 3.4, which is quite high, this can be solved by conducting a backward 
titration, which takes the pH of solution down, enough to obtain the final pKa value. For 
ISA23.HC1, two pKa values were seen, 3.3 and 7.5, which corresponds to the amino 
groups of the cyclic 2-MePip. It was not possible to obtain the third pKa value of ISA23
- 5 9 -
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Table 3.2 Characteristics of the PAAs batches synthsised, and their code numbers.
PAAs Salt forms Method of synthesis Codes Yield (%)
ISA 1 Chloride 1 % excess a ISA1.HC1 . 75
_ 1 % excess ISA1 73
ISA 23 Chloride 1 % excess ISA23.HC1 (batch 1) 88
Chloride 1:1 ratio b ISA23.HC1 (batch 2) 85
_ 1:1 ratio ISA23 80
Citrate 1:1 ratio IS A23.citrate 83
a synthesised with 1% excess of NH2 - containing monomer
b synthesised with 1:1 ratio of NH2 - containing monomer (BAC for ISA23 polymer and 
BIS-PIP for ISA1 polymer)
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(corresponds to the carboxylic group), which is ~ 2.1, again this is due to the initial 
value of the polymer solution being higher than the third pKa value.
The GPC was first calibrated using PEG and polysaccharide standards (pullulan) 
(Figures 3.6). To obtain a calibration curve, Mw was plotted as a function of elution 
time. It should be noted that some of the PAAs synthesised in Cardiff were also sent to 
Milan to be characterised using PVP standards to allow comparison as historically 
PAAs were characterised using PVP standards (Table 3.3a,b). Both standards (pullulan 
and PEG) produce very narrow peaks, of low polydispersity.
Typical GPC chromatograms obtained for the PAAs are shown in Figure 3.7. In 
each case, it is possible to see the first PAA peak and a second solvent peak. The Mw, 
calculated using all standards, o f ISA23.HC1 batch (1 and 2) and ISA23.citrate 
synthesised in this project was higher than that of earlier ISA23.HC1 (reference batch). 
There was no significant difference in the size distribution between the ISA23 batches 
synthesised here. Generally, ISA1 had a lower Mw compared to that of ISA23 (Figure 
3.7 and Table 3.3a,b).
Three standards were used to calculate the molecular weight distribution of 
ISA1 and ISA23. The values obtained from the PVP and pullulan standards, were quite 
similar. The Mw weight o f ISA1 and ISA23 calculated using PEG standards was 
significantly different from that obtained from both PVP and pullulan standards. This 
inconsistency is due to the known high hydrodynamic radius of PEG standards, thus 
both ISA1 and ISA23 appear to be smaller in size than they really are.
3.3.2 The effect of time and temperature on ISA1 and ISA23 polymerisation
GPC calibrated using pullulan standards were used to follow changes in the 
molecular weight of PAAs synthesised as a function of time and temperature.
For both ISA1 and ISA23, the rate of polymerisation was fastest during the first 
5 h of the reaction at all temperatures examined (Figure 3.8a,b and Tables 3.4). For 
both ISA1 and ISA23, the polymerisation process at 50 and 70 °C slowed down 
virtually to zero, after this initial 5 h period. This was also true for the polymerisation of 
ISA1 at 35 °C. Polymerisation o f ISA1 and ISA23 at 25 °C, continued for the whole 3 
days, but the rate of reaction slowed down over time. For ISA23, the polymerisation at 
35 °C continued for an additional 20 h (at a slower rate), before the reaction stopped.
Temperature (between 25 and 35 °C) had an effect on the rate of polymerisation
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Figure 3.6 GPC of PEG and pullulan standards. Panel (a) show the GPC traces of 
PEG standards, and panel (b) a plot of elution time against log PEG Mw. Units of 
Mw are g/mol
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Figure 3.6 (continued). GPC of pullulan standards. Panel (c) shows the GPC 
traces of pullulan standards, panel (d) a plot of elution time against log pullulan 
Mw. Units of Mw are g/mol
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Table 3.3a The molecular weight characteristics of PAAs calculated using PVP 
standard.
PVP standard
Codes Mw (g/mol)* M„ (g/mol)* Mw/Mn
ISA1.HC1 23,000 14,000 1.6
ISA23.HC1 (batch 1) 67,000 31,000 2.2
ISA23.HC1 (batch 2) 62,000 32,000 2.8
ISA23.citrate 52,000 16,000 3.3
Table 3.3b The molecular weight characteristic of PAAs calculated using PEG and 
pullulan standards.
PS standards PEG standards
Codes Mw(g/mol)
Mn
(g/mol) Mw/Mn
Mw
(g/mol)
m  /m  
(g/mol) w n
ISA1.HC1 5,000 4,000 1.2 2,000 1,000 1.2
ISA1 5,000 3,000 1.5 2,000 1,000 1.5
ISA23.HC1 (batch 1) 68,000 41,000 1.7 32,000 17,000 1.8
ISA23.HC1 (batch 2) 64,000 39,000 1.6 29,000 16,000 1.9
ISA23 75,000 44,000 1.7 35,000 18,000 1.9
ISA23.citrate 63,000 40,000 1.6 29,000 16,000 1.8
* The Mw and Mn values are rounded to the nearest thousand
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Figure 3.7 The GPC traces of PAAs.
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Figure 3.8 The effect of time and tem perature on PAA polymerisation. The 
molecular weight of: ISA1 panel (a), and ISA23 panel (b) is shown, and the 
data points are a single GPC value collected at each time point
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Table 3.4 The final molecular weight (Mw) of ISA1 and 
ISA23 after polymerisation, at different temperatures.
Temperature
(°C)
ISA1 
Final Mw 
(g/mol)
ISA23 
Final Mw 
(g/mol)
25 22,000 74,000
35 17,000 70,000
50 13,000 69,000
70 9,000 60,000
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of ISA1, but increasing the temperature above 35 °C did not affect the rate of 
polymerisation. Changes in temperature had the greatest effect on the maximum, and 
the final molecular weight of ISA1. Increasing temperature caused a decrease in 
molecular weight.
For ISA23, temperature did not increase the rate of polymerisation, and the final 
molecular weight of ISA23 was unaffected by varying the temperature.
3.3.3 Studies on the degradation of PAAs at room temperature and 37°C (pH 7.4 
and 5.5)
GPC was also used to investigate the rate degradation of ISA23 over time at 
different pHs (7.4, 6.5 and 5.5), and temperatures (room temperature and 37°C). GPC 
showed that the elution time of ISA23.HC1 (batch 1 and 2) and ISA23.citrate, remained 
constant with time (Figure 3.9a,b,c). This was not affected by varying pH. No 
degradation of ISA23.HC1 (batches 1 and 2) was seen at 37 °C (results not shown), and 
again changing the pH had no effect on the degradation rate.
3.3.4 Evaluation of the haemolytic activity
The ISA23.HC1 reference polymer did not cause RBC lysis at pH 7.4 or 6.5, but 
did cause a significant haemolysis at pH 5.5 (Figure 3.10). No haemolysis was observed 
in the PBS control or for dextran at any pHs. The haemolysis seen for PEI decreased 
with decreasing pH (22%, 8%, and 2.5% at pH 7.4, 6.5 and 5.5 respectively).
The new batches of PAA, ISA23.HC1 (batch 1 and 2) and ISA23.citrate, 
displayed pH-dependent haemolysis. No haemolysis was seen at pH 7.4 and 6.5, but 
there was haemolytic activity at pH 5.5. It is important to mention that these pH values 
are nominal, and they are altered following the addition of the polymer (see discussion).
The effect of polymer concentration on the haemolytic activity was examined at 
pH 5.5. Generally, as the polymer concentration increases the percentage haemolysis 
also increases, and it reached a plateau at a polymer concentration of ~ 1.5 mg/ml 
(Figure 3.11).
3.4 Discussion
A library of PAAs were synthesised (Table 3.2) and analysed using biological, 
chemical and physical methods. It is quite difficult to characterise the molecular weight 
of PAAs accurately due to the lack of appropriate molecular weight standards.
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Figure 3.9 Evaluation of the degradation of ISA23 using GPC. Panel (a) 
ISA23.HC1 (batch 1), panel (b) ISA23.HC1 (batch 2), at room tem perature 
Key: pH 7.4 (circle), pH 6.5 (square) and pH 5.5 (diamond)
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Figure 3.11 Concentration dependent haemolysis of ISA23. Panel (a), ISA23C1 
(reference batch) at pH 5.5 (1 h incubation, n = 3), panel (b), concentration 
dependent heamoglobin release by PAA polymers at pH 5.5 (n = 3), ISA23.HC1 
batch 1 and 2, and ISA23.citrate, following 1 h incubation
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Although PEG, pullulan and PVP standards were used here, differences in their solution 
properties (coil dimension) can introduce error when calculating the Mw and Mw/Mn.
Historically, PVP had been used in Milan as a standard to obtain the molecular 
characteristics of PAAs (reviewed in Franchini and Ferruti, 2004). In these experiments, 
PS and PEG standards were also used. PS calibration produced Mw and Mn values that 
were in the same range as the PVP standards (ISA23 50,000-75,000 g/mol; ISA1 5,GOO- 
23,000 g/mol). In contrast, the PEG standards gave much lower apparent molecular 
weight values for the PAAs. As mentioned before, this is due to the large hydrodynamic 
radius of PEG (Magazu, 2000; Rangelov and Brown, 2000). PEG is known to have a 
highly extended, flexible and hydrated polymer chain, and this gives the polymer a 
much higher radius in solution than would normally seen for a random-coil polymer 
chain.
The PAAs synthesised here displayed a relatively high polydispersity (1.6-1.7, 
calculated using pullulan standard and 2-3.3, calculated using PVP standards). 
Ultrafiltration using a 10,000 or 5,000 g/mol membrane cut-off led to a reduction of 
polydispersity, but it was still in the range 1.3-1.5 (calculated using PS standards). 
Further fractionation or solvent precipitation could be used to decrease polydispersity, 
but this was not undertaken here.
For parental administration it is important to use either a biodegradable polymer 
or a polymer weight that allows renal elimination (reviewed in Duncan, 2005). 
Although it has been shown before that PAAs are “biodegradable polymers” (Ferruti et 
al, 1994), it is clear from the degradation experiments undertaken here that ISA23 did 
not degrade over the period examined. Changing the incubation pH, the counterion or 
increasing temperature to 37 °C (results not shown) did not accelerate degradation. 
These results are not consistent with previous studies. Ranucci et al (1991) have shown 
using viscosity measurements and GPC analysis that PAAs do degrade. It was also 
reported that pH had an effect on the extent and rate of degradation (Ranucci et al, 
1991). There is one important difference between the PAAs synthesised here and those 
tested previously that might be responsible for this, the molecular weight. Ranucci et al 
(1991) tested PAAs of low Mw, i.e. in the range of 16,500 to 28,000 g/mol (Ranucci et 
al, 1991). This can be compared to the PAA Mw of 50,000 to 70,000 g/mol tested here. 
It is possible that the higher molecular weight might cause a change in polymer 
conformation, leading to intramolecular coil-coil interactions or differences in
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hydration, that might have an impact on the PAA degradation behaviour. It is important 
to add, that the degradation experiments were conducted in the absence of enzymes that 
would also be present in the body. It would be interesting to repeat these experiments in 
different physiological solution (e.g. plasma), in the presence of enzymes and for longer 
times to see if this would affect the rate of degradation of ISA23.
The batches of ISA23 synthesised here displayed pH-dependant haemolytic 
properties consistent with the results described previously (Ferruti et al, 2000; Wan et 
al, 2004). However, there were some key differences. For example, the degree of 
haemolysis produced by ISA23.HC1 batch 1 and 2 (1 mg/ml), at pH 5.5 was lower than 
reported previously (Wan et al, 2004) (Figure 3.10). This could be simply due the 
higher molecular weight of the polymer. Previous studies have shown that molecular 
weight of cationic polymers in general can play a key role in determining the 
haemolytic activity (Ferruti et al, 2000). However, in the case o f PLL and PEI 
increasing molecular weight causes an increase in haemolysis (Hill et al, 1999). The 
amphoteric nature of PAAs might complicate things. In this case increasing molecular 
weight might cause the amphoteric polymer to aggregate, thus leading to a decrease in 
the number of positively charged amino groups available to interact with the negatively 
charged head groups of the RBC membrane. This would limit membrane interaction and 
limiting breakage.
In the context of these haemolysis experiments, it is important to note that the 
initial pH of the solutions used, and the final pH (following the addition of PAAs) is not 
the same. For example, in the experiments conducted at a starting pH 7.4, 6.5 and 5.5, 
the actual pH of the polymer solution decreased to ~ pH 6.5, 5 and 3.5 respectively. 
Even when a buffer of higher buffering capacity was used, it improved buffering 
towards PAA (1 mg/ml) at pH 7.4 and 6.5 but not at pH 5.5. This could be expected, as 
a PBS buffer has pKa values of 12.4, 7.2 and 2.1, and it is known that a buffer will work 
best at, or close to its pKa value (pKa 7.2). Although other buffers could have been 
explored, these experiments were designed to mimic the physiological situation where 
physiological buffering would be limited
When the degree of haemolysis was plotted against the final pH, it was clear that 
no significant haemolysis is produced until the final pH is below 4 (Figure 3.12).
At lower pH haemolysis increased sharply. There is a direct correlation between, PAA 
protonation and haemolytical activity.
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Figure 3.12 The relationship between PAA induced haemolysis and solution pH. 
Data show ISA23 (red diamonds), ISA23.HC1 (empty black diamonds) and 
ISA23.citrate (solid black diamonds)
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Increasing the polymer concentration caused an increase in haemolysis (Figure 
3.11 a,b). Although the haemolysis seemed to decrease after a certain concentration. 
This is probably due to either (i) polymer induced precipitation of the released 
haemoglobin or as mentioned earlier (ii) the amphoteric nature of ISA23, which can 
lead to aggregate formation at higher concentration.
3.5 Conclusions
ISA23.HC1 (batch 2) was synthesised in sufficient quantity to allow the 
investigation of the solution properties (Chapter 4), and interaction with micelles 
(Chapter 5) or liposomes (Chapter 6) as model membranes. Previous work conducted by 
Wan et al (2004) have demonstrated that ISA1 displayed pH-dependent haemolysis, but 
the ISA1 batch synthesised here did not display this, because of this it will not be 
investigated further. Physico-chemical characterisation showed that this ISA23.HC1 
had similar pKa values to those repeated in the literature, and a relatively high 
molecular weight (Mw ~ 62,000 g/mol). Evaluation of the haemolytic activity 
confirmed the ability of this batch o f ISA23.HC1 to cause pH-dependent membrane 
breakage. These properties confirmed the suitability of this batch of ISA23.HC1 for use 
in the further studies designed to examine further its physicochemical properties. 
Interestingly, the PAAs synthesised here did not undergo hydrolytic degradation over 
time (up to 2 weeks). This was not consistent with the literature. If the ISA23.HC1 
synthesised here was to be used in vivo, further studies would be required (over longer 
time and in the presence and absence of enzymes) to confirm that the polymer would 
eventually degrade.
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The investigation o f the solution behavior o f  
ISA23.HCI using SANS
Chapter 4 SANS PAA in solution
4.1 Introduction
Having synthesised the PAA, ISA23.HC1 and shown that it displayed biological 
properties consistent with previous studies using this PAA (Ferruti et al, 2000; 
Richardson et al, 1999; Wan et al, 2004), the aim of this study was to investigate the 
conformation of ISA23.HC1 in solution. In addition, the aim was to study how 
conformation would change according to polymer concentration and molecular weight 
at pHs (7.4 and 5.5) that the endosomolytic polymer would be exposed to at the cellular 
level.
Few studies have investigated the physico-chemical properties of ISA23 (see
11Chapter 1; section 1.5.3), although (potentiometric and calorimetric) C-NMR have 
been used to study the protonation of several other PAAs (Barbucci et al, 1980). Also 
techniques such as GPC (Ferruti et al, 2000), light scattering (Ferruti et al, 2000) and 
viscosity measurements have been used to investigate the solution properties of specific 
PAAs (Barbucci et al, 1981b).
As mentioned earlier in Chapter 1, previous studies have shown that ISA23 can 
deliver genes (Richardson et al, 2001), and ISA1 can deliver non-permeant toxins such 
as ricin A chain and gelonin (Pattrick et al, 2001) into the cytosol. However, Pattrick et 
al (2001) found that the ability o f the PAA ISA1 to deliver toxin molecules was poorly 
efficient. Many polymer molecules were required to deliver a single toxin molecule. 
Unless the efficiency can be improved, application of these PAAs as endosomolytic 
polymers for in vivo delivery is unlikely to succeed. To improve PAA design, it is 
crucial to better understand their precise mechanism of membrane destabilisation. Here 
SANS was used to investigate ISA23.HC1 conformation in solution. The theoretical 
basis of SANS is introduced briefly below.
4.1.1 SANS
Two main techniques are used to produce neutrons for SANS, a nuclear reactor 
or a spallation neutron source. In the case of the nuclear reactor (Figure 4.1a), neutrons 
are released by fission of uranium-235, each fission event releases 2-3 neutrons (King, 
2000) with the release of ~ 180 MeV of energy per fission (Dianoux, and Lander, 2002). 
The most powerful reactor in the world is the 57 MW High-Flux Reactor at Institute 
Max von Laue-Paul Langevine (ILL) in Grenoble, France (Ibel, 1994) (Figure 4.1b). 
Spallation neutron sources produce neutrons by the process of ‘spallation’. This is a
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common reaction that occurs when high energy particles bombard heavy atoms 
(Dianoux, and Lander, 2002) (Figure 4.2a) and this generates an intense, high energy, 
proton beam (King, 2000). The most powerful spallation neutron source is ISIS, located 
near Oxford, in the UK (Boland and Whapham, 1992) (Figure 4.2b).
SANS has been used in many scientific disciplines (Shibayama et al, 1998) 
(Figure 4.3). It provides unique information on the structure and function of biological 
and synthetic macromolecules. In the context of this work, SANS has been widely used 
to study polyelectrolyte behaviour (Nishida et al, 2002; Nakamura et al, 2005), 
polymer-surfactant interactions (Aswal, 2003; Bergstrom et al, 2004), and dendrimer 
conformation (Ramzi et al, 2002; Hedden and Bauer, 2003). However, although these 
studies were mainly conducted in aqueous solution (D2 O), physiologically relevant salt 
concentrations and temperatures were not used.
During SANS the neutron beam is elastically scattered by the nucleus of any 
atoms in its path. Isotopes of the same element are scattered differently. The scattering 
of the neutron by single nucleus can be described in terms of the cross section of the 
nucleus (the apparent area that the nucleus presents to the neutron) (Griffiths and King, 
2002). The strength of the nucleus-neutron interaction is characterised by the scattering 
length, which is independent o f atomic number and varies randomly throughout the 
periodic table.
The scattering length densities differ for each particle of interest, and the 
solvent. This is described as the contrast [(pscattererpsoivent)2]. It plays a key role in the 
determination of scattered radiation intensities, and the scattering length densities for 
any compounds. These parameters can be calculated as the following:
p - 2 bl£^ r A - N - ' 2 b^
M  0 4.1
where b\ is the coherent neutron scattering length of the nucleus (the coherent scattering 
lengths of some nuclei are shown in Table 4.1),
Pbuik is the bulk density of the scatterer,
Na is Avogardo’s number,
M is the molecular weight.
The difference between the coherent scattering length of hydrogen and deuterium is 
great (opposite side of the scale), so deuteration of molecules or solvent can be used in a 
system to allow the study of a specific part of the macromolecule or a single molecule
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Table 4.1 The coherent scattering lengths of some common nuclei.
Nucleus Coherent scattering lengths, b / 1 0 1 5 M
'H -3.74 x 10'15
2D 6.67 x 10'15
c 6.65 x 10'15
N 9.37 x 1 O'15
0 5.80 x lO '15
Cl 9.58 x 10'15
Na 3.63 x 10'17
P 5.13 x lO '17
S 2.80 x 10‘17
Cu 7.72 x 10'17
La 8.27 x 10'17
K 3.71 x 10'17
* Adapted from Koester et al, 1991 and Sears, 1992
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in a multi-components system (see examples in Figure 4.4).
Neutron scattering data are usually recorded in terms of wavevector (Q), (or 
scattering vector) which is the modulus of the resultant between incident (kj) and 
scattered (kf) wavevectors (Griffiths et al, 2002) (Figure 4.5), and k, = kf for elastic 
scattering and k* = kf = 2nn/X, where n is the refractive index of the medium. For the 
neutron the refractive index is 1. Q has a dimension of (length)'1; normally quoted in 
nm '1 or A-1 (King, 2000), and Q can be given by:
Q = | Q |= | kf -  kj| = 4 3t n / X sin (0 / 2) 4.2
Where q is the scattering angle and X is the neutron wavelength (Figure 4.6).
The substitution of equation (4.2) to Bragg’s law of diffraction (equation (4.3))
produces a useful expression (equation 4.4), where d is a distance,
l = 2 d s i n ( 0 )  4.3
d = 2 n / Q  4.4
Equation 4.3 highlights the simple relationship between the characteristic dimensions 
associated with d and Q (Griffiths and King, 2002). Both equation 4.2 and 4.4 are used 
to configure an instrument, to select a Q-range, and to size the scattering bodies in a 
sample from the position of any diffraction peak in Q-space (King, 2000). The distance 
(d) is inversely proportional to q, thus small q values are required to investigate the 
large-scale structure in a sample.
The number of neutrons that are incident on an area of detector can be measured, 
and this flux of neutrons can be described as:
/(A,0) - /o(A)AQ»j(A)7r^(0
d Q  4 .5
where I(X,0) is the flux,
Io(X,0) is the incident flux,
AQ solid angle element that the neutrons are scattered onto, 
ri the detector efficiency, T is the sample transmission,
V is the sample volume and da/dQ(Q) is the differential cross section and this is given
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Figure 4.4 Schematic diagram showing the mechanism for studying a multicomponent 
system by varying the contrast. This is achieved by deuteration of the components that 
will not be studied (they turn  invisible), and the regions of interest are protonated
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by:
^ - ( Q )  -  N V2(\p)P(Q)S{Q)  + B,„c
aii 4.6
where Np is the number of scattering bodies,
Vp is the volume of scattering body,
(Ap)2 is the contrast term (is the square of the difference in the neutron scattering length 
density), P(Q) is the form factor,
S(Q) is the structure factor and Binc is the incoherent background
The form factor is used to describe how the scattering is modulated by 
interference effects arising from different parts of the same scattering body. Thus it 
depends on the shape of the scattering body (King, 2000).
First it was necessary to determine the most appropriate mathematical model to 
fit the SANS data derived from ISA23.HC1 (batch 2) which was used for the studies and 
in subsequent chapters this polymer will only be known as ISA23.HC1. Rod, sphere, 
polyelectrolyte and Gaussian coil models were explored (Figure 4.6). The impact of 
data interpretation using each model on the calculated polymer coil radius was 
determined. As ISA23.HC1 induces a pH-dependant haemolysis (Chapter 3), the effect 
of pH on the size of the polymer coil was also examined using SANS. It was also 
demonstrated in Chapter 3 that polymer concentration and molecular weight might also 
play an important role in the chemical, physical and biological behaviours of 
ISA23.HC1, so the effect of these parameters on the polymer conformation was also 
investigated using SANS.
4.2 Methods
4.2.1 Sample preparation
ISA23.HC1 (Mw = 62,000 g/mol, Mn = 32,000 g/mol) was synthesised and 
characterised as previously described (see Chapter 3). The ISA23.HC1 samples used for 
SANS experiments were generally prepared by dissolving a known mass of polymer in 
PBS (D2 O, pH 7.4). Following the addition o f ISA23.HC1, the pH dropped and it was 
subsequently adjusted to different pH values ranging from pH 2 to 13 by adding 
concentrated NaOH (5 M) or HC1 (5 M). In certain experiments, scattering o f the 
polymer solution at different concentrations (10, 25 and 50 mg/ml), at pH 7.4 and 5.5
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Figure 4.6 The theoretical shapes that ISA23.HC1 might adopt. Panel (a) sphere, 
panel (b) Rod, panel (c) polyelectrolytes and panel (d) Gaussian coil
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were measured.
To examine the effect of temperature, scattering of ISA23.HC1 (50 mg/ml, at pH
7.4 and 5.5) was measured at 25 or 37 °C. To study the effect of molecular weight, 
SANS of an ISA23.HC1 sample with lower molecular weight (Mw = 21,000 g/mol) was 
also measured at pH 5.5, for comparison.
4.2.2 SANS measurements of ISA23.HC1 in solution
The SANS experiments were conducted using both the LOQ diffractometer at 
the ISIS Spallation Neutron Source (Oxfordshire), and the D11 and D22 diffractometers 
at the ILL (Grenoble). LOQ is a fixed-geometry, time-of-flight (TOF), instrument 
whereas the ILL (D11 and D22) is a steady-state reactor source. Neutron wavelengths 
between 2 and 10 A (LOQ) and 8 A (D11) or 6 A (D22) were employed to span Q- 
ranges (see below) of approximately 0.001 to 0.6 A ’1.
In all cases the samples were placed in 2 mm pathlength, UV-spectrophotometer 
grade, quartz cuvettes (Hellma, Ltd., UK), and mounted in aluminium holders on top of 
an enclosed, computer-controlled, sample changer. Sample volume was approximately 
0.4 ml. Temperature control was achieved through the use of a thermostated circulating 
water bath pumping fluid through the base of the sample changer. Under these 
conditions, a temperature stability of ± 0.5 °C can be achieved. Experimental measuring 
times were approximately 40 min. Dependent on which instrument was used, all 
scattering data were :
(a) normalised for the sample transmission and incident wavelength distribution
(b) background corrected using a solvent filled quartz cell (this also removes the 
inherent instrumental background arising from vacuum windows, etc.)
(c) corrected for the linearity and efficiency of the detector response using the 
instrument-specific software package
The data obtained were put onto an absolute scale by reference to the scattering 
from a well-characterised partially deuterated polystyrene-blend standard (LOQ) or 1 
mm thick sample of water (D ll, D22).
As it was mentioned earlier P(Q) gives information about the size and shape of 
the polymer in solution. Given the knowledge of the chemical composition of the 
polymer and its concentration, some of the factors may be estimated. A fitting approach 
was therefore used to calculate the theoretical scattering from a model in terms of the
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parameters describing the size and shape of the polymer. “Best fit” values o f these 
parameters were then determined via a non-linear least squares iterative process.
The following formulae were explored as a possible fit for the raw data:- 
(i) A spherical scatterer
P ( Q ) -
3(sin(QR) -  QR COS (Q R ))
(Q R ) 4.7
(ii) A rod shaped scatterer, where the object has negligible cross-section is given by:
.2|’QL'
P ( Q ) -
sin
2S,(QL) V 2
QL QL
4.8
where Si is the sine integral function and L is the length of the rod.
(iii) A polyelectrolyte model, obtained by incorporating a finite cross-section to the rod:
' - Q 2R ^  I Q 2x 2
2 „ 21 + Q x
4.9
(iv) A Gaussian coil model (derived by Debye, 1947), modified to include 
polydispersity;
’ u p )
1 + - I  + u + l
P(Q) -
( l+ v )u 2
4.10
q 2r 2
where v is a measure of the polydispersity, (Mw/Mn)-1 and u = ^  where Rg is the
(l + 2v)
polymer radius of gyration.
4.3 Results
4.3.1 Data fitting of neutron scattering data using rod, sphere and Gaussian coil 
models
Figure 4.7, panel (a) shows neutron scattering data of ISA23.HC1 (50 mg/ml), at
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Figure 4.7 SANS data obtained for ISA23.HC1 (50 mg/ml) in D20  (pH 3.15) at 37 °C. 
Panel (a) The lines represent the calculated behaviour for the solid sphere models (eqn 
4.7) where R = 10 A (long dashed line) or R = 25 A (dash dot line) and R = 40 A (dotted 
line). The solid line represents the ‘best fit’ using this model
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pH 3.15, analysed in terms of the spherical solid scatterer model. In this case, the 
principle fitting parameter is the radius, so three representative radii were examined ( 1 0  
A, 25 A and 40 A). A fit to the data without constraining the radius was also examined. 
None of these models were reasonable over the entire Q range.
Figure 4.7, panels (b,c) shows the scattering data of ISA23.HC1 fitted using the 
rod model. In this case, the fitting was performed by fixing the length (L) to different 
values and allowing the calculation of R. Increasing the length caused a decrease in the 
radius and vice versa. Changing the length did not affect the quality of the fitting to the 
data using the rod model. The fitting was best in the middle Q range, but the quality 
decreased at high and low Q values, but altogether, poor fits were produced.
Using the poly electrolyte model, varying the length parameter did not affect the 
quality of the fitting to the scattering data. However, changing the radius, significantly 
altered the fittings, and the calculated length (Figure 4.7d,e). The quality of the fits 
decreased with increasing radius, but no appropriate fit could be achieved.
Finally, the Gaussian coil model was used to fit the scattering data of 
ISA23.HC1. The Rg was estimated using theoretical polydispersity values of 1 (for a 
monodisperse polymer), 1.8 (the actual dispersity index of ISA23.HC1 obtained from 
the GPC) and 3. The latter was chosen, it is arbitrarily value, which is greater than the 
true dispersity of ISA23.HC1. This value was used for comparison, and to examine the 
effect o f the polydispersity on the quality o f fittings and Rg. Overall this model 
produced a very good fit to the data in the whole Q range (Figure 4.7, panel (f)). Fixing 
the polydispersity to 1.8 (the true value) and 3 produced a better fitting compared to the 
fit seen when polydispersity was fixed to 1. The calculated radii of gyration were rather 
insensitive to the polydispersity values assumed, and Mw/Mn values of 1, 1.8 and 3, 
which gave Rg values of 78, 85 and 8 8  A  respectively.
4.3.2 The effect of pH on ISA23.HC1 conformation
Figure 4.8 shows (a selection of) the data replotted in the form
 7  ------y  where is cp the polymer volume fraction and V is the sample
*P V  \Ppolymer ~  Psolvent /
volume, to remove the slight concentration and contrast variations within the pH series. 
Clearly, all the data have a very similar form suggesting that there was no significant 
change in polymer morphology with pH, simply a change in radius of gyration.
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Figure 4.7 (continued). Panel (b) the lines show calculated representation of the rod 
model, with length fixed at L = 10 A (solid line), L = 100 A (dashed line), L = 500 A  
(dashed-dotted line), and L = 1000 A (dotted line). Panel (c) the lines represent 
calculated representation of the rod model, with radius fixed at R = 10 A (solid line), R 
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Figure 4.7 (continued). Panel (d) the lines show the calculated representation of the 
polyelectrolytes model, allowing the rod radius to vary, the length is fixed at L = 10 A  
(solid line), L = 100 A (dashed line) and L = 500 A (dotted line). Panel (e) the lines 
represent the calculated representation of the polyelectrolytes model, allowing the rod 
length to vary, the radius is fixed at R = 10 A (solid line), R = 20 A (long dashed line) 
and R = 30 A (short dashed line), R = 50 A (dotted line) and R = 100 A (dotted line)
-96-
Chapter 4 SANS PAA in solution
(f)
ECJ
O'
• mmVIco
0.1
0.10.01
W avevector, Q (A")
Figure 4.7 (continued). Panel (f) the lines show the representation based on a 
polydisperse Gaussian coil model constraining the polydispersity, P = 1 i.e. 
monodisperse (long dashed line), P = 1.8, the GPC derived estimate (solid line) and P = 
3 (dotted line)
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Figure 4.8 The effect of pH on the data form of ISA23.HC1. Normalized SANS data for 
polymer I(Q)/[qp V(p polymer - p solvent)2] for 5 wt % ISA23 polymer in D20  as a 
function of pH. Diamonds, pH 2.0; squares, pH 3.7; inverted triangles, pH 5.5; 
triangles, pH 7.4; circles, pH 13.0
Chapter 4 SANS PAA in solution
Some data extend to higher Q depending on the instrument configuration. A fit has been 
drawn through each dataset, and the obtained radii of gyration presented as a function of 
pH in Figure 4.9. On decreasing the pH from pH = 13 the radius of gyration increases. 
The size attained a maximum value Rg=80 (±3) A  at around pH = 3, roughly an order of 
magnitude greater than the pH = 13 value. Subsequently, the radius further decreases 
with decreasing pH (Figure 4.9).
As mentioned before, the pH of the polymer samples was determined by the 
addition of base. This does not only alter the pH, but also alters the ionic strength. Thus, 
to study the effect of pH alone, two ISA23.HC1 samples were prepared. To the first 
sample (sample 1), a known amount NaOH was added (just enough to reach pH 12) and 
to the second sample (sample 2), NaCl solution was added (the amount added was 
equivalent to the added NaOH in sample 1, the pH of this sample is 3.3). To obtain 
ISA23.HC1 samples at pH 7.4 and 5.5, a known amount of sample 1 and 2 were mixed 
together. It is clear from Figure 4.10, that the data forms were quite similar at the two 
pHs. This suggested a change in size and not the shape. Gaussian coil model was again 
used to fit the data at these pH values. The Rg changed from 22.4 A (pH 7.4) to 39.1 A  
(pH 5.5). These is in agreement with the Rg values mentioned earlier.
4.3.3 The effect of concentration, molecular weight and temperature on the 
polymer conformation
Figure 4.11 (a,b) shows the raw scattering data obtained for a series of 
ISA23.HC1 samples of different polymer concentration recorded at ISIS. Table 4.2 
shows the fitting parameters obtained. The data have been normalised to account for the 
volume fraction. They are relatively noisy due to the weak contrast ( ( p P-pm )2). 
Nonetheless, as may be seen by the shapes of the curves and the fit parameters, it is 
clear that the shape of curves is not effected by the change of concentration that was 
examined. The Gaussian coil remained the most appropriate model to fit these data. 
There may be a small change in size with concentration but such a conclusion is at the 
resolution limit of these data. This pattern was observed at both pH values, but is more 
pronounced at pH 5.5 compared to that at pH 7.4. However, the error in this data is 
significant.
Changing temperature from 25 and 37 °C did not effect the conformation of 
ISA23.HC1, at pH 7.4 or pH 5.5 (Figure 4.12, Table 4.3).
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Figure 4.10 The scattering data of ISA23.HC1 samples at pH 7.4 and 5.5 with the 
same ionic strength, with the fitting using the Gaussian coil model (solid line).
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Figure 4.11 Effect of concentration and pH on the solution conformation of ISA23.HC1 in 
D2O (37 °C) evaluated by SANS. The data were interpreted using the Gaussian coil model. 
Panel (a) shows SANS data of 5 w t% , 2.5 wt%  and 1 wt% ISA23.HC1 at pH 5.5. Panel (b) 
shows SANS data obtained at 5 w t% , 2.5 w t%  and 1 wt% ISA23.HC1 and at pH 7.4
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Table 4.2 The effect of concentration on the size of 
ISA23.HC1, at pH 7.4 and 5.5.
pH
Concentration
(mg/ml)
Rg
(A)
7.4 10 24.7 ± 1.1*
25 23.5 ±3.6
50 21.4 ± 1.1
5.5 10 40.0 ± 2.3
25 38.5 ±8.6
50 32.8 ± 1.1
* Data represent Rg ± error in the fitting
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Figure 4.12 The effect of tem pera tu re  on the scattering raw data obtained for 
ISA23.HC1 at different pHs. Panel (a) shows pH 5.5 (25 °C; open circles, 37 °C; solid 
circles) and 7.4 (25 °C; open triangles, 37 °C; solid triangles), and panel (b) pH 7.4 (open 
triangles) and 5.5 (open circle), at 25 °C, solid lines represent the fittings obtained using 
Gaussian coil model
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Figure 4.12 (continued). Panel (c) pH 7.4 (open triangles) and 5.5 (open circles), at 37 °C. 
The solid lines represent data fittings data using the Gaussian coil model
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Table 4.3 Summary of the fitting parameters for ISA23.HC1 calculated using 
Gaussian coil model.
Polymer
(Mw) pH Temperature
Radius of gyration
(A)
ISA23.HCf 
(21,000 g/mol) 5.5 37 32.2 ±3.0*
ISA23.HC1+ 
(71,000 g/mol) 5.5 25 40.6 ±3.0
5.5 37 40.1 ±3.2
7.4 25 21.8 ±4.0
7.4 37 22.0 ±3.2
* Data represent Rg ± error in the fitting
f ISA23.HCl was the same batch, but the polymer was separated using 
membranes with different molecular weight cut-offs
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Finally, when the effect of molecular weight of ISA23.HC1 was studied, (Figure 4.13; 
Table 4.3), it appeared that ISA23.HC1 size decreased as molecular weight decreased. 
This was to be expected, although, the difference in molecular weight o f the two 
polymers was much greater than the difference in the radius of gyration seen. For 
example decreasing of the molecular weight from 71,000 g/mol to 21,000 g/mol caused 
a decrease Rg of only by 7 A.
3.4 Discussion
These SANS experiments show that ISA23.HC1 adopts a Gaussian coil-like 
structure in aqueous solution. Changing the pH, polymer concentration, polymer 
molecular weight, and temperature did not affect polymer shape, only the radius of the 
Gaussian coil (Griffiths et al, 2004). This was surprising, as ISA23.HC1 is amphoteric in 
nature. It was expected that a rod or poly electrolyte mathematical model would produce 
the best fit to the raw data. Upon protonation PAAs become charged, and a previous 
study using GPC with light scattering detection had concluded that ISA23.HC1 adopts 
an elongated, rod-like structure (Ferruti et al, 2000). It is safe to say that this early 
conclusion was not true, as the data fit was not really good enough to state that the 
polymer would adopt this shape in aqueous solution.
Although changing the pH did not have any effect on PAA shape, it did greatly 
affect the polymer size. At high pH values (pH 13) the Rg was ~ 10 A. This was very 
small, considering the high molecular weight of ISA23.HC1 (Mw = 71,000 g/mol). It is 
interesting to note that PEG of the same molecular weight in a theta solvent would have 
an Rg= 50 A (Griffiths et al, 2004). A PEO with the same degree of polymerisation as 
for ISA23 has a Rg= 25 A  (Griffiths et al, 2004). At pH 13, ISA23 is negatively charged 
with 100% of the carboxylic acid groups deprotonated. It would be expected that 
repulsion between these negative charges would cause the expansion of the polymer 
chain. However, the results show that the polymer chain is very compact with very 
small radius of gyration. It is possible that the number of the negative charges are not 
enough to cause repulsion or polymer expansion, but the exact reason for the small 
polymer size is still unclear.
As the pH was decreased the ISA23.HC1 radius started to increase. Initially, 
between pH 10 to 6, this occurred slowly, but as the pH was lowered, the radius started 
to increase significantly. At ~ pH 9.4, the first nitrogen in ISA23.HC1 starts to protonate 
and at pH 7.4, 50% of the first nitrogen will be protonated (Figure 4.14). Between pH
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Figure 4.13 The effect of ISA23.HC1 molecular weight on SANS. Data obtained at pH 5.5 
for low molecular weight ISA23.HC1 (Mw = 21,000 g/mol, open circles), and high 
molecular weight ISA23.HC1 (Mw = 71,000 g/mol) (open triangles). The solid lines 
represent the fitting obtained using the Gaussian coil model
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Figure 4.14 Correlation between ISA23.HC1 haemolytic activity and its Rg and degree 
of protonation. Panel (a) haemolytic activity (filled diamonds) and Rg (open circles) of 
ISA23.HC1 as a function of pH. Panel (b) The overlapping haemolysis activity (filled 
diamonds) and the percentage of negatively charged carboxylic acid groups (solid 
lines), the first positively charged nitrogen (long dashed lines) and the percentage of 
the second nitrogen (short dashed lines)
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7.4 to 6 the overall ISA23.HC1 charge remains negative and Rg measured was 21 to 24 
A. Rg continued to increase, and as pH reached 5.5, the Rg increased sharply as a result 
of repulsion between the like-charged groups along the polymer backbone. This sharp 
increase in Rg starts to occur when the second amino group begins to protonate at ~ pH 
5.4. The maximum Rg was 80 A seen at pH 3.15. This occurs close to the pKa value of 
the second amino group. However, as pH decreased further, Rg began to decrease. This 
was quite confusing as ISA23.HC1 is becoming more positively charged as pH falls. 
However, by decreasing the pH further, the carboxylic acid groups gains a hydrogen, 
and at pH 2.1 half of the population of the carboxylic acid groups gain a proton and thus 
become neutral. This will make the polymer less hydrophilic (and more hydrophobic) 
and thus affects polymer solubility. This effect can result in the collapse of the polymer 
coil. The exact reason for this pattern of the behaviour is not known, but a combination 
of the inter-and intra-molecular interactions may be responsible.
Increasing ISA23.HC1 concentration caused a slight increase in the Rg observed 
(Table 4.3). This effect was observed at both pH values, but was more pronounced at 
pH 5.5. Previous studies using light scattering and GPC, suggested that ISA23 tends to 
form aggregates (Mencdichi et al, 2005; Ferruti et al, 2000). However, the SANS 
experiments reported in this chapter did not confirm these observations. This variation 
in results could be due to the differences in how the experiments were conducted, e.g. 
concentration of the polymer, solvent used or the ionic strength.
As described in Chapter 3, pH affects the haemolytic activity of ISA23.HC1. 
This was consistent with previous observations (Ferruti et al, 2000; Richardson et al, 
1.999; and Wan et al, 2004). The increase in Rg and the increase in positive charge of 
ISA23.HC1 as pH decreases is likely to be responsible for the polymer’s membrane 
activity. However, there was no close correlation between the haemolytic activity and 
the Rg of ISA23.HC1 (Figure 4.14). A better correlation was seen between polymer 
positive charge and haemolysis. The best correlation was found when ISA23.HC1 
haemolytic activity was related to the percentage of positive charge on the second 
nitrogen atom. One can say that for ISA23.HC1 to cause a significant haemolysis, 100% 
of the first nitrogen must be positively charged together with ~ 20% of the second 
nitrogen. From these results it is possible to state the hypothetical number of positive 
charged groups that are required to cause RBC membrane breakage at a particular pH
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value. Ideally an endosomolytic polymer should cause membrane permeabilisation at ~ 
pH 6.5. The observations made here can be used to tailor polymer structure to provide 
pKa values that should promote significant haemolysis between pH 6.5 to 5 without 
haemolysis at pH 7.4.
The data reported here are interesting as they demonstrate for the first time the 
correlation between PAA Rg and pH. Also they show the importance of protonation of 
the second aminic nitrogen in the process.
4.5 Conclusions
To define the conformation of PAAs under different environmental conditions 
the raw data obtained by SANS for ISA23.HC1 (37 °C at 50 mg/ml) were analysed in 
terms of best fit of various models to the raw data. The Gaussian coil model gives the 
best fit for ISA23.HC1 and the shape of the polymer was not affected by pH (pH 2 to 
14) or polymer concentration examined (10 mg/ml to 50 mg/ml). These results help to 
better understand the mechanism of action of ISA23.HC1. It is clear that polymer Rg is 
pH-dependent, this coupled with the increase in the cationic nature of ISA23.HC1 could 
be responsible for their membrane breakage activities. Thus the next step is to study the 
interaction between ISA23.HC1 with micelles, a simple model membrane, using various 
physico-chemical techniques.
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5.1 Introduction
The effect o f pH, polymer concentration, ionic strength, temperature and 
molecular weight on the solution conformation of ISA23.HC1 were investigated in 
Chapter 4. It was shown that pH was the dominant factor that affected the solution 
morphology (size and shape) of ISA23.HC1. However, it is probable that the 
conformation of the polymer at the interface will be different to that in solution.
Therefore, the main aim of this study was to examine the effect of pH on the 
interaction of ISA23.HC1 and a series of “model” surfaces. Techniques that are well- 
established in the colloid field -  surface tension (Goddard, 2002), small-angle neutron 
scattering (Haidar et al, 2004; Bergstrom et al, 2004), and electron paramagnetic 
resonance (Bales and Stenland, 1992; Griffiths et al, 2002) - were applied to study the 
biologically relevant systems being considered here. Micelles with surfaces that 
increased in complexity were used as model surfaces. Initially, a single type of 
surfactant was chosen to prepare micelles, but as biological membranes are rather 
heterogeneous in nature -  they are principally a phospholipid surface populated with 
proteins and glycoproteins -  some studies were also undertaken with surfactant 
mixtures containing bulky, spherical (C 12BNMG) or bulky, highly extended headgroups 
(C 12E4 ). The surface composition of the surfactant micelles used were changed by 
varying the surfactant mole fraction. Finally, the most biologically relevant model was 
then systematically studied using spherical micelles composed of lyso-PC. These 
studies link most closely to those in Chapter 6 , which used liposomes as model 
membranes.
To investigate ISA23.HC1 surface interaction, surface tension measurements 
were first used to give a picture o f how pH influenced the ISA23.HC1 -  surfactant 
interaction. Such an interaction might have an affect on the localised fluidity and the 
morphology of the micelle, and this can be quantified using EPR and SANS. So far 
such techniques and experimental models have rarely been used to help better 
understand the mechanism of action of endosomal polymers as non-viral vectors for 
protein or gene delivery. To better understand the background to these studies, first the 
micellar systems chosen as models will be described in more detail. The theoretical 
basis of the analytical techniques used are also briefly described.
-112-
Chapters PAA-model
micelle interaction
5.1.1 Surfactants and Model surfaces
Surfactants or swr/ace active agents are amphiphilic in nature, i.e. they contain 
both hydrophilic and hydrophobic regions, and due to this property, surfactant 
molecules adsorb at the gas-liquid interface (surface), liquid/liquid, solid/liquid or 
solid/air interface (Fainerman et al, 2 0 0 2 ).
The surfactants used for these studies are shown in Figure 5.1. Initially, model 
surfaces composed only of SDS were used. This surfactant was chosen as it is a well 
known surfactant, and it is negatively charged in the pH range of interest. Then, the 
non-ionic surfactants, C 12BNMG, and C 12E4 , which have bulky headgroups, were also 
included to produce mixed surfaces. Finally, micelles composed of lyso-PC 
(zwitterionic surfactants) were used. Lyso-PC was chosen as its headgroup is the most 
abundant phospholipid headgroup found in biological membrane.
Generally, surfactants can be classified in terms of the nature of the headgroup :-
>■ Nonionic surfactants have an uncharged headgroup.
>■ Anionic surfactants possess a negatively charged headgroup. Examples of this 
group include sulfate and phosphate esters.
>■ Zwitterionic surfactants contain a polar region carrying negatively (usually 
carboxyl or sulfonic acid groups) and positively charged functional groups 
(usually quartemary amine groups). Examples of zwitterionic surfactants are 
betaines, sulphobetaines, and in the context of this thesis natural lipids such as 
lysophospholipids and phospholipids.
When surfactants are added to pure water, the surfactant molecules typically 
locate at the surface, and after a certain surfactant concentration, the critical micelle 
concentration (CMC), the surfactant molecules start to form aggregates called micelles 
(Figure 5.2). These micelles can have different shapes (e.g. spherical, cylindrical) that 
are determined by their surfactant chemistry, the “surfactant number” or the packing 
parameter (see Chapter 6  for details), solvent used, pH, temperature and type of salt 
present. The number o f surfactant molecules needed to form the micelle is called the 
“aggregation number ” This is usually high (~ 50 -  1000s), and is greatly influenced by 
a number of factors like pH, temperature, ionic strength and the nature and the purity of 
the surfactant.
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Figure 5.1a The chemical structu re  of non-ionic and anionic surfactants.
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surfactant
Lyso-PC
(C H 3 ) 3  surfactant
H3COOC(CH 2)14
16-DSE
Figure 5.1b The chemical structure of zwitterionic and cationic surfactants, and 
the spin-probe.
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Figure 5.2 The distribution of surfactant molecules at the surface and the bulk of the solution, and the maximum bubble 
pressure technique used to measure the surface tension.
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5.1.2 Methods used to characterise polymer-micelles interaction
Studies examining the surface tension were used to measure the onset of 
interaction, not only between the polymer and the surfactants present in the micelles, 
but also the interaction between ISA23.HC1 with free surfactants found in the bulk 
solution, and the surfactants adsorbed on the surface (shown schematically in Figure 
5.3). Surface tension (expressed in Nm’1) is the storage of energy at the surface of 
liquids, and it accounts for observations such as the spherical shape of water droplets 
and the fact that some insects can walk on water. The surface tension of surfactants is 
measured using a variety of methods including static methods (capillary rise), 
detachment methods, (e.g. drop weight and drop volume) and dynamic methods, e.g. 
maximum bubble pressure. In this study, measurement of maximum bubble pressure 
(Figure 5.2) was chosen to measure surface tension. More detail of the theory of this 
method is given in Chapter 2, section 2.3.4.1.
EPR was used to study the effect of ISA23.HC1 on the localised fluidity of the 
micelles. EPR is a spectroscopic technique that is very similar to the better known NMR 
(Lurie and Mader, 2005). Whereas in NMR the electromagnetic radiation interacts with 
magnetic moments associated with the nuclei, in EPR the magnetic moment is produced 
by the electrons. Only molecules with unpaired electrons can produce an EPR signal. 
For example, free radicals, molecules with an odd number o f electrons, triplet-state 
molecules and transition-metal complexes. In an EPR experiment, an external static 
magnetic field is applied across the sample to align the usually randomly oriented 
electrons to spin either clockwise or anticlockwise in respect to the direction of the 
magnetic field. EPR measures the amount of energy required to reverse the spin of 
unpaired electron (Dalton, 1985). In order to understand the energy splitting in a 
magnetic field, it is important to discuss the Zeeman energy effect. This is shown in 
Figure 5.4. Electrons are split into two populations, one occupying the lower energy 
level (Ms = -1/2) which occurs when the magnetic moment of the electron (p) is aligned 
with the applied magnetic field, and a second occupying the higher energy level where 
the magnetic moment of the electron aligns against the external magnetic field (Ms = 
+1/2) (Hoff, 1989). The energy required to separate the two electron populations can be 
varied by changing the static magnetic field, and the energy required for the transition is 
given by:
AE = hv = gpeB 5.1
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Figure 5.3 Schematic diagram  showing the possible location where polymer interacts with surfactants, and the techniques used to 
investigate polym er-surfactant interaction.
Chapters 
PA
A
-m
odel 
m
icelle 
interaction
Chapter 5 PAA-model
micelle interaction
B = 0
A p p lie d  m a g n e tic  F ie ld , B
Figure 5.4 Zeeman energy levels.
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where h is Plank’s constant, g is the dimensionless “g-factor” characteristic of the 
electron’s environment, jab is the Bohr magneton and B is applied magnetic field 
(Jeschke, 2003).
Information relating to the identity o f the sample, and its composition, can be 
obtained from the hyperfine interaction or hyperfine coupling between the unpaired 
electron and its nuclei with non-zero nuclear spin. The hyperfine interaction causes the 
splitting of the line spectrum, and number o f lines are equal to 2nl + 1, where I is the 
nuclear spin quantum number and n = number of nuclei. There are two types of 
hyperfine interaction, isotropic (which involves electron in the s-orbital, AiS0) and 
anisotropic interactions (involves the electron in the d- and p-orbitals) (Berliner and 
Reuben, 1989). The shape (the intensity and the line-width), the position and the 
presence of multiplet structure in the lines o f the EPR spectra can be used to extract 
information about the sample. For example, the intensity of the EPR line gives the 
amount of the paramagnetic species in the sample, and the line-width depends on the 
relaxation time of the spin. There are two types o f relaxation processes, spin-spin and 
spin-lattice interaction.
Here, in the mixture o f polymers and surfactants there are no paramagnetic 
species. Thus, in order to observe an EPR peak a spin-probe, 16-DSE must be included. 
This probe was picked as it has a narrow line-width and short correlation times. This is 
due its high intrinsic flexibility (Bales et al, 2000). Secondly, 16-DSE is hydrophobic in 
nature and only soluble when the surfactant concentration is greater than the CMC. For 
14N, the spin of the nucleus is 1, and accordingly the number o f lines that will be 
observed is 27+1 = 3 and all nearly have equal intensities.
In these studies, the EPR spectrum was fitted using the LOWFIT program. An 
example of these fittings was not included here, as it was not possible to obtain the data 
output file using LOWFIT. The parameters obtained from the fittings can be used to 
calculate the rotational correlation time xc and tb (the rotational correlation time can be 
described as the time required for the molecule of the spin probe to rotate through one 
radian around its axis, (Gabre-Mariam et al, 1991) (see equation 5.2 and 5.3.1, see 
appendix III for details).
XC =1.16Ccor 5.2
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EPR allows the characterisation o f the surface hydration of a micelle (Bales et 
al, 1998), since there is a very good correlation between Ao (the separation of the lines) 
and the polarity index. The latter defined as the ratio of the molar concentration of OH 
dipoles in a solvent or solvent mixture to that in water (Mukerjee et al, 1982; Bales et 
al, 1998). Basically the polarity (H) is the volume fraction occupied by water (Bales et 
al, 1998) in the polar shell. In this study the hyperfine spacing A+ will be used to obtain 
the polarity index as it was shown previously that Ao is more affected by the small 
second-order shifts due to motional effects (Bales et al, 1998; 2000) compared with A+. 
The polarity (H) can be calculated by:
H = ((A+) -  14.309)/ 1.418 5.6
5.2 Methods
5.2.1 Measurement of the surface tension of surfactants in the presence of 
ISA23.HC1
First, stock surfactant solutions were prepared by dissolving the appropriate 
mass of surfactant in distilled water to produce a total surfactant concentration o f 20 
mM.
100% SDS
SDS : C i2E4 (90% SDS)
SDS : C 12E4 (75% SDS)
SDS : C 12E4 (50% SDS)
SDS : C 12BNMG (50% SDS) 
CTAB : C 12BNMG (50% SDS) 
100% lyso-PC
116 mg, 20ml
104 mg of SDS and 21 mg of C 12E4, 20ml 
81 mg of SDS and 44 mg of C12E4, 20ml 
58 mg of SDS and 72 mg of C12E4, 20ml 
58 mg of SDS and 132 mg of C12BNMG, 20 ml 
73 mg of CTAB and 72 mg of C 12BNMG, 5 ml 
119 mg, 12ml
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To prepare the stock solution o f ISA23.HC1, 80 mg was dissolved in 20 ml (0.4 
w/v%) of double distilled water. For the surfactant mixture, and the polymer solution, 
the final pH was measured and adjusted accordingly to the desired value for each 
experiment using 1, 0.1 or 0.01 M HC1 or NaOH.
The concentration o f the surfactant mixture ranged from 0.002 mM to 10 mM, 
and the surface tension o f this mixture was measured in the presence or the absence of 
ISA23.HC1 as a function o f pH. Serial dilutions were prepared to obtain different 
surfactant concentration, and 3 ml o f each was added to a glass vial. The surface tension 
was measured using the maximum bubble pressure tensimeter (with a bubble life-time 
of 10 sec). For the samples containing a mixture of ISA23.HC1 and surfactant, a 1.5 ml 
of surfactant and a 1.5 ml o f ISA23.HC1 (final polymer concentration of 0.2 w/v%) 
were added to a glass vial, they were left to equilibrate for 10 min, then the surface 
tension was measured as above. Measurements were made at pH 4, 5, 6, 7 and 8.
5.2.2 EPR spectroscopy of micelle-ISA23.HCl interaction
To study the effect of pH and ionic strength on the fluidity of SDS micelles, 5 
ml of SDS (25 mM, 36 mg) was added to two glass vials containing pre-dried spin- 
probe 16-DSE (0.04 mg/ml). This was mixed and allowed to equilibrate (the ratio of 
SDS to spin probe was ~ 500:1). The pH of one sample was altered by the addition of 
HC1 (1 M or 0.1 M). To the second sample, NaCl was added to give a NaCl 
concentration equivalent to the added HC1 concentration. The EPR measurements were 
made as described below.
To investigate the ISA23.HC1/SDS interaction, 2.5 ml of SDS (50 mM, 36 mg) 
and 2.5 ml of ISA23.HC1 (0.4 w/v%) were added to a glass vial containing pre-dried 
spin-probe (16-DSE). The EPR measurements were made as described below.
To study Lyso-PC micelle ISA23.HC1 interaction, a 5 ml of lyso-PC (10 mM) 
was added to pre-dried 16-DSE (as above), and the pH was adjusted to the desired value 
by the addition of 0.1 M and 1 M HC1 or NaOH. For the EPR of lyso-PC in the 
presence of ISA23.HC1, 2.5 ml o f lyso-PC (20 mM), and 2.5 ml of ISA23.HC1 (0.4 
w/v%) were added to the glass vial containing dried spin-probe.
For EPR evaluation, an aliquot of each sample was taken using a capillary tube 
(~ 10 pi), which was then sealed at both ends by holding the capillary near the flame 
from a bunsen burner. EPR measurements were made using Bruker EMX spectrometer
-122-
Chapters PAA-model
micelle interaction
at 25°C. For each sample 5 scans were performed and the spectra were saved in ASCII 
format. LOWFIT was used to fit the spectra.
5.2.3 SANS of ISA23.HCl-micelIe interaction
To study SDS micelle-ISA23.HCl interaction, three stock solutions of SDS (50 
mM) were prepared in D20  (SDS, 58 mg, 4 ml, d-SDS, 63 mg, 4 ml), and the pH was 
adjusted to the required value (pH 7.4, 5.5 or 4). ISA23.HC1 solutions were also 
prepared (concentration o f 2 w/v %) at pH 7.4, 5.5 or 4. Prior to the SANS 
measurements, 1.5 ml o f SDS and 1.5 ml ISA23.HC1 solution were mixed.
To study lyso-PC micelles-ISA23.HCl interactions, a 20 mM of lyso-PC (20 mg, 
2 ml) was prepared at pH 5.5 or 7.4. 2 w/v % solution of ISA23.HC1 (40 mg, 2ml, at pH
7.4 and 5.5), PEI (40 mg, 2ml), dextran (40 mg, 2ml) and TX-100 (40 mg, 2ml) stoke 
solutions were also prepared in D20 . Prior to the SANS measurements, 1.5 ml of the 
lyso-PC solution with 1.5 ml o f the polymer solution were mixed.
In both cases, SANS measurements were performed on the LOQ diffractometer 
at the ISIS, at 37°C, each sample took around 40 -  60 min to run. The scattering data 
were normalised for the sample transmission and incident wavelength distribution, 
background corrected and were also corrected for the linearity and efficiency of the 
detector response.
5.3 Results
First, the results obtained when measuring the interaction with the simplest SDS 
micelles model are presented, followed by the heterogeneous micelle model and then 
the lyso-PC micelle models. For each micellar model, the data obtained using each 
technique are described individually. The overall picture is presented in Section 5.4.
5.3.1 Interaction of ISA23.HC1 with SDS surfactants
A pH range o f pH 4 to 7.4 was chosen as this is the range where ISA23.HC1 
changes from a positively to a negatively charged polymer. At pH 4, a very strong 
interaction was seen between ISA23.HC1 and the SDS mixture in the surface tension 
studies. Precipitation or phase separation occurred over surfactant concentration from 
0.1 mM to 0.8 mM (Figure 5.5a). At pH 5 and 6, the surface tension of SDS altered
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Figure 5.5 Effect of ISA23.HC1 on the surface tension of SDS surfactant solution. 
Panel (a) surface tension of SDS in the presence (red diamond) and absence (blue 
squares) of ISA23.HC1 at pH = 4 ( strong interaction with phase separation). 
Panel (b) surface tension of SDS in the presence (red diamond) and absence (blue 
squares) of ISA23.HC1 at pH 5.5 (weak interaction)
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Figure 5.5 (continued). Panel (c) the surface tension curve of SDS in presence (red 
diamond) and absence (blue squares)of ISA23.HC1 a t pH = 7.4 (no interaction)
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following the addition o f ISA23.HC1, but phase separation did not occur at any of the 
surfactant concentrations examined (Figure 5.5b). And finally at pH 7.4, no interaction 
occured between ISA23.HC1 and SDS, as the surface tension of SDS was the same in 
the presence and absence of ISA23.HC1 (Figure 5.5c).
Likewise, in the SANS studies, at pH 7.4 (Figure 5.6a) the scattering did not 
change when ISA23.HC1 was added. However, at pH 5.5 and 4 (Figure 5.6b,c), changes 
in the scattering were evident. The magnitude of the change increased with the decrease 
in pH. Two shell ellipsoid with a charged sphere H-P S(Q) was used to fit the SANS 
data acquired from SDS micelles - in the presence and absence of ISA23.HC1. The 
scattering from SDS/ISA23.HC1 mixture was predominately from the SDS micelles, as 
the polymer is a weak scatterer (Chapter 4). Changing the pH alone (just the effect of 
pH, no polymer was involved) did not affect the overall morphology of the SDS 
micelles. However at pH 4, the aggregation number (Nagg) is higher than the Nagg SDS 
micelles at pH 5.5 and pH 7.4 (Table 5.1).
At pH 4, ISA23.HC1 caused an increase o f the radius of SDS micelles and 
ellipticity (and due to this, the Nagg also increases), but the thickness of the shell 
decreased by 1.4 A (from 3.6 A to 2.2 A). At pH 5.5, the ellipticity (and Nagg) increased 
in the presence of ISA23.HC1. Finally at pH 7.4, ISA23.HC1 did not have any effect on 
the morphology (radius and ellipticity) of the SDS micelles.
In the d-SDS/ISA23.HCl system, the scattering from d-SDS was much weaker 
and the polymer conformation played greater importance. At pH 5.5 and 7.4 the 
scattering from d-SDS/ISA23.HCl resembled that of ISA23.HC1 alone (random coil) at 
these pHs. However, at pH 4, the scattering data o f the d-SDS/ISA23.HCl resembled 
that of the SDS micelles (spherical model). A Gaussian coil model produced the best fit 
for d-SDS/ISA23.HCl data at pH 7.4 and 5.5, and the radius o f gyration calculated 
using this model is 25 A and 35.6 A respectively (Figure 5.7a,b). For the d- 
SDS/ISA23.HC1 system the best fit to the data at pH 4, was the two shell ellipsoid, 
charged sphere model (Figure 5.7c). A model that also incorporated a contribution for 
the polymer scattering produced in an equally good fit o f this data, similar conclusions 
were drawn from the two models. The polymer scattering resembled that of the SDS 
micelle. However, the overall radius of the sphere, and the ellipticity, did increase 
following the addition of ISA23.HC1 (Table 5.2).
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Figure 5.6 The effect of ISA23.HC1 on the SANS data of the SDS micelles. SANS data 
of SDS in the presence (open triangle) and absence (open circles) of ISA23.HC1 at pH
7.4 (panel a) and pH 5.5 (panel b), plus their fittings (solid blue or red line)
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Figure 5.6 (continued). Panel (c) the SANS data  of SDS in the presence (open triangle) 
and absence (open circles) of ISA23.HC1 at pH 4, plus their fittings (solid blue or red 
line)
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Table 5.1 The summary of the parameters calculated from the 
model fittings to the SDS in the presence and absence of ISA23.HC1 
at pH 4, 5.5 and 7.4.
Parameter SDS, pH 4 SDS + ISA23.HC1, pH 4
Radius of the core (A) 16.7 16.5
Thickness of the shell (A) 3.6 2.2
Ellipticity (X) 1.77 2.6
Radius of the sphere (A) 19.3 24.8
Nagg 95 120
SDS, pH 5.5 SDS + ISA23.HC1, pH 5.5
Radius of the core (A) 16.6 16.7
Thickness of the shell (A) 3.4 2.7
Ellipticity (X) 1.66 2.2
Radius of the sphere (A) 20.2 22.8
Nagg 75 110
SDS, pH 7.4 SDS + ISA23.HC1, pH 7.4
Radius of the core (A) 16.7 16.7
Thickness of the shell (A) 3.4 3.4
Ellipticity (X) 1.37 1.40
Radius of the sphere (A) 18.8 17.1
Nagg 75 77
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Figure 5.7 The SANS data of d-SDS micelles in the presence of ISA23.HCI. Panel 
(a) at pH 7.4, and panel (b) pH 5.5, plus their fittings (solid blue line)
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Figure 5.7 (continued). Panel (c) the SANS data of d-SDS in the presence of ISA23.HC1 
at pH 4, plus the fitting (solid blue line)
- 131 -
Chapters PAA-model
micelle interaction
Table 5.2 The summary of the parameters calculated from the model fittings 
to the d-SDS micelles in the presence of ISA23.HC1 at pH 4,5.5 and 7.4.
Parameter
d-SDS + 
ISA23.HC1 
pH 4
d-SDS + 
ISA23.HC1 
pH 5.5
d-SDS + 
ISA23.HC1 
pH 7.4
Radius of the core (A) 16.5 N/A* N/A
Thickness of the shell (A) 2.3 N/A N/A
Ellipticity (X) 2.5 N/A N/A
Radius of gyration (A) 23.3 35.6 25.0
*N/A = not applicable
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The EPR spectroscopy gave additional information. When the spin-probe (16- 
DSE) was allowed to dissolve in the hydrophobic region of the SDS micelles, changing 
the pH did not affect the EPR spectra obtained (Figure 5.8 and 5.9). To alter the pH a 
certain amount o f HC1 was added, which inherently also changes the ionic strength, 
these two processes cannot be decoupled. However, changing either the pH or the ionic 
strength did not effect the EPR spectra, A+ and rotational correlation time of 16-DSE.
The EPR spectra of SDS micelles measured in the presence o f ISA23.HC1 
(between pH 4 and 6.5), produced a spectrum where it was not possible to fit the third 
peak using LOWFIT program. The shape o f the third line or peak changed with 
decreasing pH (Figure 5.10 and Figure 5.1 la,b,c,d). Consequently, it was not possible 
to calculate the corrected rotational correlation time of 16-DSE between pH 4 and 6.5. 
However, between pH 7 and 8 the EPR spectra were fitted using LOWFIT. The 
corrected rotational correlation time (0.39 to 0.47 nanoseconds) measured was not 
affected by the addition of ISA23.HC1 to SDS micelles at pH 7-8. The polarity of SDS 
micelles in the presence of ISA23.HC1 increased with increasing pH (Figure 5.12). The 
greatest change in polarity occurred between pH 4.4 and 5, increasing from 0.001 to 
0.34. The polarity increased by the least amount between pH 7.4 and 8 (from 0.69 to 
0.72).
5.3.2 Interaction of ISA23.HC1 with SDS/C 1 2E4  as heterogeneous system
When measuring surface tension, at pH 4, it was shown that a very strong 
interaction occurred between ISA23.HC1 and the surfactant mixture SDS:Ci2E4 , at all 
ratios, 1:1, 3:1 and 9:1. This resulted in precipitation or phase separation over a certain 
range of surfactant concentration, which was between 0.8 mM and 0.1 mM.
At pH 5 (for 50% and 75% SDS), the surface tension of the surfactants did not 
change following the addition of ISA23.HC1. This was also true at pH 6 and 7.4. For 
90% SDS, at pH 5, a clear interaction is observed but not at pH 6 or 7.4.
5.3.3 Interaction of ISA23.HC1 with SDS/C12BNMG and CTAB/C 1 2BNMG as 
heterogeneous system
Initially the surface tension of the sugar surfactant C 12BNMG was measured 
(CMC = 3 mM). The surface tension of the C 12BNMG was not effected by the presence 
of ISA23.HC1, indicating no interaction (Figures 5.13).
- 133-
N
or
m
al
ise
d 
in
te
ns
ity
 
/a
u
Chapter 5 PAA-model
micelle interaction
SDS, pH 7.4 
SDS, pH 6.5 
SDS, pH 5.5 
SDS, pH 4.5 
SDS, pH 3.5 
SDS, pH 3.0
0.5-
0.0
-0.5-
-1.0
3280 3290 3300 3310 3320 3330 3340
Magnetic field / Gauss
Figure 5.8 EPR spectra of SDS micelles as a function of pH.
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Figure 5.9 The polarity of SDS + HC1 (open diamond) as a function of pH and the polarity 
(open circle) of SDS plus NaCl with concentration that is equivalent to that of HC1.
- 134-
N
or
m
al
ise
d 
in
te
ns
ity
 
/a
u
Chapter 5 PAA-model
micelle interaction
1.5 
1
0.5 
0
-0.5 
-1
-1.5 ------------- ■--------------1--------------■-------------->--------------- ------------ -
3280 3290 3300 3310 3320 3330 3340
Magnetic field / Gauss 
Figure 5.10 The EPR of SDS in the presence of ISA23.HC1 as a function of pH.
  SDS + ISA23.HC1, pH 5.5
  SDS + ISA23.HC1, pH 4.44
  SDS + ISA23.HC1, pH 6.5
  SDS + ISA23.HC1, pH 7.4
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Figure 5.11 The effect of ISA23.HC1 on the fluidity of SDS micelles, as a function pH. 
EPR spectra of SDS in the presence (red line) and absence (blue line) of ISA23.HC1 at 
pH 4.5 (panel a) and pH 5.5 (panel b)
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Figure 5.11 (continued). The EPR  spectra of SDS in the presence (red line) and 
absence (blue line) of ISA23.HC1 at pH 6.5 (panel c) and pH 7.4 (panel d)
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Figure 5.12 The polarity of SDS micelles in the presence (open circles) and absence 
of ISA23.HC1 (open diamond) as a function of pH (the ratio  between SDS and 
ISA23.HC1 is 3.6:1).
- 138-
Su
rfa
ce
 
ten
sio
n 
(m
N
/m
)
Chapter 5 PAA-model
micelle interaction
80
70
60
50
40
-3
 1 1-------------------------------------1—
-2 -1 0
Log (concentration)
Figure 5.13 The surface tension of CnBNM G in the presence (black circles) and absence 
(blue squares) of ISA23.HC1.
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When the effect of pH on the interaction between ISA23.HC1 and the SDS surfactant 
micelle was investigated, at pH 7.4, the surface tension of SDS/C12BNMG was exactly 
the same in the presence and absence of ISA23.HC1. The same was also true at pH 5.5 
(Figure 5.14a,b). However, at pH 4, there was a clear change in the surface tension in 
the presence of ISA23.HC1 (Figure 5.14c). At pH 2 and 3, following the addition of 
ISA23.HC1, precipitation / phase separation occurred (i.e. the solution turned cloudy).
For the CTAB/C12BNMG system, at pH 5.5, the surface tension of the surfactant 
mixture was altered slightly by the addition of ISA23.HC1 (Figure 5.15). At pH 7.4, 
following the addition of ISA23.HC1, precipitation was observed.
5.3.4 Interaction of ISA23.HC1 with Lyso-PC micelles
Lyso-PC is a phospholipid - based surfactant but unlike usual phospholipids, the 
lyso-PC contains only one hydrophobic chain. Due to the molecular shape of this 
surfactant molecule (cone shape), these form spherical micelles, and not the lamellar 
sheet or liposomes that are observed with normal phospholipids with two fatty acid 
chains. Due to this property, and the fact that phosphatidylcholine is the most abundant 
phospholipid found in the biological membrane, lyso-PC was chosen as a more realistic 
surfactant model to investigate ISA23.HC1 / membrane interaction.
The CMC of lyso-PC was shown to be ~ 2 mM, and it was invariant with pH. 
The surface tension of lyso-PC was not affected by the addition of ISA23.HC1 at either 
pH 7.4 (Figure 5.16a), or pH 5.5 (Figure 5.16b).
Following the determination of ISA23.HC1 interaction by SANS, the model used 
to fit the data (in the absence and the presence of ISA23.HC1) was the same as used for 
the SDS/ISA23.HC1 system (see section 5.3.1). A number of parameters (e.g. scattering 
length density) were fixed to values that correspond to the lyso-PC micelles.
In the absence of polymer, the scattering of lyso-PC micelles did not change the 
pH 7.4, but the ellipticity was slightly affected by the reduction in pH. It increased from
1.3 (at pH 7.4) to 1.6 at (pH 5.5) (Table 5.3). The form of the scattering data of lyso-PC 
was also not altered by the presence of ISA23.HC1 across the pH range 7.4 - 5.5 (Figure 
5.17a,b). The shape o f the micelle remained unaltered, and in the presence of 
ISA23.HC1 and the same model was used to fit the data (Table 5.3).
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Figure 5.14 The surface tension curve of SDS/C 12BNMG in the presence (blue 
triangles) and absence (black circles) of ISA23.HC1 at pH 5.5 (panel a) and pH 7.4 
(panel b).
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Figure 5.14 (continued). Panel (c) the surface tension curve of SDS/CnBNMG in the 
presence (blue triangles) and absence (black circles) of ISA23.HC1 at pH 4, it is very 
clear from this graph that there is an interaction
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Figure 5.15 The surface tension curve of CTAB/C 12BNMG in the presence (blue squares) 
and absence (black circles) of ISA23.HC1 at pH 5.5.
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Figure 5.16 The effect of ISA23.HC1 on the surface tension of lyso-PC. The surface 
tension of lyso-PC in the presence (open red triangles) and absence (open blue squares) 
of ISA23.HC1 at pH 7,4 (panel a) and 5.5 (panel b), no interaction occurs between the 
polymer and the surfactant, at both pH values
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Table 5.3 Summary of the parameters calculated from model fittings to lyso-PC 
in the presence and absence of ISA23.HC1 at pH 5.5 and 7.4.
Parameter Lyso-PC, pH 5.5 Lyso-PC + ISA23.HC1, pH 5.5
Radius of the core (A) 20.5 21.9
Thickness of the shell (A) 12.8 13.1
Ellipticity (X) 1.6 1.6
Lyso-PC, pH 7.4 Lyso-PC + ISA23.HC1, pH 7.4
Radius of the core (A) 20.4 21.1
Thickness of the shell (A) 12.7 13.1
Ellipticity (X) 1.3 1.5
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Figure 5.17 The effect of ISA23.HC1 on the morphology of lyso-PC micelles. SANS 
data of lyso-PC micelles in the presence (open triangles) and absence (open circles) of 
ISA23.HC1 at pH 5.5 (panel a) and pH 7.4 (panel b), plus their fittings (solid blue or 
red line), it is hard to distinguish between the SANS data of lyso-PC in the presence 
and absence of ISA23.HC1 at both pH values
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The LOWFIT program did not produce a fit for the EPR spectra of lyso-PC in 
the presence and absence of ISA23.HC1 as a function of pH. Changing pH and the 
presence of ISA23.HC1, the line position, spacing and shape of EPR spectra were not 
altered (Figure 5.18 - 5.20). The polarity was calculated using equation 5.6 (see 
earlier), and this did not vary with pH or following the addition of ISA23.HC1.
5.4 Discussion
When examining the interaction o f ISA23.HC1 with charged micelles composed 
of SDS and/or C 12E4 or C 12BNMG, by measuring surface tension, three different 
responses were observed, depending on the pH, and the composition of the micelles. 
These are summarised in Figure 5.21. Strong interaction, in this case at low SDS 
concentrations, where a single homogenous phase existed, and the positive charge on 
ISA23.HC1 exceeded the amount o f the negatively charged SDS particles. When the 
polymer-surfactant system had a positive charge it was soluble. As the concentration of 
SDS was increased, precipitation began to occur (two phases), and phase separation 
occurred close to the charge neutralisation. Both, inter-and intra-molecular interaction 
in the system accounts for this observation, as it is governed by the subtle balance 
between hydrophilic and electrostatic interaction (Bai et al, 2002). When the 
concentration of SDS was increased further, the polymer-surfactant system returned to 
single homogenous phase. In this case the negative charge of the SDS exceeds the 
positive charge of ISA23.HC1, and this leads to the stabilisation o f the system (Figure 
5.22).
For the weak interaction of ISA23.HC1 and SDS, at a concentration above the 
CMC, the surface tension of the surfactant micelles increased following the addition of 
ISA23.HC1. This can be explained by the binding of the free surfactants molecules to 
ISA23.HC1, which caused the reduction of surface activity of the surfactant resulting in 
an increase in surface tension. Below the CMC, the surface tension of the surfactants 
decreased in the presence of ISA23.HC1. Since ISA23.HC1 is not surface active, this 
observation indicates that the complex formed between the surfactants and ISA23.HC1 
accumulates at the surface causing a decrease in surface tension.
When there was no association between ISA23.HC1 and surfactant (no 
interaction). This occurred due to the reduced cationic nature of ISA23.HC1, there was 
not sufficient positive charge of the polymer to cause interaction with the surfactant,
- 147-
H 
/ p
ol
ar
ity
 
in
de
x 
N
or
m
al
ise
d 
in
te
ns
ity
 
/a
n
Chapter 5 PAA-model
micelle interaction
Lyso-PC, pH 3.0 
Lyso-PC, pH 4.5 
Lyso-PC, pH 5.0 
Lyso-PC, pH 5.5 
Lyso-PC, pH 6.0 
Lyso-PC, pH 6.5 
Lyso-PC, pH 7.0 
Lyso-PC, pH 7.4 
Lyso-PC, pH 7.9
3280 3290 3300 3310 3320 3330 3340
Magnetic field / Gauss 
Figure 5.18 The EPR spectra of lyso-PC micelles as a function of pH.
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Figure 5.19 The polarity of lyso-PC micelles in the presence (open red circles) 
and absence of ISA23.HC1 (open black diamonds) as a function of pH.
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Figure 5.20 The EPR spectra of lyso-PC in the presence (red line) and absence 
(blue line) of ISA23.HC1 at pH 5.5 (panel a) and pH 7.4 (panel b).
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Figure 5.21 Summary of the ISA23.HC1 interaction with SDS/C12E4 micelles using 
surface tension.
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Figure 5.22 The schematic diagram which represent the hypothetical interaction of ISA23.HC1 with SDS 
molecules as a function of surfactant concentration (adapted from Goddard, 2002).
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thus the surface tension remained exactly the same in the presence of ISA23.HC1.
Polyelectrolytes and oppositely charged surfactants form aggregates that occur 
at a point known as the critical aggregation concentration (CAC), which is usually 
below the CMC (Voisin and Vincent, 2003). However, in the case of the SDS- 
ISA23.HC1 and SDS-C12E4 -ISA2 3 .HCI systems, a CAC was not observed. It is not clear 
why. Possibly there was not a high enough surfactant concentration reached to detect it. 
However, this could also be due to the nature of interaction between the surfactants and 
the polymer, or the fact that the aggregates formed were too small to be detected by the 
surface tension measurements.
The effect of ISA23.HC1 on the fluidity of the SDS micelles measured by EPR 
was pH-dependent. At low pH values, it was not possible to fit the EPR spectra of SDS 
micelles using LOWFIT program. This may have been due to the fact that the addition 
of ISA23.HC1 could either change the motion o f the spin-probe from isotropic to 
anistropic, or it caused a decrease or an increase in the motion of the 16-DSE molecules 
themselves. From these studies, it is not possible to determine the exact reason, or if it is 
a combination of the two. As it was mentioned earlier, EPR can also be used to obtain 
information on the hydration of the micelle and how this was effected by the presence 
of ISA23.HC1. At low pH following the addition of ISA23.HC1, the polarity is low (the 
number of water molecules on the surface o f the micelle), so the water molecules at the 
surface of the micelles would be replaced by ISA23.HC1 molecules. As the pH 
increases, ISA23.HC1 become less positively charged and the interaction with the 
oppositely charged surfactants becomes weaker. This would cause a decrease in the 
number of polymer molecules at the surface of the micelles, and they would be replaced 
by water molecules (Figure 5.23).
From the SANS results, ISA23.HC1 and SDS micelles produced three 
interaction responses, these were further investigated using SANS. At pH 4 (strong 
interaction with precipitation), the SANS showed that ISA23.HC1 caused the SDS 
micelle overall sphere size to increase and become more elongated. The data indicated 
that the polymer wrapped around the micelle changing its overall radius. This could be 
due to the intercalation of the polymer into the shell of the micelle, which is due to the 
charge interaction of the polymer and the SDS headgroups (Figure 5.23).
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Figure 5.23 The possible structures that represent the three different possible responses 
observed in SANS and EPR study. The strong interaction (pH 4, panel A), the weak 
interaction (pH 5.5, panel B) and no interaction (pH 7.4, panel C)
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At pH 5.5 (weaker interaction, no phase separation), SANS data suggested the 
size of the SDS micelle was slightly affected by ISA23.HC1 but at lesser extent than 
seen at pH 4 (Figure 5.23).
At pH 7.4, SANS showed that ISA23.HC1 had no effect on the size of SDS 
micelles. At this pH, only 50% of one o f the amine groups of the ISA23.HC1 is 
positively charged, and at this pH all the carboxylic groups are negatively charged, thus 
the polymer carries an overall negative charge. As SDS is also negatively charged, 
repulsion would be presented, which is in agreement with the SANS observation 
(Figure 5.23).
For the lyso-PC-ISA23.HCl, the surface tension studies showed no interaction at 
pH 7.4 and 5.5, the surface tension o f lyso-PC was not affected by the presence of 
ISA23.HC1. These observations were reinforced by the EPR and SANS studies. The 
EPR spectra of lyso-PC micelles in the presence and the absence of ISA23.HC1 could 
not been fitted using LOWFIT. Again it is quite difficult to know why. The shape of the 
EPR spectra of the lyso-PC micelles remained the same following the addition of 
ISA23.HC1 (this includes line shape, position and spacing), so it is possible to conclude 
that the speed and the type o f motion of the lyso-PC molecules was not affected by 
ISA23.HC1. Overall, the polarity, shape and size o f Lyso-PC micelles were also 
unaltered by the addition of ISA23.HC1, at both pHs. Where it was expected that no 
interaction would occur between lyso-PC and ISA23.HC1 at pH 7.4 (due to the overall 
negative charge that is carried by the polymer) lack of interaction at pH 5.5 was perhaps 
surprising. At this pH, the polymer is more cationic in nature. However, it is important 
to note that the ISA23.HC1 synthesised here did not produce significant haemolysis 
until the pH reached ~ 4 (Chapter 3). Either the polymer did not carry sufficient cationic 
charge to promote interaction with lyso-PC or the amphoteric polymer prefer self­
association at this pH. When the interaction between lyso-PC and ISA23.HC1 was 
measured at pH 3 and 4 using both surface tension and EPR (results not shown), still no 
interaction was seen. Perhaps this is also due to the zwitterionic nature of lyso-PC. The 
headgroup of lyso-PC is composed of positively charged groups (quaternary ammonium 
group, (+N)Rt) and negatively charged groups (phosphodiester phosphate, pKa value of 
1-1.7) (Marsh, 1990). Thus between pH 7.4 and 3, the lyso-PC molecule will carry both 
positive and negative charge, and the net charge is zero. The careful examination of the
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structure of lyso-PC suggests, it might be quite difficult for ISA23.HC1 to access and 
interact with the negatively charged headgroup due to the steric hindrance caused by the 
quaternary ammonium group. This would explain the lack of interaction seen. 
Molecular modelling could be used to investigate this further.
SANS of lyso-PC in the presence o f TX-100, PEI or dextran were also 
conducted. These compounds were picked because they were used as “controls” in the 
haemolysis experiments (described in Chapter 3). TX-100 caused complete haemolysis. 
The SANS results show an interaction, as the scattering data of lyso-PC changed in the 
presence of TX-100 (Table 5.4, Figure 5.24a), it is possible that the micelles are not 
solely composed of lyso-PC but a mixture of lyso-PC and TX-100 molecules, which is 
due to TX-100 being a non-ionic surfactant. Dextran is a non-ionic polymer and was 
used as the negative control in the haemolysis experiments (produced ~ 0 % haemolysis, 
see Chapter 3). It is expected that no interaction will occur between lyso-PC micelles 
and dextran, which is shown by the SANS data (Figure 5.24b). Finally, PEI was used as 
the positive control. It is clear from both the scattering data and the fitting parameters 
that there is no interaction between the micelles and the polymer, as there was no 
change in micelle shape and size (Figure 5.24c). This is unexpected, as PEI is a cationic 
polymer, and has a pKa value of ~ 9, so at pH 7.4 about 99% of the amine groups are 
positively charged. In the haemolysis assay (Chapter 3), PEI caused ~ 42% haemolysis 
at pH 7.4. It is quite hard to explain why no interaction exists between lyso-PC and PEI. 
It is possible that the high molecular weight o f PEI, (Mw 750,000 g/mol) and its 
branched structures might cause the amine groups to be sterically hindered from the 
interaction with the opposite charges o f the micelles. But this does not explain the 
haemolytical activity observed with PEI at pH 7.4. It is clear that the target also plays a 
key role, and just like for ISA23.HC1, the nature of lyso-PC can account for this result.
5.5 Conclusions
The strength of interaction between ISA23.HC1 and the SDS, SDS/C12E4 and 
SDS/C12BMNG depend on the pH and the composition of the surfactant mixture, thus 
the amount of the negative SDS particles and the amount o f positive charges of 
ISA23.HC1 polymer (can be varied by changing the pH or the concentration o f the 
polymer), play a key role on polymer/micelle interaction. The window at which 
interaction occurs between polymer and surfactant, without phase separation is small,
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Figure 5.24 The effect of the control polymers used in the haemolysis assay on the 
morphology of lyso-PC micelles. SANS data of lyso-PC micelles in the presence (open 
triangles) and absence (open circles) of TX-100 (panel a) and dextran (panel b), plus 
their fittings (solid blue or red line), it is hard  to distinguish between the SANS data of 
lyso-PC in the presence and absence of dextran
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Figure 5.24 (continued). Panel (c) the SANS data  of lyso-PC micelles in the presence 
(open triangles) and absence (open circles) of PEI, plus their fittings (solid blue or red 
line)
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Table 5.4 Summary of the parameters calculated from the model fittings to 
the lyso-PC in the presence of TX-100, dextran and PEI.
Parameter Lyso-PC + 
TX-100
Lyso-PC + 
dextran
Lyso-PC + 
PEI
Radius of the core (A) 20.1 21.9 20.1
Thickness of the shell (A) 11.1 12.6 12.7
Ellipticity (X) 1.2 1.2 1.3
Chapter 5 PAA-model
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but this increases with the increase of the negatively charged SDS molecules. So it is 
quite important to achieve the correct balance between the negative charges of the 
micelles to the positive charge on the polymer to cause sufficient interaction to measure 
using surface tension, but not too strong to cause phase separation. Changing the pH, 
i.e. the charge on the polymer has greater effect on the interaction between surfactants 
and ISA23.HC1 than varying the amount of negative charges of the model surfaces. At 
acidic pH, ISA23.HC1 is adsorbed at the surface of the micelles affecting the motion of 
the surfactant micelles and affecting their size, elongating its spherical shape. No 
interaction was observed with more biologically relevant lyso-PC surfactants at pH 5.5, 
and also there was no interaction observed between lyso-PC and PEI (positive control). 
These results are not as expected but the nature and the molecular structure of lyso-PC 
molecules is such that there is no displaceable water.
- 159-
Chapter 6 
Studies on the interaction 
between ISA23 and liposomes
Chapter 6 PAAs - liposome
interaction
6.1 Introduction
In the previous chapter the interaction between ISA23.HC1 and well-defined 
interfaces composed o f non-ionic, anionic, cationic and zwitterionic surfactants was 
studied. A number o f conclusions were drawn. Here, the validity of these conclusions 
was investigated further using more complex and biologically related models i.e. 
liposomes composed o f the main phospholipids commonly found in the biological 
membranes, and what the endosomolytic polymer would meet during endocytic uptake.
6.1.1 Biomembranes and their organisation
Biological membranes (see Figure 1.2b in Chapter 1) are very complex 
heterogeneous structures composed o f lipids, phospholipids and proteins. The main 
constituents are phospholipids, o f which phosphoglycerides are the largest group, 
(Pollard and Earnshaw, 2002). They include phosphatidic acid (PA), 
phosphatidylglycerol (PG), phosphatidylethanolamine (PE), phosphatidylcholine (PC), 
phosphatidylserine (PS) and phosphatidylinositol (PI) (Figure 6.1) (Pollard and 
Earnshaw, 2002). Another important constituent of membranes are the saccharides 
containing lipids, the glycolipids, e.g. the sphingolipids and glycerol glycolipids.
As amphiphilic m olecules, phospholipids have both hydrophilic and 
hydrophobic groups, they tend to orient and self-organise in polar and non-polar 
solvents, due to the hydrophobic and hydrophilic interactions (Dumitriu, 2002). The 
geometric packing constraint is an important factor in determining the structural 
organisation and the phase transition (White and King, 1985; reviewed in Seddon, 
1990), and shape plays a key role in determining these parameters (Figure 6.2) 
(Shumilina and Shchipunov, 1997). Phospholipids usually adopt concentric bilayer 
vesicles in water (Dumitriu, 2002), but lamellar or hexagonal II phases are also 
observed depending on the length and the composition o f the phospholipids 
hydrocarbon chain, the water content and temperature (Cullis and DeKruijff, 1978 and 
Seddon, 1984).
In general, the morphology o f the aggregation formed by amphiphiles is 
determined by the ratio between the size of the hydrophilic and hydrophobic moieties, 
semi-empirically quantified via the packing parameter P. P  is defined by P = v / a /, 
where v is the volume of the hydrophobic moiety, / is the length o f the hydrophobic 
chain and a is the effective area o f the cross-section of the polar group (Bhattacharya 
and Haidar, 2002) (Figure 6.2).
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For normal spherical micelles, P < 1/3, whilst for a bilayer P ~ 1. For values of 
P > 1, inverse structures are favoured (Dumitriu, 2002) (Figure 6.2). An amphiphile 
with a large headgroup and short saturated hydrophobic tail tends to form a spherical 
micelle, while an amphiphile with a small polar headgroup and a long saturated group 
will favour an inverted hexagonal morphology. Thus, factors that affect P include the 
size and nature o f the polar headgroup, the length of the hydrocarbon chain(s), the 
presence of unsaturation and branching within the hydrophobic chain(s), temperature, 
pH and the presence o f electrolytes (Bhattacharya and Haidar, 2002). It is therefore 
quite important to consider the m olecular geometry of amphiphiles such as 
phospholipids, to understand better the organisation of phospholipid in biological 
membranes, which in turn defines their function and interaction with other molecules 
present in the membrane.
An important therm odynam ic param eter o f a lipids is its “transition 
temperature” (Tm). At low temperatures (T < Tm), the lateral movement of the 
hydrocarbon chain is restricted leading to a structure known as the gel phase. At high 
temperature, the hydrocarbon chain is mobile and disorded; and it is known as the fluid 
or liquid-crystalline phase (Dumitriu, 2002). Table 6.1 shows the main transition 
temperatures of the three phospholipids used in this study. Factors that affect the phase 
transition are those that also determine P,  e.g. the type of hydrophilic headgroup, the 
presence of saturation and the length o f hydrocarbon tail. Tm increases with chain 
length, as solid phases are stabilised by the additional increment in the van der Waals 
interaction between the hydrocarbon chains (Gauger et al, 2001). For certain 
phospholipids, e.g. PE, it is also possible to have a lamellar to non-lamellar hexagonal 
phase transition. Lipids that can adopt a hexagonal phase make up a substantial part of 
the biological membrane (30% o f the total lipids) (Winter, 2002), therefore PE has an 
important role in determining the physical properties of the membrane, and the activity 
of membrane peptides and proteins (reviewed in Epand, 1998).
6.1.2 Selection of lipids compositions for these studies
To study IS A23-membrane interaction, liposomes composed of phospholipids, 
PC, PE and PS, were prepared. These phospholipids were picked as they are the most 
common or abundant phospholipids found in the biological membranes (plasma, 
endosome and lysosome) that ISA23.HC1 will encounter at the cellular level (Table 
6.2). The issues that need to be taken into account while choosing the phospholipids are
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Table 6.1 Transition temperature of the phospholipids used to prepare 
the model liposomes in this study. It is important to consider the Tm 
while preparing the model liposomes
Phospholipid Carbon : unsaturated
Transition
Temperature
Tm(°C)
DPPC 16:0 41
DPPE . 16:0 54
DPPS 16:0 63
Table 6.2 Summary of the major components of the three biological membranes, 
plasma, endosome and lysosome.
Composition (in percentage) of the different 
biological membranes*
Plasma Endosomal Lysosomal
Phosphatidylcholine 39.89 55.41 31.34
Phosphatidylethanolamine 19.37 22.35 16.96
Phosphatidylinositol 4.36 1.35 4.68
Phosphatidylserine 8.73 4.7 11.54
Sphingomyelin 15.21 16.02 26.82
cholesterol 12.43 0 8.68
Total 100 100 100
* Adapted from Quinn, 1976; Robinson, 1975; Gallegos et al, 2002; Bergstrand et 
al, 2003; Evans and Hardison, 1984; Urade et al, 1988
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the headgroup and the length and the presence of double bond in the fatty acid chain 
(i.e. unsaturated or saturated fatty acid chain). The exact phospholipids picked were 
DPPC, DPPE and DPPS. All these phospholipids have two unsaturated 16-carbon 
atoms in their fatty acid. These phospholipids were also used due to their availability of 
the deuterated form, allowing examination of the morphology of ISA23.HC1 in the 
presence of the model liposomes.
Using liposomes as model membranes, has the advantage of being able to 
prepare different models o f liposomes with a phospholipids composition similar to that 
of specific biological membranes (plasma, endosome and lysosome). However there 
are disadvantages o f using liposomes as models. For example, in the case of plasma 
model-liposomes, liposomes surface curvature will be different (higher) from the cell 
surface. ISA23.HC1 approaching the cell surface would be located towards the outside 
face of the plasma membrane as it is in the case of the liposomes.
In the case o f endosome and the lysosome, the model-liposomes morphology is 
similar to that of intracellular vesicles. However, an endosomolytic polymer would 
normally be located inside the vesicles. In these experiments ISA23.HC1 is added to the 
outside of the liposomes. Therefore, the curvature and the surface tension of the 
membrane will be different compared to the normal physiological situation. This will 
likely effect how the polymer associate / interact with and cause damage to the lipid 
bilayer.
Another major difference between the real biological membrane and the model 
liposomes, is the absence o f proteins and cholesterol in the model system, where they 
are found in all biological membranes, and this will also have an effect on the action of 
the polymer.
The aims of this study were:
(i) Prepare liposomes composed o f DPPC, DPPE and DPPS, with a composition 
similar to that of the plasma, endosome and lysosome membranes (see Table 6.2 for the 
phospholipids composition o f the three biological membrane).
(ii) The stability of the liposomes were assessed as a function of time and pH.
(iii) Prepared liposomes with calcein-entrapped liposomes. By studying the release 
rate of the dye and the use o f different dyes with different molecular weight, it was 
possible to get information on the mechanism by which the polymer causes membrane 
destabilisation, and the size o f the pore caused by the polymer.
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(iv) SANS was used to study the effect o f the ISA23.HC1 on the morphology of 
plasma model-liposomes (at pH 7.4, 37 °C), endosomal model-liposomes (at pH 5.5 
and 4) and lysosomal model-liposomes (at pH 5.5 and 4).
(v) Through the use o f deuterated phospholipids, SANS experiments permit the 
study of the target/model membrane (plasma-, enodomal-, and lysosomal- model 
liposomes) and the morphology o f ISA23.HC1.
(vi) Finally, the interaction between endosomal- and lysosomal model-liposomes 
and the “controls” in the haemolysis experiments (TX-100, dextran and PEI), were also 
investigated in order to compare their interaction to that of ISA23.HC1.
6.2 Methods
6.2.1 Preparation of liposomes and stability testing
Preparation o f liposomes
Liposomes composed o f protonated and deuterated DPPC/DPPE/DPPS with the 
phospholipids composition similar to that o f the plasma, endosomal and lysosomal 
membranes (Table 6.3 presents the composition) were prepared using a freeze/thaw 
extrusion method. The size of the resultant liposomes was characterised using PCS, for 
full details regarding the preparation o f liposomes please see Chapter 2, section 2.3.3.
Stability testing of the liposomes.
To test the stability o f liposomes during storage at 4 °C, their stability was 
assessed over two days (following liposome preparation), at pH 7.4, 5.5, 4 and 3. The 
stability assessment was performed by measuring the size of the liposomes using PCS 
at room temperature. A stock liposome solution was prepared at pH 7.4 (10 mM in 2 
ml), the desired pH of the other samples was achieved by the addition of HC1. The 
stability of these liposomes (all with a final phospholipids concentration of 4 mM) was 
analysed using PCS.
Preparation and purification o f  calcein-entrapped liposomes
The calcein-entrapped liposomes were prepared in exactly the same manner as 
empty liposomes, with two differences 1) the aqueous phase contained 4 mM calcein 
and 2) an extra step was required to remove the free (non-entrapped) calcein from the 
calcein entrapped-liposomes. Several methods were attempted to remove the material:
1) Ultracentrifugation:
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Table 6.3 The molar ratio of the three phospholipids used to prepare 
the liposomes.
Liposomes Molar ratio
DPPC : DPPE : DPPS
Protonated 0.59:0.28:0.13
Plasma
Deuterated 0.59 : 0.28 : 0.13
Protonated 0.67 : 0.27 : 0.06
Endosome
Deuterated 0.67 : 0.27 : 0.06
Protonated 0.52:0 .28:0 .19
Lysosome
Deuterated 0.52 : 0.28 : 0.19
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a) 35,000 rpm for one hour (Kusonwiriyawong et al, 2003)
b) 200,000 g (43,000 round per minutes, rpm) for 20 minutes (Tokudomea 
and Sugibayashia, 2004)
2) Centri-prep Filtration
Centrifuged at a speed of 2000 rpm for 20 min.
3) PD50 and PD25 columns
For both columns, the liposomes were diluted 1 in 5, and 0.5 ml of this solution 
was added to the column. PBS (pH 7.4) was used as the mobile phase.
To break the liposomes and estimate the entrapped calcein, the liposomes 
fraction was diluted 1 in 50, and 10 pi o f 5% TX-100 was added to 2 ml of the diluted 
liposomes solution. The fluorescence o f the sample was measured at room temperature.
6.2.2 SANS measurements
The neutron scattering o f deuterated and protonated liposomes in the presence 
and absence of ISA23.HC1 was measured (Table 6.4). All the samples were prepared in 
D2 O, and the pH of the samples was altered using 1, 0.1 M of HC1 or NaOH. Prior to 
SANS measurements, 1 ml o f liposomes solution (4 mM) and 1 ml of either D2 O 
(SANS of the liposomes alone) or 1 ml ISA23.HC1 (the SANS of liposomes in the 
presence of polymer) for solution (5 wt%) were added to glass vial, and this was 
allowed to equilibrate for about 10 min. Then, 0.5 ml of the sample was added to UV- 
spectrophotometer grade, quartz cuvettes. SANS measurements were conducted at 37 
°C on the LOQ diffractometer, at the ISIS. For the protonated liposomes systems the 
scattering was measured for 30 min and for the deuterated liposomes system it was for 
45 min.
6.3 Results
6.3.1 Liposome characterisation
Following the hydration step the liposomes obtained were large with an average 
diameter of 262 nm. Following 5 cycles o f freezing and thawing, three liposome 
populations were formed having an average diameter o f 285, 361 and 609 nm 
respectively After 10 cycles of liposomes extrusion through 200 nm membrane, the 
diameter of the liposomes was on average 217 nm (Figure 6.3a). Finally, following 20 
cycles of extrusion through 100 nm, the size of the liposomes decreased to an average
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Table 6.4 Experiments undertaken to study liposomes ISA23 interaction.
Liposomes pH Polymer
Protonated 7.4 ± ISA23.HC1
Plasma
Deuterated 7.4 ± ISA23.HC1
7.4 PEI, Dextran and TX-100
Protonated 5.5 ± ISA23.HC1
Endosome 4 ± ISA23.HC1
5.5 ± ISA23.HC1
Deuterated
4 ± ISA23.HC1
7.4 PEI
Protonated 5.5 ± ISA23.HC1
Lysosome 4 ± ISA23.HC1
5.5 ± ISA23.HC1
Deuterated
4 ± ISA23.HC1
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Figure 6.3 The effect of extrusion on liposome size distribution. Panel (a) the size 
distribution of endosome- model liposomes following 10 cycles of extrusion through 200 
nm membrane, and 20 cycles of extrusion through 100 nm m em brane (panel b) (the 
three lines represents three repeats)
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of 78 nm in diameter (Figure 6.3b). Similar results were also observed for plasma and 
endosome model-liposomes (results not shown).
6.3.2 Stability of liposomes
The stability o f the liposomes was examined at pH 7.4, 5.5, 4 and 3. Plasma 
membrane model-liposomes (Figure 6.4) were stable at pH 7.4, 5.5 and 4 over the test 
period, however, at pH 3, the liposomes were slightly less stable, as can be seen due to 
liposome aggregation.
The endosome model-liposomes (Figure 6.5) were also stable at 4 °C at pH 7.4 
and 5.5 two days after preparation. At pH 4, the liposomes were only stable over a day, 
and a small population of larger liposomes were formed after this time. Finally at pH 3, 
the liposomes were not stable following 8 h (results not shown).
The lysosomal model-liposomes (Figure 6.6) were stable at 4 °C at 7.4, 5 and 
were quite stable at pH 4, although at this pH, on day two, the liposomes did slightly 
increase in size due to aggregation. Again these liposomes were unstable at pH 3 and 
their size decreased with time.
6.3.3 Preparation of calcein entrapped liposomes
In order to remove un-entrapped calcein several methods were attempted. The 
ultracentrifugation step, separation was produced but the liposomes were destroyed by 
this process. The use of Centri-prep Filtration was also unsuccessful, the liposomes 
were stuck on the membrane o f the centri-prep and it was not possible to extract them.
Finally the purification using PD50 and PD25 columns, this process took over 
two days to complete for a very diluted liposome sample. The fluorescence of the 
purified calcein entrapped liposomes was measured in the presence and absence of TX- 
100. The fluorescence o f the liposomes with entrapped calcein was not affected by TX- 
100, this indicates that calcein was not released from the liposomes.
6.3.4 SANS analysis of protonated and deuterated liposomes mimicking biological 
membranes
First it was necessary to define a mathematical model able to fit both deuterated 
and protonated liposomes (plasma, endosomal, and lysosomal-model membranes). It
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Figure 6.4 The stability of plasm a-m odel liposomes at 4 °C. Panel (a) show pH 7.4 
and panel (b) shows pH 5.5, a fter 0, 1 and 2 days. The three lines represents three 
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Figure 6.4 (continued). Panel (c) at pH 4 and panel (d) at pH 3, after 0, 1 and 2 
days. The three lines represents three repeats
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Figure 6.5 The stability of endosomal-m odel liposomes. Panel (a) at pH 7.4 and 
panel (b) at pH 5.5, after 0 ,1  and 2 days. The three lines represents three repeats
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Figure 6.5 (continued). Panel (c) at pH 4 and panel (d) at pH 3, after 0, 1 and 2 days. 
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Figure 6.6 The stability of lysosomal-model liposomes. Panel (a) at pH 7.4 and panel (b) 
at pH 5.5, after 0,1 and 2 days. The three lines represents three repeats
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Figure 6.6 (continued). Panel (c) at pH 4 and panel (d) at pH 3, after 0 ,1  and 2 days. The 
three lines represents three repeats
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was found that the Schultz polydisperse 3 shell sphere model was suitable (Figure 6.7). 
This model can have five scattering densities for each layer or part of the model. 
Scattering length density 1 (pi), corresponds to the inner aqueous phase entrapped in 
the liposomes, p2 is the second headgroup layer, p3 is the hydrophobic (or hydrocarbon) 
bilayer, p4 is the second headgroup layer, and finally ps corresponds to the aqueous 
phase outside the liposomes. The parameters for these studies were: the difference in 
scattering between the different layers, the length of headgroup layer and hydrocarbon 
bilayer. Table 6.5 summarises the parameters fixed in the model when the fittings were 
performed.
Overall this model produced a good fit for both the deuterated and protonated 
plasma model-liposomes. In both cases the average radius of the liposomes determined 
was 50 nm and the polydispersity was around 0.25 (Figure 6.8 and Table 6.6). These 
results are in agreement to that obtained from the PCS.
At pH 5.5, the protonated endosomal model-liposomes have an average radius 
of 50 nm (polydispersity o f 0.25) (Figure 6.9a). The size of the liposomes was not 
altered by changing to the deuterated phospholipids. At pH 4, the shape of the 
liposomes remained the same, but the size o f the protonated and the deuterated 
liposomes was slightly smaller at pH 4 (the radius o f the deuterated liposomes was 44 
nm and for the protonated liposomes the radius was 45 nm) (Figure 6.9b). The 
polydispersity was slightly altered by changing pH, the size of the liposomes appeared 
to be more dispersed.
Whilst a simultaneous fit to the protonated and deuterated lysosome model- 
liposomes (Figure 6.10) was not carried out, it is important to note that identical size 
parameters were obtained for both systems, with only slight change in polydispersity.
6.3.5 The effect of ISA23.HC1 on the morphology of biological membranes model 
liposomes
For the liposomes (alone), it is obvious that the scattering will only come from 
the liposomes. For the liposomes in the presence o f polymer, for both the deuterated 
and protonated liposomes, the scattering is caused by two components, but for each 
case the scattering will be dominated by one of the component.
The scattering data obtained for the protonated plasma membrane- model
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Figure 6.7 Schematic represen ta tion  of the changing scattering  length densities of the 
different layers of liposomes in solution (the Schultz polydisperse 3 shell sphere model). Panel
(a) the scattering length density of liposomes composed of protonated phospholipisds, panel
(b) the scattering length density of the liposomes composed of phospholipids containing 
deuterated hydrocaron chains
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Table 6.5 Summary of the fixed parameters used to fit the SANS data obtained using liposomes.
System Pi P2 P3 P4 P5 P1 -P 2
Parameters 
P2  - p3 p3 - P4 p4-p5
Length of 
headgroup 
layer (A)
Length of 
hydrocarbon 
bilayer (A)
DPPC 7.6* 33*
DPPE 6 . 1 * 33
DPPS 4  4 ** 33
Protonated liposomesf
Plasma 6.4 1 . 2 1 -0.086 1 . 2 1 6.4 5.19 1.3 -1.3 -5.19 6 . 8 33
Endosome 6.4 1 . 1 2 -0.086 1 . 1 2 6.4 5.28 1 . 2 1 - 1 . 2 1 -5.28 7.0 33
Lysosome 6.4 1.29 -0.086 1.29 6.4 5.11 1.38 -1.38 -5.11 6 . 6 33
Deuterated liposomest
Plasma 6.4 1 . 2 1 7.4 1 . 2 1 6.4 5.19 -6.19 6.19 -5.19 6.8 33
Endosome 6.4 1 . 1 2 7.4 1 . 1 2 6.4 5.28 -6.28 6.28 -5.28 7.0 33
Lysosome 6.4 1.29 7.4 1.29 6.4 5.11 -6 . 1 1 6 . 1 1 -5.11 6.6 33
* Obtained or calculated from Nagle and Wiener, 1988 ** calculated from Petrache et al, 2004
+ Calculated using equation 4.1 (Chapter 4 , section 4.1.1) and obtained from (based on) Griffiths et al, 2005 and Ristori et al, 2005
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Figure 6.8 SANS data  obtained  using the plasm a m em brane-m odel liposomes. The 
scattering data of the deuterated (circles) and protonated (diamonds) liposomes are shown 
at pH 7.4, plus their fittings (solid blue line) using Schultz polydisperse 3 shell sphere 
mathematical model
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Table 6 . 6  Summary o f liposome characteristics, calculated from the Schultz 
polydisperse 3 shell sphere mathematical model.
System pH Radius (nm) Polydispersity
Protonated-Plasma 7.4 50 0.25
Protonated-Endosome
5.5 50 0.25
4 45 0.3
5.5 50 0.25
Protonated-Lysosome
4 50 0.25
Deuterated- Plasma 7.4 50 0.26
5.5 50 0.25
Deuterated-Endosome
4 44 0.4
5.5 50 0.26
Deuterated -Lysosome
4 50 0.26
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Figure 6.9 SANS data obtained using the endosom al m em brane-m odel liposomes. The 
scattering data of the deuterated (circles) and protonated (diamonds) liposomes at pH 4 
(panel a) and pH 5.5 (panel b) are shown plus the ir fittings (solid blue lines) using Schultz 
polydisperse 3 shell sphere mathematical model
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liposomes changed very slightly in the presence o f ISA23.HC1 at pH 7.4 (Figure 
6.11a). Between wavevector 0.025 A*1 to 0.29 A’1 the scattering from these liposomes 
was slightly higher than the scattering of the liposome alone. At a very low Q value (Q 
<0.015 A'1), the liposome scattering in the presence of ISA23.HC1 was slightly lower 
than that of the liposomes alone.
Very little scattering was produced from the deuterated plasma membrane- 
model liposomes (Figure 6.11b) at high/middle Q values (0.033 A'1- 0.29 A'1) and in 
this Q range the scattering seen was predominately from the polymer. Beyond this Q 
range, scattering was caused by the polymer and the protonated headgroups of the 
phospholipids in the liposomes. At very low Q values (between 0.07 A'1 -  0.01 A-1) 
there was no difference between the scattering from the liposomes in the presence and 
absence of ISA23.HC1, indicating no interaction.
At pH 5.5, (Figure 6.12a) the scattering of the protonated endosome-model 
liposomes changed significantly in the presence o f ISA23.HC1. Between Q values of 
0.04 A'1 and 0.28 A'^Q), liposomes scattering was higher in the presence of 
ISA23.HC1 and is higher than seen for the liposomes alone. Scattering o f deuterated 
liposomes changed in the presence o f ISA23.HC1 (Figure 6.12b) due to both the 
scattering caused by the polymer, and also possibly a changed morphology of the 
bilayer. At pH 4, addition of ISA23.HC1 appeared to affect the shape or size of the 
liposomes to a lesser extent than seen at pH 5.5. For the protonated liposomes, the 
scattering data form was almost identical to that of the liposomes in the presence of 
ISA23.HC1 (Figure 6.13a).
Addition of ISA23.HC1 to the protonated lysosomal-model liposomes at pH 5.5, 
did not seem to affect the scattering observed (Figure 6.14). In contrast to the 
endosomal-model the scattering o f the lysosomal-model was affected by ISA23.HC1 
more at pH 4 than pH 5.5 (Figure 6.15). The same affect was observed with the 
deuterated lysosomal-model liposomes in the presence and absence of ISA23.HC1.
For the deuterated liposomes-ISA23.HCl system, it was possible to examine the 
effect of the liposome on the morphology o f the polymer. The scattering data of 
ISA23.HC1 can be extracted by subtracting the scattering data o f the deuterated 
liposomes (alone) from data o f the deuterated liposomes in the presence of ISA23.HC1, 
and this data was then fitted.
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Figure 6.10 SANS data  obtained  for the lysosomal m em brane-m odel liposomes. The 
scattering data of the deuterated (circles) and protonated (diamonds) liposomes at pH 4 
(panel a) and pH 5.5 (panel b) are shown plus their fittings (solid blue lines) using Schultz 
polydisperse 3 shell sphere m athem atical model
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Figure 6.11 The effect of ISA23.HC1 on the sca ttering  of plasm a m em brane-m odel 
liposomes. SANS data of p ro tonated  (panel a) and deuterated (panel b) liposomes were 
obtained in the presence (empty circles) and absence (solid circles) of ISA23.HC1 at pH 7.4
- 186-
s
.w
3
HH
£
cCi
s<->
a
' w 'HH
£
s
100  1 
10 -  
1 
0.1 
0.01 
0.001 -
(a) Chapter 6 PAAs-liposomeinteraction
(b)
0.01 0.1 
W avevector (Q) / A
0.01 ■
0.001 •
0.01 0.1
W avevector (Q) / A
Figure 6.12 The effect of ISA23.HCI on the scattering of endosomal membrane- 
model liposomes. SANS data  of protonated (panel a) and deuterated  (panel b) 
liposomes were obtained in the presence (em pty circles) and absence (solid 
circles) of ISA23.HC1 at pH 5.5
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Figure 6.13 The effect of ISA23.HC1 on the scattering of endosomal m embrane- 
model liposomes. SANS data  of p ro tonated  (panel a) and deuterated (panel b) 
endosomal model-liposomes w ere obtained in the presence (empty circles) and 
absence (solid circles) of ISA23.HC1, a t pH 4
- 188-
Chapter 6 PAAs-liposome
interaction
su
aw'
HH
&
’5sa>
E
6>
HH
(a)
100 n
10 -
0.01 -
0.001 -
0.0001 ■ T T
0.01 0.1 
W avevector (Q) / A
10 i
1 ■
0.1 -
0.01 -
(b)
0.001
1
9
0.01 0.1
W avevector (Q) / A
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The Gaussian coil model was used to fit the extracted ISA23.HC1 data. It 
produced a good fit for all the data sets (results not shown). Table 6.7 summarises the 
Rg of the polymer measured in the presence and absence of the model-liposomes. At 
pH 7.4, the Rg o f ISA23.HC1 changes only very slightly in the presence of plasma 
model-liposomes. However at pH 5.5, ISA23.HC1 appeared to have increased in size by 
a factor of 1.4 in the presence of the endosome- and lysosome-model liposomes. The 
polymer also increased in size at pH 4 in the presence o f lysosome model-liposomes 
(increased from 6.6 nm to 7.3 nm), but not for the endosome model-liposomes. In the 
latter case, the size o f polymer remained unaltered (the Rg decreased by 0.4 nm).
An attempt was made to try and fit the scattering data o f the liposomes in the 
presence of ISA23.HC1 using Schultz poly disperse 3 shell sphere but this was 
unsuccessful. A modification to the model maybe required, or a new mathematical 
model might be necessary to fit these data. In both cases it would be important to 
include the polymer scattering to get good fits with accurate parameters (i.e shape and 
size, radius and polydispersity). It became clear that interpreting these results was far 
harder than anticipated.
6.4 Discussion
Liposomes were prepared with a phospholipid composition chosen to mimic the 
biological membrane that ISA23 would encounter during endocytic internalisation. All 
these liposomes were stable (at pH 7.4, 5.5 and 4) over two days, and thus stable 
enough to enable the ISA23.HC1 -liposom e interaction studies conducted using SANS. 
None of the liposomes (plasma membrane-, endosomal membrane- and lysosomal 
membrane-model liposomes) were stable at pH 3. This was probably due to an 
increased rate of hydrolysis o f the ester bonds in the phospholipids in acidic media 
causing liposomes disintegration, aggregation and/or fusion (Zhang and Pawelchak, 
2000).
Calcein-entrapped liposomes
The aim of this experiment was to study polymer model liposomes interaction 
by investigating the release o f calcein entrapped in the liposomes (Karoonuthaisiri et al, 
2003). It is possible to get information on the rate at which the polymer causes 
liposomes destabilisation by measuring the rate o f the calcein release from the
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Table 6.7 The summary of the R g of ISA23.HC1, in the presence and the absence of 
the different model liposomes at pH 7.4, 5.5 and 4.
Polymer pH Liposomes Rg(nm)
Effect of ISA23.HC1 on 
the scattering data of the 
protonated liposomes
ISA23.HCI
(alone) 7.4 - 2.1 N/A*
ISA23.HC1 7.4 deuterated plasm a m em brane 2.7 No change in scattering
ISA23.HC1
(alone) 5.5 - 3.0 N/A
ISA23.HC1 5.5 D euterated endosome m em brane 4.3
Significant changes in 
scattering
ISA23.HC1 5.5 deuterated  lysosome m em brane 4.4 No change in scattering
ISA23.HC1
(alone) 4
- 6.6 N/A
ISA23.HC1 4 deuterated endosome m em brane 6.2
Slight change in 
scattering
ISA23.HC1 4 deuterated lysosome m em brane 7.3
Slight change in 
scattering
* N/A - not applicable
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liposomes (Karoonuthaisiri et al, 2003). If  different molecular weight dyes were used 
(e.g. different molecular weight FITC-dextran, also one with molecular weight similar 
to that of PAAs), it is likely to get information on mechanism of action of the polymer,
i.e. does it cause a complete destruction o f the liposomes or does it form pores, and if 
so then it would be likely to get an idea on the size o f these pores. Also, the stability of 
the liposomes can be studied by measuring the leakage of calcein as a function of time 
and pH.
The preparation o f calcein-entrapped liposomes was not successful. The 
fluorescence o f calcein-entrapped liposomes in the presence of TX-100 did not 
increase. It is not clear why this occurs, but is it possible that at 5% w/v of TX-100 was 
not enough to cause liposome breakage. Thus PCS was used to examine the effect of 
TX-100 (5% w/v) on the size distribution o f liposomes. It is clear from Figure 6.16 that 
the size changes from 70 nm (monodisperse population) to 10, 20 30 nm and 1000 nm 
(very polydisperse population), so it is obvious that the liposomes are broken by TX- 
100. Another possible explanation is that that TX-100 is interacting with calcein, but 
the effect of TX-100 is more noticeable in the liposome preparation, as the TX-100 
might be forming micelles with the phospholipids of the liposomes thus can entrap the 
calcein causing a decrease in the fluorescence.
It is also possible that the calcein might leak out the liposomes due to the low 
molecular weight of calcein, absence o f cholesterol in the liposome preparation and the 
purification of the liposomes.
SANS studies o f polymer-model membrane interaction
SANS was used to study the morphology o f model-liposomes/ISA23.HCl 
system. For the protonated liposomes (alone) the scattering came from both the 
headgroup and hydrocarbon tail o f the phospholipids (Figure 6.17a). For the protonated 
system in the presence o f ISA23.HC1, the scattering is predominately from the 
liposome as the polymer is a weak scatterer, but the presence o f ISA23.HC1 does 
slightly contribute to the scattering data (Figure 6.17b). For the deuterated system, the 
tails of the lipids are deuterated but the headgroup is protonated, so for the deuterated 
liposomes (alone) a little scattering was still expected (Figure 6.17c), and for the 
deuterated liposomes in the presence o f ISA23.HC1, the scattering is from both the 
headgroup of the phospholipids and the polymer (Figure 6.17d).
Very little interaction occurred between ISA23.HC1 and plasma model-
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Figure 6.16 The size distribution of liposomes m easured by PCS in the presence (panel 
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liposomes at pH 7.4, as the scattering data does not change in the presence of 
ISA23.HC1. For the endosome model-liposomes, ISA23.HC1 appears to have more 
effect on the scattering data at pH 5.5 compared to pH 4. This is quite surprising as the 
polymer at pH 4 is more positively charged at pH 4, but it is important to mention that 
the protonation of the first amino group increases by one percent where the protonation 
of the second amino group increased from 0 to 10%.
It is possible that the charge o f the target and how the functional group appears 
to the polymer play a key role. The pKa o f the phosphodiester group of the three 
phospholipids ranges from 1 to 2, thus about 100% of the phospholipids population 
carries a negative charge and this does not change between pH 5.5 and 4. The 
quaternary ammonium group, ((+N)R4  or ) o f the phospholipids will be fully
protonated at both pH 5.5 and 4, on the other hand for the carboxylic acid group the 
population of the charged species decreases from 50% at pH 5.5 to only 10% at pH 4. 
This decrease in the negative charge on the target might cause a decrease in the 
interaction between ISA23.HC1 and liposomes.
An opposite trend, was observed with the lysosomal model liposomes. 
ISA23.HC1 had more affect on the liposome scattering at pH 4 than at pH 5.5. At this 
pH there appeared to be more interaction between the liposomes and ISA23.HC1 at pH 
4 than at pH 5.5. This was opposite to the observation made with the endosome model- 
liposomes. However, this does correlate with the increase o f the positive charge of the 
polymer. These data emphasise the importance o f both the charge on the polymer, and 
the target membrane (liposomes) on the presence/or the strength o f interaction between 
polymer and liposome.
Interaction with the model-liposomes did not have an effect on the shape of 
ISA23.HC1, only its size. Combining the results from the protonated liposomes in the 
presence and absence o f ISA23.HC1, and the extracted polymer data, one can say that 
polymer Rg is altered only if  an interaction exists between the model liposomes and the 
polymer. But, this is not always true. For example, for the lysosomal model at pH 5.5, 
the scattering data from the protonated system indicate no interaction (as the scattering 
was exactly the same in the presence and absence of ISA23.HC1). However, the Rg of 
the polymer increased by 1.4 nm. These observations indicate the importance of 
distinguishing between the existence o f an association / interaction with measurable 
physical changes and association / interaction with no measurable physical change.
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During interaction it is possible that the polymer binds to the liposomes by 
electrostatic interaction and this could cause breakage by the removal of phospholipids 
from the bilayer (Figure 6.18). It is unlikely that the polymer causes a complete 
destruction of the liposomes.
As in Chapter 5, the SANS of model liposomes in the presence of polymers 
(control polymers used in the haemolysis assay in Chapter 3) was also measured.
The negative control (dextran) did not interact with the model liposomes, as the 
data had similar form to that of the endosome (alone) (Figure 6.19a).
The addition of TX-100 caused a complete destruction of the liposomes (Figure 
6.19b) as the data form of the liposome completely changed in the presence of 
ISA23.HC1. This result is in agreement with that obtained from examining the effect of 
TX-100 on the size distribution o f the liposomes using PCS. It is possible that TX-100 
breaks the liposomes by forming micelles with the phospholipids (in the liposomes).
For the positive control, PEI, the results are quite interesting. No interaction 
was observed (Figure 6.19) between ISA23.HC1 and lysosome model-liposomes, but 
the scattering of the endosome model-liposomes does alter quite significantly in the 
presence of ISA23.HC1. The only difference between the two models is the amount of 
the DPPC and DPPS (DPPS is higher in the lysosomal model liposomes compared to 
that of endosomal model-liposomes, and the opposite is true for DPPC). The scattering 
of the endosome model-liposomes is higher (in the whole Q range) in the presence of 
PEI, this could be due to the association o f the polymer with phospholipids headgroups, 
thus the polymer could be wrapped or located on the liposomes, and this causes the 
increase in the scattering from the system. As the data form o f the endosome model- 
liposomes in the presence and the absence o f the PEI is almost identical, this could 
indicate that PEI is not breaking the bilayer, so there is only association / little 
interaction, but no physical change in the liposomes bilayer.
The scattering data from lysosomal model-liposomes was not at all effected by 
the presence of ISA23.HC1, this is not as expected as the lysosomal model contain 
more DPPS, which carries two negatively charged groups, on the other hand DPPC 
only carries one negatively charged group, thus there should be more association / 
interaction between PEI with the lysosome liposomes compared to that with endosome 
model, however the opposite was observed.
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6.5 Conclusions
To conclude it was possible to prepare liposomes with the desired 
phospholipids composition and they were stable at the pH values used to conduct 
polymer-liposomes study. The preparation of calcein-entrapped liposomes was not 
successful as a number of problems were encountered in the preparation process and 
solving this would require more time or changing the composition of the liposomes, but 
this would be something to do for the future.
The existence or the strength o f interaction depends on both the charge of the 
polymer and the charge o f the liposomes (the target), also the flexibility of the polymer 
and how the charges appear to the membrane. Also, the accessibility of the 
phospholipids charged groups to the polymer is also important for polymer-membrane 
interaction. It is important to acknowledge that an association / interaction between 
model liposomes and polymer is possible but without physical change in the liposomes 
or change in the polymer morphology.
Chapter 7 
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Increased understanding o f the human as a “biological system” is leading to 
advances in science and technology that can be used to develop new diagnostics and 
medicines, to improve the design of endosomolytic polymers for cytosolic delivery of 
genes and proteins.
The aim o f gene therapy is often delivery of a specific sequence of DNA into 
the nucleus o f a cell to correct the faulty gene. This seems a relatively simple and 
straight forward idea. It would be easy to realise if  the body did not have so many 
defence systems (i.e RES) and biological barriers (i.e. the therapeutic agent could 
freely enter the cell), and was allowed free access to the cytoplasm and the nucleus 
without any challenge. Then the process would be simple, and there would not have 
been the need to conduct the studies described here. Numerous studies have been 
conducted using viral and non-viral vectors, and it has proven very difficult to 
overcome the many different obstacles in the biological system and thus it is hard to 
produce safe and efficient transfection agents. As discussed in Chapter 1, there are a 
number of advantages and disadvantages associated with both viral and non-viral 
vectors. Many challenges remain to be solved, but each step is a little piece in this large 
complex jigsaw puzzle. Section 7.3 describes the contributions this study has made to 
the scientific field, but first the other recent developments with non-viral are briefly 
summarised.
7.1 Recent development in the non-viral vectors
The development o f effective non-viral vectors is still considered an important 
part of the development o f successful gene therapy. Over the last 3 years, most studies 
have focused on the development o f cationic polymers by the preparation of hybrid 
derivatives, and also using derivatives enclosing targeting ligands (reviewed in Park et 
al, 2006). Most studies have tried to correlate structure with biological properties such 
as cytotoxicity and transfection efficiency. The most popular cationic polymer, PEI, 
displays a high transfection efficiency compared to other polycationic polymers, but 
many derivatives have been very cytotoxic. Although PEI’s have relatively high 
transfection efficiency compared to other polymers, their transfection efficiency is still 
low compared to the viral vectors (Boussif et al, 1995; Godbey et al, 1999b; 2001). A 
number of approaches are being employed to try and solve this problem. For example,
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the conjugation o f PEI to polymers such as PEG (Ogris et al, 1999; Kim et al, 2004), 
dextran (Tseng and Jong, 2003), polyacrylic acid (Trubetskoy et al 2003), dextran 
sulfate (Tiyaboonchai et al, 2003) and poly(N-(2-hydroxypropyl)methacrylamide) 
(pHPMA) (Oupicky et al, 2002b; Carlisle et al, 2004) (reviewed in Lungwitz, 2005). 
Generally, hybrid polym er systems have been successfully synthesised that can 
increase stability o f the polyplex in the circulation, reduce non-specific interaction with 
blood cells, reduce RES clearance and reduce general toxicity. However, the ability of 
these PEI-based polyplexes to transfect cells is still poor (Ogris et al, 2003). To try and 
solve this problem, targeting moieties, such as transferrin (Kircheis et al, 2001), 
antibodies (Merdan et al, 2003; Chiu et al, 2004) and folate (Benns et al, 2001; Kim et 
al, 2005) have been included (reviewed in Park et al, 2006). Although this approach 
can significantly increase transfection efficiencies in vitro, with minimal toxicity, these 
new hybrid constructs will be able to target the desired cells in vivo. These systems 
provide potential candidates for gene delivery, but they are still far from ideal.
The second most widely studied cationic polymer is PLL. Just like PEI, the 
main disadvantages o f PLL is its high toxicity. Similar approaches (as applied to PEI) 
have been used to improve PLL. PEGylation of PLL caused a decrease in toxicity and 
the PLL-PEG copolymer was able to protect/stabilise DNA better, and gave higher 
transfection efficiencies compared to the PLL alone (Lee et al, 2001).
Chitosan is another cationic polymer that is being widely studied. A number of 
modified chitosans have been reported, but generally they show lower transfection 
efficiencies compared to PEL Quaternised chitosan derivatives displayed improved 
gene delivery and reduced toxicity in MCF-7 cells compared to PEI (Kean et al, 2005). 
However, lactosylated chitosans failed to enhance transfection in HepG2 cells 
(Erbacher et al, 1998; reviewed in Gupta et al, 2005).
Research into new PAA chemistry (not conducted in this study) continues. 
Emilitri et al (2005) prepared new PAAs containing disulfide linkages in their main 
chain with the aim o f providing carriers for drugs and peptides. Their degradation 
behaviour was investigated, and it was shown that PAAs containing disulfide groups 
were susceptible to reductive cleavage in the presence of thiols (Emilitri et al, 2005).
As it was discussed before (Chapter 1, section 1.5), ISA1 and ISA23 are
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relatively non-toxic and they display pH-dependant membrane activity. ISA1 is able to 
deliver non-permeant toxins, but displays poor transfection efficiency, whereas ISA23 
is able to transfect cells, avoids hepatic clearance, and targets tumours by the enhanced 
permeation retention effect but ISA23 did not promote intracellular delivery of non- 
permeant toxins (Richardson et al, 1999; Pattrick et al, 2001a). It appeared that both 
polymers ISA1 and ISA23 have some desirable properties that the other is lacking 
(Lavignac et al, 2004). This initiated the synthesis o f new block and random 
copolymers composed o f ISA1 and ISA23, in order to assess whether new PAAs could 
be made with increased toxin delivery efficiency (Lavignac et al, 2004). The random 
and block copolymers are not cytotoxic and still displayed pH-dependant haemolytical 
activity, but to a lesser degree compared to ISA23. Only one block copolymer 
composed of ISA1 : ISA23 o f 1 : 2 ratio, was able to deliver toxins, better than the 
parent polymers (Lavignac et al, 2004). This was however a marginal improvement.
Several attempts to improve endosomolytic efficiency of ISA 1 and ISA23 were 
carried out by conjugating with the polymer melittin (Lavignac et al, 2005). ISA1- 
melittin showed a better gelonin delivery than ISA1, but ISA23-melittin was still 
unable to deliver gelonin. Just like ISA23, this conjugate showed pH-dependant 
haemolysis (non-haemolytic at pH 7.4), and had low cytotoxicity (Lavignac et al, 
2005).
The idea of PAA block and random copolymers is interesting, and it provides a 
bench mark to establish new approaches to combine crucial and desirable properties of 
different PAAs (or monomers).
7.2 Mechanism of action of ISA23.HC1 as an endosomolytic polymer
The main objective o f this study was to establish the mechanism by which 
PAAs caused pH-dependant membrane breakage by studying their physico-chemical 
properties. It was hoped that an insight into the molecular mechanisms would allow 
prediction of chemical improvements to structure.
At the cellular level, the PAA polymer will first encounter the plasma 
membrane. It was shown using SANS, that at pH 7.4, ISA23 did not appear to interact 
with the plasma membrane-model liposomes. Therefore it is likely that the polymer is 
internalised by fluid-phase endocytosis, although a non-specific adsorptive pinocytosis 
process could still play a part (no evidence was found here).
The decrease in pH to 6.5 as would be seen in the early endosome caused the
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slight increase in ISA23 size (but the polymer shape remained unaltered) as a Gaussian 
coil was still the best model (Chapter 4) (Griffiths et al, 2004; Khayat et al, 2006). As 
the pH was decreased further as would be seen in the late endosome (pH 6.5 -  5.5), the 
size of ISA23 increased further to 3.6 nm (measured alone in solution) and/or 4.3 nm 
(measured in the presence o f endosomal model liposomes). It is unlikely that this 
increase in size would be sufficient to cause endosomal breakage as the overall 
diameter o f the endosome is around 100 nm. As discussed in Chapter 1, the proton 
sponge hypothesis and the pore formation through the membrane bilayer are unlikely to 
be the mechanism o f action o f PAAs. Induction of membrane curvature/membrane 
bending, is the m ost likely  hypothesis, w ith the decrease in pH in the 
endosomal/lysosomal system, the cationic nature o f the PAA will increase, causing an 
increase in size, but not shape (it does not become more elongated or rod-like). It is 
possible that the polymer expansion will expose the positive charges, allowing the 
chain to associate/bind to the vesicle membrane by the electrostatic interaction 
(between the opposite charges on the polymer and the phospholipids). As interaction 
increases, the polymer may destabilise the bilayer by inducing strains/curvatures and/or 
due to the removal o f phospholipids. I f  an increase in tension occurs, this will be 
followed by the perturbation o f the vesicle.
This is a reasonable hypothesis based on the results obtained in this study. 
However, the experimental design could still be improved. For example, as it was 
mentioned in Chapter 6, the ISA23.HCl-liposomes interaction was studied by the 
addition of the polymer to the outside o f the liposomal preparation. At the cellular 
level, the PAA will be concentrated inside the endosomes and lysosomes. The external 
surface curvature o f a bilayer is very different, and this will probably have a major 
effect on the polymer and the way the polymer interacts with the target (Figure 7.1). In 
addition, the surface tension inside the vesicle will be affected by the polymer- 
membrane interaction. This in turn will affect the way the vesicles are destabilised.
Before we go any further it is important to ask if  the objectives o f this study 
were fulfilled? Unfortunately there is no clear answer to this question; some of the aims 
were achieved, while others were partially achieved.
Studies investigating the effect o f pH on the morphology/size o f the ISA23
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Endosome or 
lysosome vesicles
Polymer
Here the polymer is located inside the 
endosome and lysosome vesicles
Polymer
Plasma The polymer is located outside the
membrane plasma membrane bilayer
Polymer-liposomes (plasma, endosome and Polymer-micelles interaction
lysosome) interaction
To investigate the polymer-model membrane interaction, the polymer were located
outside the model
F igure 7.1 The co m parison  betw een w h a t the po lym er en coun tered  during  
intracellular trafficking and it com parison to the experiments conducted here.
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polymer coil were successfully accomplished. Wan et al (2004) used SANS for the first 
time to investigate PAA solution conformation. These studies confirmed the previous 
results, but there were also new findings. For example, my studies also examined the 
affect o f polymer concentration and temperature on the morphology of the polymer 
(Khayat et al, 2006). In both cases the PAA size and shape were not affected.
The next objective was to establish how the PAA caused pH-dependent 
membrane breakage. This was partially answered, it is clear that the increase in the 
positive nature o f polymer is the key factor promoting interaction. Overall, the results 
obtained using the three m em brane m odels (RBCs, m icelles/surfactants, and 
liposomes) were in agreement. However, there were a few exceptions. The micelles 
composed of lyso-PC alone, did not interact with ISA23 at pH 5.5 (Khayat et al, 2005). 
This was shown using three techniques:- surface tension, EPR and SANS. Interestingly, 
ISA23 did interact w ith the endosom e membrane-model liposomes and micelles 
composed o f SDS, at this pH. There was also no interaction observed between 
lysosome membrane-model liposomes and ISA23.HC1 at pH 5.5. The scattering of both 
endosome- and lysosome models was only slightly altered by ISA23.HC1 at pH 4, 
where the polymer is even more cationic in nature.
Another interesting observation was made in the experiments investigating 
ISA23.HC1 interaction with the surfactant micelles composed o f the positively charged 
CTAB surfactant (Chapter 5). It was found that there was clear interaction between the 
model micelle and the polymer at pH 7.4, and to a lesser extent at pH 5.5. These results 
show that the carboxylic acid group o f ISA23.HC1 was able to promote interaction with 
the positively charged micelles. It was also found that an increase o f the positive charge 
of the amphoteric ISA23.HC1 decreased the extent o f interaction. This being the case, 
then is it also possible that the carboxylic acid groups o f ISA23 might also have a 
negative effect on the interaction between the cationic groups o f the polymer with the 
model membrane? It is well known that the physiological membrane often carries an 
overall net negative charge. Hence, cationic polymers are mainly used to promote 
interaction and destabilisation. However, phospholipids can also carry a positively 
charged group, so it might also be possible that there is an interaction between this 
group and the negatively charges carried on the polymer. Is it also possible that there 
could be a PAA-PAA chain interaction, which results in aggregation. However as it
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was shown in Chapter 4, there was no evidence o f this.
Do these experiments give some hint as to the improved design of a PAA? It 
appears that the increase in positive charge on PAA between 7.4 and 5.5 does not occur 
rapidly enough to ensures efficient endosomal breakage at pHs less than 5.5. For 
optimum polymer-membrane interaction, both the target membrane and the polymer 
would play a part. Both the charge ratio on membrane and the polymer, and the 
accessibility o f one to the other would be very important. Recent studies (unpublished) 
have shown lower molecular weight PAAs to be most effective.
7.3 Conclusions and fu tu re  studies
These studies will play an important role in the forward progression of the field 
of endosomolytic polymers. Particularly for PAAs, but the techniques established can 
be much more generally applied. These studies are the first to use SANS to study the 
morphology and size changes o f an endosomolytic polymer. Also it was the first time 
that polymer-membrane interactions had been probed in this way. The morphology of 
model membrane (liposom es and micelles) was investigated in the presence o f 
polymer, and the effect o f the model membrane on the morphology o f the polymer was 
also examined. Surface tension and EPR techniques are commonly employed to 
investigate colloidal system, but here they were used to investigate endosomolytic 
polymer-model membrane interaction in a new way.
Usually biologists use RBC lysis to investigate polymer-membrane interaction. 
It is arguable that this is far from a ‘normal’ cell membrane, and intracellular vesicle 
membranes will be different in composition. Here other models were developed. First 
micelles were used as a simple model to obtain a general picture o f polymer-membrane 
interaction. This was tuned by varying the micelle composition and the ratio o f the 
surfactant mixture. Thus it was possible to systematically study the effect o f target on 
the strength of interaction.
The use of liposomes as model membranes to study polymer interaction was not 
original. However we believe that no one has used liposomes prepared to contain a 
phospholipid composition chosen to mimic the plasma, endosome and lysosome 
membranes respectively. Both the micelles and liposomes were also prepared with 
deuterated surfactants and phospholipids, to allow contrast matching and thus they 
could be used to extract information on the polymer.
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This was a multidisciplinary project, and it highlights the importance of 
collaboration across different scientific disciplines. In this case biology, chemistry and 
physics were combined to try and better understand an endosomolytic polymer. In 
addition, the mathematical modelling was much more complex than the usual statistical 
methods commonly employed in scientific research.
The results presented here have opened many further questions and would be a 
great opportunity for further research. Polymer-membrane interaction using liposome 
as a model, provides the greatest potential for further work. Listed below are a number 
of different experiments that could have been done (if time had permitted) to further 
improve our understanding o f PAA as an endosomolytic polymer:
1) Time was needed for the fitting o f the scattering data obtained from the 
liposomes in the presence o f the polymer. The calculated parameters could then 
be compared to those o f liposomes alone.
2) It would have been interesting to use PCS to study the effect of ISA23.HC1 on 
the size distribution o f plasma, endosome and lysosome membrane-model 
liposomes at pH 7.4, 6.5, 5.5 and 4. These results can be then compared to the 
result obtained from SANS.
3) D ifficulties were encountered in the preparation o f calcein-entrapped 
liposomes, with further work this could be solved and such models used to 
study the release rate o f the entrapped fluorescence dye by ISA23. Liposomes 
containing a macromolecular probe (e.g. FITC-dextran) could also be used.
4) It would be interesting to try and entrap the PAA inside o f the liposomes to 
study its effect on the inner face. By carefully changing the pH inside the 
liposomes, the polym er-m em brane interaction could be investigated by 
measuring the release o f radiolabeled-PAA. This is a more realistic model for 
both the endosome and lysosome vesicles.
5) In addition it would be interesting to investigate the effect that cholesterol, 
proteins, lipid rafts, and the distribution o f phospholipids between the inner and 
outer leaflet o f the bilayer had on polymer-membrane interaction. These studies 
would be more complex.
6) EPR could also be used to study the effect o f polymers on the fluidity o f the 
bilayer of the model liposomes.
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7) Another topic, which remained unexplored would be the use of molecular 
modelling to examine sterically how the phospholipids in the membrane bilayer 
might access and interact with ISA23.
Although many experiments remain, this thesis has started a new field that 
brings together physico-chem ical methods and the understanding and design of 
endosomolytic polymers. Hopefully in the future this approach will help realise 
improved efficiency o f cytosolic delivery systems.
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Understanding the Mechanism of Action of Poly(amidoamine)s 
as Endosomolytic Polymers: Correlation of Physicochemical 
and Biological Properties
P. C. Griffiths,*1- A. Paul,* Z. Khayat,*-* Ka-Wai W an ,11 S. M. King,§ I. Grillo," R. Schweins,1 
P. Ferruti,1 J. Franchini/ and R. Duncan*
School of Chemistry, Cardiff University, PO Box 912, Cardiff CF10 3TB, United Kingdom, Centre for 
Polymer Therapeutics, Welsh School of Pharmacy, Redwood Building King Edward VII Avenue, 
Cardiff CF10 3XF, United Kingdom, ISIS Facility, Rutherford Appleton Laboratory, Chilton, 
Oxfordshire 0X11 OQX, United Kingdom, Institut Laue-Langevin, 6 rue Jules Horowitz, Grenoble, France, 
and Dipartimento di Chimica Organic e Industhale, Universita’ degli Studi di Milano, via Venezian 21,
20133, Milano, Italy 
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Bioresponsive poly(amidoamine)s (PAA)s are currently under development as endosomolytic polymers for 
intracellular delivery of proteins and genes. Here for the first time, small-angle neutron scattering (SANS) 
is used to systematically investigate the pH-dependent conformational change of an endosomolytic polymer, 
the PAA ISA 23. The radius of gyration of the ISA23 was determined as a function of pH and counterion, 
the aim being to correlate changes in polymer conformation with membrane activity assessed using a rat 
red blood cell haemolysis assay. With decreasing pH, the ISA23 radius of gyration increased to a maximum 
(/?g~  80 A ) around pH =  3, before subsequently decreasing once more. At high pH and therefore high 
ionic strengths, the polymer is negatively charged and adopts a rather compact structure (Rs ~  20 A ), 
presumably with the dissociated carboxylic groups on the exterior of the polymer coil. At low pH, the coil 
again collapses (Rg < 20 A ), presumably due to the effects of the high ionic strength. It is concluded that 
the nature of the salt form has no direct bearing on the size of the polymer coil, but it does indirectly 
determine the prevailing pH and, hence, polymer conformation. Pulsed-gradient spin—echo NMR 
measurements were in good agreement with the SANS estimates of the radius of gyration, although ISA23 
polydispersity does complicate the data interpretation/comparison. These results support the proposed mode 
of action of PAAs, namely a coil expansion on passing from a neutral pH (extracellular) to an acidic pH 
(endosomal and lysosomal) environments. The results do, however, suggest that the charge on the polymer 
shows a closer correlation with the haemolysis activity rather than the polymer conformation.
Introduction
Increased understanding of the genetic basis of disease 
has led to growing interest in the use of macromolecular 
drugs such as genes, proteins, and peptides. At the cellular 
level, inadequate cytosolic access is one major challenge that 
must be overcome if these macromolecules are to become 
effective therapies.1 Consequently, there is a recognized need 
to design safe and efficient delivery vehicles. The viral 
vectors currently being used for gene delivery have clinical 
limitations including immunogenicity and transgene ex­
pression,2-4 so the search is on for endosomolytic polymers 
that can be used to design a synthetic viral mimetic. The 
construct must efficiently mediate membrane translocation 
from the endosomal compartment into the cytosol, delivering 
its payload there, thus avoiding lysosomal degradation.5
* To whom correspondence should be addressed. Phone: +44-29 
20875858. Fax: +44-29 20874030. E-mail: griffithspc@cardiff.ac.uk.
t School of Chemistry.
* Welsh School of Pharmacy.
5 Rutherford Appleton Laboratory.
11 Institut Laue-Langevin.
Universita’ degli Studi di Milano.
A number of bioresponsive, endosomolytic polymers 
(weak acids and weak bases) are under study as nonviral 
vectors. These include poly(ethylene imine) (PEI),6 poly- 
[(2-diethyIaminoethyl)-methacryIate] (pDMAEMA),7 poly- 
(ethyl acrylic acid) (PEAAc) and related polymers,5-8 poly- 
amidoamine (PAMAM) dendrimers,9-10 poly(2-methyl-acrylic 
acid 2-[(2- (dimethylamino)-ethyl)-methyI-amino]-ethyl es­
ter) (pDAMA),11 and linear polyamidoamines (PAAs).12 The 
mechanism of this membrane destabilization is poorly 
understood but is triggered by a fall in pH following 
endocytic internalization of the polymer.
It has been suggested that PEI acts by the “proton sponge 
effect”.6 PEI entering the endosome absorbs protons, swells, 
and causes an influx of Cl- which in turn creates an osmotic 
effect leading to water influx. These events are purported to 
cause membrane destabilization. The universal importance 
of the proton sponge effect is hotly debated. It has recently 
been shown that pDAMA-based polyplexes do not escape 
endosomes by this mechanism.11
Over the past decade, we12-13 have designed PAAs as 
endosomolytic polymers for gene and nonpermeant toxin 
delivery.14-15-16-17 The preferred amphoteric PAA structures
10.1021 /bm049936g CCC: $27.50 ©  2004 American Chemical Society
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Table 1. Molecular Weight and Ionization Properties of ISA23
tSAll
KI* (g/mol) M J M * pKai pKb2 p K b 3
16 500 1.8 2.1 7.5 3.3
(including ISA 23; Table 1) are highly water-soluble, linear 
polymers and much less toxic than other polycations.15 Using 
both isolated rat red blood cells (RBCs) and isolated 
lysosomes,15 these PAAs have shown pH-dependent mem­
brane perturbation that correlates with their ability to facilitate 
gene and toxin delivery in vitro. Furthermore, PAAs do not 
accumulate in the liver and intravenous injection and so can 
be used to target tumors by the EPR (enhanced permeability 
and retention) effect.18
Recent studies have shown the PAA counterion influences 
both membrane activity (in the RBC lysis model)19 and toxin 
delivery in vitro. Although PAA acetate, citrate, and lactate 
were nonhaemolytic at the starting pH of 5.5, the sulfate, 
hydrochloride, and phosphate forms ISA23 caused significant 
haemolysis (up to 80% Hb release at 1 h). The observation 
that systematic tailoring of the p/£a of monomers used to 
prepare PAAs did not enhance pH-dependent haemolysis 
compared to ISA23,13 PAA graft and block copolymers, 
ISA23-protein conjugates, and ISA23 of increased molecular 
weight (from ~15 kDa to 50 kDa) led to decreased 
membrane activity would suggest that PAA action is medi­
ated predominantly by membrane interaction and not the 
proton sponge effect.
The aim of this study was to use small-angle neutron 
scattering (SANS) to systematically investigate the pH- 
dependent conformational change of ISA23 as a function of 
pH and counterion and to relate changes in polymer 
conformation with the membrane activity of ISA23. For 
comparative purposes, pulsed-gradient spin—echo NMR 
measurements were also used to obtain a complementary 
estimate of the solution conformation of ISA23 via the 
hydrodynamic radius (Rh)-
Materials
ISA23 was synthesized as previously described15 by 
polyaddition of 2,2'bis(Ar-acrylamido)acetic acid (BAC) and 
2-methylpiperazine (2-MePip) (Table 1). ISA23 samples for 
SANS and NMR were prepared at a concentration of 50 mg/ 
mL in D2O. Subsequently, the pH was altered by the addition 
of concentration base (NaOD or NaOH) or acid (HC1 or 
DC1). Given the strong buffering character of ISA23, this 
often resulted in significant changes in ionic strength.
Methods
Small-Angle Neutron Scattering. SANS measurements 
were performed on the LOQ diffractometer at the ISIS 
Spallation Neutron Source, Oxfordshire and on the DI 1 and 
D22 diffractometers at the ILL, Grenoble.
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LOQ is a fixed-geometry, time-of-flight (TOF), instrument, 
whereas the ILL (Dll and D22) is a steady-state reactor 
source. Neutron wavelengths between 2 and 10 A  (LOQ) 
and 8 A (DI 1) or 6 A (D22) were employed to span Q-ranges 
of approximately 0.001 to 0.6 A -1 . On Dll and D22, this 
required three separate instrument configurations (sample— 
detector distances and collimation).
On all of the instruments, the samples were contained in 
2 mm path length, UV-spectrophotometer grade, quartz 
cuvettes (Hellma) and mounted in aluminum holders on top 
of an enclosed, computer-controlled, sample changer. Sample 
volumes were approximately 0.4 cm3. Temperature control 
was achieved through the use of a thermostated circulating 
bath pumping fluid through the base of the sample changer. 
Under these conditions, a temperature stability of ±0.5 °C 
can be achieved. All measurements were carried out at 
25 °C. Experimental measuring times were approximately 
40 min.
Dependent on which instrument was used, all scattering 
data were (a) normalized for the sample transmission and 
incident wavelength distribution, (b) background corrected 
using an empty quartz cell (this also removes the inherent 
instrumental background arising from vacuum windows, 
etc.), and (c) corrected for the linearity and efficiency of the 
detector response using the instrument-specific software 
package. The data were put onto an absolute scale by 
reference to the scattering from a well-characterized partially 
deuterated polystyrene-blend standard sample (LOQ) or flat 
scatterer such as water (Dll, D22).
Pulsed-Gradient Spin—Echo NMR Studies. The self­
diffusion measurements (]H 360 MHz) were measured using 
a stimulated echo sequence. The attenuation of the spin— 
echo amplitude after Fourier transformation was recorded 
as a function of the duration, <5, of the applied gradient pulses 
for a fixed gradient intensity, G, and separation A. A typical 
diffusion time would be A= 500 ms, and thus, the experi­
ment is dominated by center-of-mass motion.
Many artifacts can be present in a PGSE-NMR experiment. 
Pulsed gradients often produce eddy currents in the metallic 
components of the probe and assembly that result in a 
mismatch between the pairs of gradient pulses used during 
the experiment. To eliminate these problems, a current 
regulated gradient driver delivers pairs of read and write 
gradients matched to better than 10 ppm, and three field 
gradient pre-pulses were applied to bring the effects of eddy 
currents to a first-order steady state. To minimize any 
physical disturbances associated with switching gradients, 
the gradient pulses are ramped up to their plateau value and 
back down to zero, typically over 250 fis.
The self-diffusion coefficient, Ds, for isotropic, polydis- 
perse polymer molecules is extracted by fitting to eq 1, the 
measured peak height, A(d,G,A), as a function of field 
gradient pulse duration, d, intensity, G, and separation, A
A(d,G,A) =  A0 exp[-(£Ds/ ]  (1)
where k — —y 2G2(30A(<5 +  o)2 (10<53 + 30<7<52 +
35o2d +  14o3)/30).
y  is the magnetogyric ratio, and /3 is a phenomological 
parameter which quantifies in a purely arbitrary manner, the
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distribution of diffusion coefficients associated with poly- 
disperse polymers.
Results and Discussion
The term “polymer therapeutic” has been coined to 
describe several new classes of polymer-based drugs and 
delivery systems.18 These include polymeric drugs,18 polymer— 
drug conjugates,20 polymer-protein conjugates,21,22,23 poly­
mer micelles which entrap drugs by covalent linkage,24 and 
also those endosomolytic polymers used as nonviral vec­
tors.616 These nanosized medicines are quite different to 
conventional drug delivery formulations that simply solu­
bilize, entrap, or control drug release without resorting to 
chemical conjugation.18 Little is known of the solution 
properties of polymer therapeutics, and this study reports the 
first use of SANS to understand the conformation changes 
of an endosomolytic polymer being designed to assist protein 
and gene delivery. In parallel studies, we are applying the 
same methodology to gain increased understanding of the 
solution conformation of polymeric anticancer agents in early 
clinical development.25,26
SANS experiments carried out at the ILL to determine 
the radius of gyration of ISA23 showed a pronounced upturn 
at low Q. The origin of this upturn is still under discussion. 
It could be due to an error in the transmission measurement 
because of fast neutrons going through the selector; however, 
the velocity selector lets through only neutrons with a 
selected wavelength ±10%. Also, as neutron transmissions 
generally fall with increasing wavelength, fast neutron 
contamination would increase transmission with the result 
that the incorrect transmission would lower the scattering.
It is more likely, although unfortunate, that this upturn at 
low Q is due to background scattering which arises from 
something in the instrument. The data obtained with the same 
samples at the LOQ (ISIS facility, U.K.) showed no evidence 
of this upturn although the Q range does not extend to quite 
the lowest values accessible on D22.
The low-2 scattering follows a power law I(Q)clQ~" with 
n % 4.3 ±  0.2. Attempts to remove this scattering in the 
usual manner, i.e., subtract the scattering from an empty cell 
or a cell filled with D20, introduces further artifacts at low 
Q such as negative scattering. We therefore have adopted 
an approach where this anomalous scattering is fitted 
simultaneously to the polymer scattering. An example of this 
is shown in Figure 1.
A simple polydisperse Gaussian coil approach best de­
scribes the polymer scattering
^polym e/2) ^ ^ P p o ly m er  Psolvent) u 2
(1 +  V)
(2)
where cp is the polymer volume fraction and V is the sample 
volume, p is the scattering length density of the polymer 
and solvent (subscripts polymer and solvent respectively), 
with the bracket (Ppoiymcr — Psoivcnt)2 being known as the 
“contrast”; this is an indication of how strongly (or not) a 
particular system scatters neutrons, v is a measure of the
i + a n + . - i
Griffiths et al.
0 .5
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0.1
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0.01 0.1
wavevector, Q / A 
Figure 1. Typical raw SANS data for 5 wt % ISA23 polymer in D2 O 
(• ) ,  showing the separate “anomalous scattering” (long dashed line) 
and the polymer data (O). The fits to these data correspond to eq 3 
(dotted line) and eq 2 (solid line).
polydispersity, M JM n ~  1 and u =  Q2Rg2/( 1 +  2v) where 
Re is the polymer radius of gyration.
Hence, the fit to the raw data in Figure 1 utilizes
W e r  (Q) =  KQ)Q~n +
^ ( P p o ly m e r  “  Psolvent)2   ~ 2-------------+  K c  ( 3 )
(1 +  v)u
where the first term is the anomalous scattering, and the 
second term is that arising from the polymer. Bmc is the 
incoherent scattering, generally dominated by the protons 
present in the sample, which depends on the concentration 
of polymer, added base/acid etc. Having fitted the raw data 
to eq 3, the anomalous scattering can be easily subtracted 
leaving simply the polymer term as given by the open 
symbols in Figure 1. The fit to these data is shown as a solid 
line.
PAAs are weak scatterers and in order to observe viable 
scattering, the experiments are performed at a polymer 
concentration that is significantly greater (>50-fold) than that 
at which the physiological effects are observed in the RBC 
haemolysis assay. Figure 2 shows (a selection of) the data 
replotted in the form /polym er(Q)lrpVTPpolymer -  Psolvent)2 to 
remove the slight concentration and contrast variations within 
the pH series. Clearly, all of the data have a very similar 
form suggesting that there is no significant change in polymer 
morphology with pH, simply a change in radius of gyration. 
Some data extend to higher Q depending on the instrument 
configuration. A fit has been drawn through each dataset, 
and the thus obtained radii of gyration presented as a function 
of pH in Figure 3.
On decreasing the pH from pH =  14, the radius of gyration 
increases. The size attains a maximum value R&=  80 (±3) 
A  at around pH =  3, roughly an order of magnitude greater 
than value at pH =  13. Subsequently, the radius further 
decreases with decreasing pH.
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Figure 2. Normalized SANS data for fcdymerfayto Uppoiyme, -  p****)2) 
for 5 wt % ISA23 polymer in D2 O as a function of pH; diamonds 
pH =  2.0; squares pH =  3.7; inverted triangles pH =  5.5; triangles 
pH =  7.4; circles pH =  13.0.
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Figure 3. Radius of gyration of ISA23 polymers from the SANS data 
as a function of pH for various salt forms; (filled circles) hydrochloride 
(ILL data); citrate (empty squares); simple polymer, plus 0.1 M NaCI 
(empty circles); (filled triangles) hydrochloride (LOQ data); (filled 
squares) phosphate (LOQ data) and simple polymer (empty triangles). 
Also shown are the “weight average” PGSE-NMR estimates of the 
hydrodynamic radius for the citrate (inverted open triangles) and the 
hydrochloride (closed inverted triangles). The vertical lines correspond 
to the pKa values presented in Table 1.
Table 1 presents the dissociation constants for the relevant 
functional groups. The carboxylic acid group has a pKa of
2.1. It is generally accepted that at pH =  pKa+ 2  there is 
99% dissociation of the ionic species; therefore, at high pH 
(above pH =  4.1), 99% of the carboxylate groups are present 
in the deprotonated form (COO- ) and are hence negatively 
charged. In Table 1 the amine groups are considered in terms 
of their conjugate acids, the pKa of which are 7.5 for Ni and 
3.3 for N2. Above their pKa, these groups are present in the 
unprotonated (charge neutral) form. Hence, at high pH
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(pH > 9.5), the overall charge on the polymer is negative, 
arising from the deprotonated carboxylic acid groups. On 
decreasing the pH below pH 9, Ni begins to become 
protonated, and hence, the overall charge on the polymer 
decreases (the polymer becomes less negatively charged), 
reaching the isoelectric point at pH ~  5.5. Below this pH, 
protonation of the second amine group imparts an overall 
positive charge.
At pH > 8 the measured Rg was «20 A. This seems quite 
small for a polymer of this molecular weight. Poly(ethylene 
oxide) (PEO) of the same molecular weight in a theta solvent 
would have Re =  50 A, but interestingly, PEO with the same 
degree of polymerization as the ISA23 would have a similar 
Rg of 25 A . Thus, at this pH, we believe 1SA23 adopts a 
rather compact structure; further, it is reasonable to assume 
that the fully deprotonated carboxylic anions are present at 
the exterior of the polymer coil. Nj is only ~20% protonated 
(20% positively charged) at this point. With decreasing pH, 
the negative charges are compensated by the increasing 
protonation of Nf; that is, the polymer is ampholytic and 
adopts a less tightly coiled conformation and Rg increases.
Below the isoelectric point (pH = 5.5), the polymer coil 
expands significantly. This is slightly surprising as at this 
pH both the carboxylic groups and Ni are fully charged. 
Clearly, the repulsion between the like-charged groups 
associated along the polymer backbone (both amine groups 
are present in the protonated form) must outweigh the intra 
group attraction between positive and negatively charged 
groups that would promote a collapse. With further decreases 
in pH, a coil collapse is observed, but this is likely to be 
due to the screening effect associated with the added ionic 
species.
Data obtained from the NMR experiment are shown in 
Figure 3. There is surprisingly good agreement between the 
NMR and SANS estimates of the radius, given the quite 
different nature of the two techniques and the polydispersity 
of the polymer. This result provides tacit confirmation that 
the anomalous scattering at low Q is not due to aggregation; 
to which the NMR experiment is highly sensitive.
A related study by Ferruti et al13 used viscosity to study 
the effects of pH on the polymer conformation observed 
somewhat different behavior. They showed that, in 0.1 M 
NaCI, the reduced specific viscosity (rj — rjo)/rjoc (where rj 
is the polymer solution viscosity at a concentration c and rjo 
is the solvent viscosity) of a related polymer decreased with 
a reduction in the pH showing two “steps” around the pATa 
values associated with the two N atoms on that polymer. 
For ISA23, the same behavior was observed, but there was 
also additional viscosity increases at high pH due to the 
deprotonation of the carboxylic group. In the absence of the 
added salt, the viscosity of the related polymer increases with 
pH to a maximum around pAfai before subsequently decreas­
ing to a constant value around pA^. The interplay between 
pH, ionic strength, and polymer conformation is therefore 
somewhat complex.
PAAs contain tertiary amino- and amido-groups regularly 
arranged along the macromolecular chain and thus behave 
as bases of moderate strength in aqueous solutions. Previ-
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Figure 4. Degrees of haemolysis of ISA23 polymers as a function 
of pH for various IAS23 salt forms; (empty triangles) chloride; (filled 
circles) polymer only; (open circles) citrate; (filled triangles) phosphate; 
(open squares) sulfate.
ously reported haemolysis studies have shown that addition 
of PAAs (up to 1 mg/mL) to RBCs in phosphate buffered 
saline (PBS) at starting pH values from 7.4 (extracellular) 
to 5.5 (secondary lysosome) results in a significant increase 
in haemolysis as pH decreases.13,15 In addition, it was recently 
shown using ISA23 of standardized molecular weight that 
the chloride, phosphate, and sulfate salt forms (strong acids) 
caused significant RBC haemolysis when added to PBS at a 
starting pH = 5.5.19 In contrast ISA23 citrate and lactate 
salt forms (weak acids) were nonhaemolytic when added to 
PBS at this starting pH. It is known that PAA addition can 
cause a significant lowering of the initial buffer pH, 
dependent on the polymer molecular weight, concentration, 
salt type, and buffering capacity of the bathing solution. For 
example, in the above-mentioned experiments, the actual PBS 
pH values at the starting PBS pH of 5.5 (1 mg/mL) were 
citrate 4.7, lactate 4.9, acetate 5.6, phosphate 4.9, chloride
3.2, and sulfate 3.0. However, it is important to note that in 
the absence of the polymer such changes in pH per se in the 
range pH 3.0—9.0 do not cause RBC haemolysis.
As the actual pH of the 1SA23 chloride solution drops to 
pH ~  3 due to the presence of ISA3 chloride, and the 
prevailing pH of the citrate form is much higher, pH ~  5, 
the resultant effect on PAA conformation could explain the 
apparent dependence of haemolysis on salt type. It has been 
hypothesised that during ISA23 protonation (Table 1) after 
internalization by the cells causes a change in polymer 
conformation thus allowing it to bind to the endosomal 
membrane, causing its disruption.15 Unravelling this mech­
anism in the biological environment is difficult as the intra- 
endosomal PAA concentration and the buffering capacity of 
the endosome are unknown. However, the observations 
presented here are consistent with changes in the conforma­
tion or ionic character of the polymer that may promote 
adsorption to- or interaction with (e.g., inducing curvature, 
pore formation) the membrane, causing it to disrupt.
The biological activity as manifested in terms of red blood 
cell (RBC) haemolysis (1 mg/mL) is shown as function of 
pH and salt type in Figure 4 for the same series of ISA23 
polymers as studied with SANS (50 mg/mL). These results 
suggest that there is a critical pH below which haemolysis 
will occur, namely pH = 5.0 ±  0.25. Overlapping the 
haemolysis behavior and the corresponding radii (Figure 5) 
suggests that there is no obvious direct correlation with the 
Rg. A closer correlation of the biological activity may be 
seen if we consider the charge on the polymer. The 
haemolysis data in Figure 5 is overlaid with a plot of the 
pH-dependence of the charge on the polymer, considered in 
terms of the three functional groups and the overall charge. 
This suggests that a high degree of haemolysis is observed 
only once the second amine group begins to protonate and 
the overall charge on the polymer becomes positive. It may 
be that the polymer must attain a minimum degree of positive 
character before a membrane disrupting adsorption will 
occur.
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Figure 5. Haemolysis results (filled circles); radii from SANS (open circles), radii from PGSE-NMR (open squares). Solid line is the overall 
charge on the polymer, broken lines are percentage protonation of the functional groups; COOH (dotted), Ni (dash-dot), N2 (dashed).
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Mechanism of Action of Poly(amidoamine)s
Making the analogy with polymer adsorption to particulate 
surfaces,27 the adsorption of PAA to the membrane may be 
rationalized based on the respective charges on the polymer 
and surface. On approach to a surface, the number of 
configurations a polymer can adopt, and hence its entropy, 
is greatly reduced. The polymer only adsorbs if the enthalpic 
interaction is greater that some critical value. In the case of 
polyelectrolytes, the strong electrostatic interactions result 
in a significant degree of binding and a flat conformation, 
at least for impenetrable substrates. The COO- group, while 
in the deprotonated form, will hinder the adsorption, both 
due the tightly coiled conformation and more significantly 
due to repulsion of like negative charges at the polymer/ 
membrane interface. One could imagine, therefore, that for 
the case of PAA/membrane interactions a positive character 
is required before the polymer will adsorb to the negative 
membrane interface. Both of these characters are pH- 
dependent.
The different salt forms lead to a pH dependent haemolysis 
behavior that is difficult to rationalize based simply on the 
polymer conformation; the radius of gyration has already 
increased significantly at pH = 4, whereas the haemolysis 
has not. However, the salt form does have a secondary effect 
on the systems; the salts of weak acids are fully dissociated 
and hence determine the prevailing pH of the solution, which 
in turn affects the degree of protonation of the polymer.
Conclusions
The radius of gyration of ISA23 has been examined as a 
function of pH and salt type by SANS. A polydisperse 
Gaussian coil treatment describes the observed scattering, 
using a polydispersity value derived from gel permeation 
chromatography. The polymer size increases gradually over 
the range 6 < pH < 13, but increases sharply to a maximum 
around pH = 3. For pH values below this, the polymer coil 
collapses. PGSE-NMR measurements gave /?h estimates in 
agreement with the SANS data. These results broadly support 
the proposed mode of action of PAAs, namely, a pH driven 
coil expansion, and there is a clear correlation between the 
cationic character of the polymer and membrane activity.
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Abstract
Bioresponsive polymers are being developed as synthetic viral mimetics to enhance the intracellular delivery of macromolecular therapeu­
tic agents such as genes, proteins and peptides. In this context we have designed pH-responsive, amphoteric polyamidoamines (PAAs) which 
change conformation on passing from a neutral pH (extracellular) to an acidic pH (endosomal and lysosomal) environments. PAAs have already 
demonstrated cytosolic delivery of genes and non-permeant toxins (e.g. gelonin and ricin A chain). The aim of this study was to use small-angle 
neutron scattering (SANS) to investigate the most likely shape of the hydrochloride salt form of one particular PAA (ISA23) in solution, under pH 
conditions that mimic those the polymer would be expected to encounter during endocytic internalisation (pH 7.4-3). It was shown that models 
based on a Gaussian coil representation of the polymer conformation described the SANS data better over this pH range than models based on a 
rod-like conformation. The conformation of IS A23 at 37 °C was expanded (radius of gyration ~  80 A) at pH ~  3 but collapsed with an increase in 
pH (radius of gyration ~  20 A at pH 7.4), a conclusion also reached in a model-free analysis of the neutron data. Outside this pH range -  at the 
extremes of high and low pH -  the polymer coil collapsed and interpretation of the scattering was slightly complicated by the presence of a very 
weak structure factor indicating that the polymer coils are highly charged. The PAA concentration did not significantly affect the polymer size 
over the concentration range 10-50 mg/ml. Characterisation of the dynamics of these polymer solutions -  diffusion coefficients and viscosity -  
ostensibly suggest a very different conclusion with the polymer expanding as the pH is increased, but this arises due to weak aggregation of the 
amphoteric polymer coils.
© 2006 Elsevier B.V. All rights reserved.
Keywords: Polymer therapeutics; Endosomolytic polymers; Pulsed-gradient spin-echo NMR; Small-angle neutron scattering; Polyamidoamines
1. Introduction
Despite progress in genomics and proteomics research, it has 
proved much more difficult than originally envisaged to realise 
effective and practical therapies based on protein-, peptide- and 
gene-based therapeutics. The principal challenge remains iden­
tification of safe and effective delivery systems able to localise 
these macromolecular therapeutics to the diseased cells or tis­
* Corresponding author. Tel.: +44 29 20875858; fax: +44 29 20874030. 
E-mail address: griffithspc@cardiff.ac.uk (P.C. Griffiths).
0378-5173/$ -  see front matter © 2006 Elsevier B.V. All rights reserved, 
doi: 10.1016/j.ij pharm .2006.03.003
sues where they are needed, and once there, promote their 
efficient delivery to the correct intracellular compartment, usu­
ally the cytosol (Wagner, 2004). Retroviral and adenoviral vec­
tors are the favoured tools for gene therapy (Edelstein et al., 
2004; Ilarduya and DuzgUnes, 2000). Undeniably, they pro­
mote highly efficient gene delivery, but they have also several 
disadvantages, particularly their mixed safety record. The death 
of an 18-year-old patient in 1999 due to an acute inflamma­
tory reaction after gene therapy (Raper et al., 2003) and the 
more recent observation that 2 out of 10 children treated with 
gene therapy to correct severe combined immunodeficiency dis­
ease (SCID) developed a type of leukaemia that was clearly
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caused by the viral vector (Hacein-Bey-Abina et al., 2003) 
led many to question the risk/benefit of this approach (Check,
2003).
It is widely acknowledged that non-viral vectors offer poten­
tial advantages in terms of safety and ease of manufacture (Pack 
et al., 2005). Lipidic-DNA complexes (lipoplexes) and polymer- 
based DNA complexes (polyplexes) have been tested in clinical 
trials (Ohana et al., 2004). Their transfection efficiency is often 
extremely low and the most popular polymeric vectors used are 
very toxic (Fischer et al., 2003). Those most frequently used 
include poly cations, e.g. poly-L-lysine (PLL) (Wu and Wu, 
1988) and poly(ethylene imine) (PEI) (Boussif et al., 1995), 
pH-responsive polyanions such as the poly(ethylacrylic acid) 
(PEAAc), and related polymers (Murthy et al., 1999), and the 
cationic poly(amidoamine) (PAMAM) dendrimers (Qin et al., 
1998).
A large family of PAAs have now been synthesised. Various 
structures have been designed for different biomedical applica­
tions including heparin binding in blood perfusion filters, metal 
ion complexation, targetable anticancer PAA conjugates and 
particularly of importance here, as endosomolytic polymers for 
cytosolic delivery (reviewed in Ferruti et al., 2002). Our research 
has designed a family of linear poly(amidoamine)s (PAAs) 
(Duncan etal., 1994; Richardson etal., 1999; Ferruti etal., 2002) 
where polymer structure has been systematically optimised to 
give relatively non-toxic polymers (IC5 0  values > 1 mg/ml over 
72 h) that are non-haemolytic at pH 7.4, but show pH-dependent 
breakage of model membranes (Richardson et al., 1999). More­
over, amphoteric structures can be synthesised, e.g. ISA23 
(Ferruti et al., 2000), that do not accumulate in liver after intra­
venous injection, and that target tumours by the enhanced per­
meability and retention (EPR) effect (Richardson et al., 1999). 
ISA23 (Scheme 1) is able to deliver genes (Richardson et al., 
2001) and promote cytosolic access of the non-permeant tox­
ins ricin A chain and gelonin (Pattrick et al., 2001a). Recent 
quantitative subcellular fractionation studies showed that PAA is 
transiently retained in the endosomal compartment (1 h) before 
transfer to the lysosomal compartment and that isolated vesi­
cles containing PAAs show enhanced membrane permeability 
(Pattrick et al., 2001b). The counterion of the PAA strongly 
affects the pH-dependent membrane interaction (Wan et al.,
2004). Nevertheless, PAA toxin delivery is still very poorly effi­
cient, requiring many polymer molecules to deliver a single toxin 
molecule. Hence there is an urgent need to better understand the 
physico-chemical properties of PAAs and their precise mecha­
nism of membrane destabilisation so that more efficient second 
generation systems can be designed.
Relatively few studies have explored PAA physico-chemical 
properties. Early investigations used potentiometric titration, 
13C NMR, viscosity measurements and conformational anal­
ysis to examine the structure of a number of cationic PAAs, 
with different alkyl chain between amino groups. In this case 
they showed that the stiffness and the flexibility depended on 
various polymer features (Barbucci et al., 1981), such as degree 
of protonation.
There is much debate as to the mechanism of endosomal per- 
meabilisation of endosomolytic polymers. Behr and colleagues
(Boussif et al., 1995) advanced the polymer “proton-sponge 
effect” as a mechanism to explain PEI action, and others have 
suggested that this combines with polymer swelling in the 
acidic endosomal compartment to cause a local osmotic effect 
that then disrupts the endosomal membrane (Sonawane et al., 
2003). Universal applicability of the proton-sponge hypothesis 
was recently questioned (Funhoff et al., 2004) when a novel 
polymer with two tertiary amine groups in each monomeric 
unit [poly(2-methyl-acrylic acid 2-[(2-(dimethylamino)-ethyl)- 
methyl-amino]-ethyl ester) (so-called pDAMA)] with pKa val­
ues of ~9, and ~5 was found to form polyplexes, but not to 
mediate endosomal escape. We believe that PAAs require direct 
membrane interaction to facilitate endosomal escape. It has also 
been shown that the counterion present is a vital component of 
this process (Wan et al., 2004). Observations that PAA-block 
copolymers (Lavignac et al., 2004), and PAA covalent conjuga­
tion via a terminal group leads to decreased membrane activity 
supports this hypothesis.
Of paramount importance here is the dependence of the poly­
mer conformation on the effective charge of the polymer, the 
latter controlled via the solution pH and ionic strength. Such 
an understanding of the physico-chemical properties of endoso­
molytic PAAs is considered essential to allow further systematic 
structure optimisation. The conformation -  or shape -  of the 
polymer may be quantified using SANS.
Small-angle neutron scattering (SANS) is a particularly pow­
erful tool that can bring a new perspective to the solution confor­
mation of polymer therapeutics (as defined by Duncan in 2003), 
and also help to probe their mechanism of membrane interac­
tion. SANS has however rarely been applied in this field yet it has 
been widely used to investigate the conformation of polymers 
in solution, polyelectrolytes (Nishida et al., 2002; Nakamura et 
al., 2005), copolymers (Pederson, 2002), at interfaces (Griffiths 
et al., 2004a; King et al., 2002) and in the presence of surfactant 
micelles (Aswal, 2003; Bergstrom et al., 2004; Griffiths et al., 
2004a) and dendrimers (Ramzi et al., 2000; Hedden and Bauer, 
2003).
A nominally identical ISA23 (Afw = 42,700 g mol-1; 
Afw/A/n = 1.7) to that studied here has been previously examined 
by viscosity measurements in solutions at 35 °C buffered at pH 
8 with a total ionic strength of 0.3 M (Ferruti et al., 2000). For 
a series of solutions satisfying the condition [/7]c = 0.1, Ferruti 
et al. analysed their intrinsic viscosity data in terms of the 
Mark-Houwink model ([rj] = kMa), concluding that amphoteric 
PAAs (in particular ISA23) possess rather stiff chains since the 
parameters A:=9.53 x 10-5 dl/g and a  = 0.85 were somewhat 
larger than expected for uncharged polymers of a comparable 
molecular weight. Further, the power law dependence of the 
radius of gyration on molecular weight had an exponent of 0.74 
-R o c  Af° 74 -  typical of an expanded (but random) coil structure. 
Ferruti’s study also considered the viscosity of solutions of 
ISA23 as a function of pH with the viscosity decreasing from 
77sp/c = 0.6 at pH 11 to a local minimum (t?sp/c = 3.0) at pH 5, 
before increasing once again below pH 3. Accordingly, this 
predicts a minimum in hydrodynamic volume coinciding with 
the isoelectric point of the polymer A similar observation was 
made by Koetz et al. (1993) for the majority (but not all) of a
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Scheme 1. Synthesis of ISA23.
number of polybetaine-based polyampholytes with differing 
chemical structure but all containing carboxylic acid groups and 
various basic nitrogen functions (Koetz et al., 1993). However, 
Feng and Huang (1997) have shown that polyampholytes of 
2-acrylamido-2-methylpropane sulfonic acid (AMPS) and 
2-dimethylaminoethyl methacrylate (DMAEMA) exhibit 
significantly enhanced intrinsic viscosity at the IEP of the 
polyampholyte.
In contrast to Ferruti’s viscosity study, Griffiths et al. in 
their SANS study on ISA23 found that the PAA polymer coil 
expands as the pH decreases from pH 11 exhibiting a max­
imum at pH ~4— an apparent contradiction to the viscosity 
data (Griffiths et al., 2004a). The charge versus conformation 
behaviour of this polymer is rather important as recent experi­
ments suggest that the degree of protonation determines whether 
an interaction occurs with model surfaces and membranes (sur­
factant micelles and liposomes). Therefore, the discrepancy 
between the scattering and viscosity insights needs addressing. 
The source of the inconsistency could be (i) the “form factor” -  
the mathematical model that embodies the shape and size of the
polymer coil -  used in the analysis of the scattering data; (ii) the 
fact that a structure factor (S(Q)) was omitted in the data anal­
ysis; or (iii) that the polymer coils are aggregating in solution; 
the validity of these various approaches is addressed here.
2. Materials and methods
2.1. Materials
The monomer 2,2-bis-(acrylamido)acetic acid (BAC) was 
synthesised as previously described (Ferruti et al., 1985). 
Hydrochloric acid (HCI) and sodium hydroxide (NaOH) were 
purchased from Fisher Scientific UK Ltd. Lithium hydroxide 
monohydrate (LiOH ^ O )  and 2-methyl piperazine (2-MP), 
were purchased from Fluka. 2-MP was recrystallised from n- 
heptane and its purity was determined titrimetrically before 
use. Phosphate buffered saline tablets (PBS) (Oxoid Ltd., Bas­
ingstoke, UK) and deuterated water (D2 O) (Goss Scientific 
Instruments Ltd.) were used as supplied.
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2.2. Synthesis o f  ISA23
ISA23 was synthesised as previously described (Richardson 
et al., 1999; Ferruti et al., 2000) by polyaddition of BAC and 2- 
MePip (Scheme 1). BAC (1 g; 5 mmol) and LiOH H20  (0.212 g; 
5 mmol) were dissolved in double distilled water (1.67 ml, 
amount required to make 3 M of BAC), this mixture was stirred 
for 10 min or until all the chemicals have dissolved. To this mix­
ture 2-MP (0.511 g; 5 mmol) was added. The reaction was stirred 
for 3 days at 25 °C under a nitrogen atmosphere in the dark. After 
this period, the reaction was stopped by dilution. HCI was then 
added to the mixture, until the pH reached 3-4. The reaction 
products were filtered using a stirred ultrafiltration cell (model 
8200, Amicon Bioseparation, Millipore), with a membrane cut 
off of 10,000 g mol - 1. The molecular weight distribution of the 
polymer was then quantified using gel permeation chromatog­
raphy (GPC) against poly(vinyl pyrrolidone) (PVP) standards.
2.3. Sample preparation
The ISA23 samples were generally prepared by dissolving 
a known mass of polymer in D20  containing phosphate buffer 
(PBS). The pH of the buffered solution drops following the addi­
tion of ISA23, and is subsequently adjusted to the desired pH 
by adding concentrated NaOH or HCI.
2.4. Small-angle neutron scattering
The SANS experiments were conducted on the LOQ diffrac­
tometer at the ISIS Spallation Neutron Source (Oxfordshire), and 
the Dll and D22 diffractometers at the ILL (Grenoble). LOQ 
is a fixed-geometry, time-of-flight (TOF), instrument whereas 
Dll and D22 are variable-geometry fixed wavelength instru­
ments. Neutron wavelengths between 2 and 10 A  (LOQ) or 8 A  
(D11) or 6 A  (D22) were employed to span g-ranges (see below) 
of approximately 0.001-0.6 A - 1 . In all cases the samples were 
placed in 2 mm pathlength, UV-spectrophotometer grade, quartz 
cuvettes (Hellma Ltd., UK) and mounted in aluminium holders 
on top of an enclosed, computer-controlled, sample changer. 
The sample volume was approximately 0.4 ml. Temperature 
control was achieved through the use of a thermostated circulat­
ing bath pumping fluid through the base of the sample changer. 
Under these conditions, a temperature stability of 0.5 °C could 
be achieved. Experimental measuring times were approximately 
40 min per sample.
Dependent on which instrument was used, all scattering data 
were (a) normalised for the sample transmission and incident 
wavelength distribution, (b) background corrected using a sol­
vent filled quartz cell (this also removes the inherent instru­
mental background arising from vacuum windows, etc.), and (c) 
corrected for the linearity and efficiency of the detector response 
using the instrument-specific software package. The data were 
put onto an absolute scale by reference to the scattering from a 
well-characterised partially deuterated polystyrene-blend stan­
dard (LOQ) or a 1 mm thick sample of water (Dll, D22).
In a SANS measurement, the neutron beam is scattered by 
the nuclei of atoms in the sample through an angle (0). The angle
is expressed in terms of a scattering vector, Q = (4n/X) sin(0/2), 
where 0 is the scattering angle and A the neutron wavelength. The 
scattered intensity, I(Q), from a polymer solution with volume 
fraction <f>p, as a function of this wavevector Q, is given to a good 
approximation by
I(Q) — ^p^p(Pp — Pm^  Pi. Q)S(Q) +  ^inc (1)
where Vp is the volume of the particle; (pp — p m)2 the contrast 
term; P(Q) and 5(G) the form and structure factors, respectively; 
and Binc is the incoherent background. The form factor P(Q) 
contains information about the size and shape of the polymer 
in solution, whilst S(Q) accounts for interactions between the 
scattering objects. For a dilute solution or non-interacting poly­
mer coils, S(Q) = 1 and may be neglected. This assumption was 
made in the original data analysis. Given the knowledge of the 
chemical composition of the polymer and its concentration, the 
pre-factors in Eq. (1) may be estimated. The approach to data 
analysis is therefore to calculate the theoretical scattering from 
a model in terms of the parameters describing the size and shape 
of the polymer. “Best fit” values of these parameters were then 
determined via an iterative non-linear least squares process. The 
model is selected based on a priori knowledge, comparison to 
related systems or commonly, starting from a model-free Guinier 
analysis. For the latter case, Bmc needs to be carefully subtracted; 
here this was done by fitting a linear relationship to the measured 
scattering intensity over the last 15 points of the data (i.e. over 
a Q range where only incoherent scattering is present).
2.5. Pulsed-gradient spin-echo NMR experiments
The self-diffusion coefficients were measured on a Bruker 
AMX360 NMR spectrometer using a 5 mm diffusion probe 
(Cryomagnet Systems, Indianapolis), a Bruker gradient spec­
troscopy accessory and a stimulated echo sequence.
The self-diffusion coefficient Ds is extracted by fitting the 
integrals for a given peak to the following equation:
A (8 ,G ,A )  =  A0 ex p [-(k D s)] (2)
where A(8,G,A) is the signal integral in the presence and 
Ao is the absence of the gradients. k = — y 2G2([30A(8 + cr)2 — 
(10<53 + 30ct2<5 + 14or2)]/30) where y  is the magnetogyric ratio, 
A  the diffusion time (0.24 s), a  the gradient ramp time (250 ps), 
8 the gradient pulse length (400 ps < 8 < 2.8 ms) and G the field 
gradient strength (0.86 T m-1) i.e. typically 3.8 A into a coil with 
dG/d/=0.227 Tm-1 A-1.
3. Results and discussion
Consider the absolute intensity of the scattering, Fig. 1 (a). For 
the data recorded at the ILL and for the particularly weak scatter­
ing systems, there is an upturn in scattering at low Q. This may 
be due to aggregation -  an attractive interaction -  although in 
our earlier treatment of related data, this was considered to be an 
artefact since (i) no such scattering was observed in similar sam­
ples recorded at ISIS and (ii) the Q dependence of this upturn is 
unphysical (i.e. greater than Q~4). Accordingly initially at least,
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Fig. 1. (a) Small-angle neutron scattering for IS A23 (5 wt.%) in D2 O as a func­
tion of pH; (b) small-angle neutron scattering for ISA23 (5 wt.%) in D2 O as a 
function of pH. Each dataset has been offset by a factor of 10.
ignore the first two or three datapoints in the following analysis. 
As Q tends to zero, the factors P(Q) and S(Q) in Eq. (1) also tend 
to unity, and thus one may write I(Q —► 0) = Vp<pp(pp — pm)2 for 
a dilute system. From the composition of the polymer, the abso­
lute intensity of the scattering of these solutions and noting that 
concentration is 50 mg ml-1 in D2 O, the volume of the polymer 
coil (Vp) may be estimated; expressed in terms of a (spherical) 
radius this corresponds to R ~  50 A. Equally as important is the 
simple insight this approach provides into the change in vol­
ume due to the effects of pH—clearly, the data with pH 2.0 and
12.0 have least scattering (ignoring the weak upturn in the data) 
and are therefore, of smallest volume (collapsed). The scattering 
intensity for the solution at pH 3.7 is most intense, and therefore 
the polymer coil most expanded.
Overall, the intensity of the various datasets follow the 
pH order 3.7 > 5.5 «  2.7 > 6.4 > 7.4 > 12.0 «  2.0. This appar­
ently random order actually correlates well with a maximum 
in the volume of the polymer coil extracted from our previous 
analysis of such data, centred around pH 4.0 (±0.5). The inten­
sities over this pH range change by a factor of 5, corresponding 
to a change in the effective radius of a factor of ~2. The data at 
pH 12.0 and 2.0 are different to those at the other pHs, with a 
very weak signature of a structure peak around Q ~  0.06 A. The 
data have been replotted in Fig. 1(b) with each dataset offset 
by a factor of 10 in an attempt to emphasis this feature. Such a 
peak arises due to a highly charged, collapsed structure such as 
a micelle, unfortunately rendering data interpretation less facile. 
However, since these polymers will not experience such extreme 
pHs during internalisation into cells, a rigorous analysis is not 
warranted.
When the shape of the scattering object is not known, is irreg­
ular or not describable in a simple manner, the low Q data from 
a SANS experiment may be analysed in a model-free fashion to 
yield an estimate of the size of the scatterer (Guinier and Foumet, 
1955). The form factor, P(Q), provided the system is dilute (non­
interacting scatterers, S(Q)=  1), may be approximated at small 
<2 as
(  Q2R l\P(Q->  0) =  exp I  j-M  (3)
where Rg is the rms radius of gyration averaged over the volume 
of the polymer. A Guinier plot (In 7(0 versus Q2) will exhibit a 
linear portion over the region QRg < 1.
However, to estimate the most likely overall shape of a scat­
terer, Eq. (3) may be generalised;
pm--=ie~D<=xP | (4)
where R is the characteristic dimension—for a sphere, R cor­
responds to the radius, D = 0 and K = 5; for a long thin rigid 
cylinder, R is the cross-sectional radius, D - 1 and K =4 and 
whilst for large rigid discs, R gives the thickness, D = 2 and 
K =  12. Thus, an appropriate form of Eq. (4) ln[/(0<2°] ver­
sus Q2 will display a linear region in an appropriate Q range if 
the scatterer conforms to that particular gross morphology, from 
which the characteristic dimension may be extracted.
To estimate the conformation of ISA23 under different envi­
ronmental conditions, or to provide a coarse picture of the size at 
different pH values, the raw data obtained by SANS for ISA23 
(37 °C at 50 mg/ml) were analysed in terms of a model-free 
Guinier analysis. Selected data are presented in Fig. 2(a)-(c) 
over the Q range for which the Guinier representation is valid 
(QRg < 1). Clearly, the functional form of Fig. 2(a) exhibits the 
region of largest linearity, implying that the polymer has a more 
spherical shape, and one that does not change with pH. Derived 
radii are discussed later in this paper (Figs. 5 and 7).
0.1
Wavevector. Q /  A’1
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Fig. 2. (a) Spheres Guinier analysis ln[/poiymcr( Q)/<pV(ppolymcr -  p Soivent)2] Q °  for ISA23 (5 wt.%) D20  as a function of pH: (□ ) pH 3.7; (V ) pH 5.5 and (A )  pH 
7.4. (b) Disk Guinier analysis for ISA23 (5 wt.%) polymer in D20  as a function of pH: (□) pH 3.7; (V) pH 5.5 and (A) pH 7.4. (c) Cylinder Guinier analysis for 
ISA23 (5 wt.%) polymer in D20  as a function of pH; (□ ) pH 3.7; (V) pH 5.5 and (A) pH 7.4.
Whilst such a model-free approach is helpful, a complete 
analysis of the data requires a somewhat more involved approach 
in order to fully characterise the polymer conformation. Criteria 
to assess the most likely shape include not only an appropriate 
fit to the data but also an assessment of the absolute scatter­
ing intensity. Given that upon protonation the polymer becomes
charged, and remembering the conclusions drawn from the vis­
cosity data of Ferruti et al. (2000), an appropriate model to test 
is one that embodies an elongated or “rod-like” morphology.
For semi-flexible polymers in solution, the form factor can 
be “dissected” into three key parts, defined by an appropriate 
Q range: (i) at low Q -  corresponding to large distances -  the
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Table 1
Gaussian coil fits to the SANS data— the effect of concentration on the size of 
ISA23, at pH 7.4 and 5.5
PH Concentration (mg/ml) Radius of gyration, Rg (A)
7.4 10 24.7 ±  1.1
25 23.5 ±  3.6
50 21.4 ±  1.1
5.5 10 40.0 ±  2.3
25 38.5 ±  8.6
50 32.8 db 1.1
scattering is sensitive to the overall size of the polymer, and 
the overall radius of gyration may be determined as outlined in 
Fig. 2(a)-(c); (ii) over an intermediate Q range, excluded volume 
effects dominate the conformation of the chain and the classical 
worm-like chain described by a Kratky-Porod relationship is 
observed, from which the length of the coil may be calculated; 
whilst (iii) at high Q, the cross-sectional area of the chain may 
be extracted (although this is often too small to be seen clearly).
For region (i), a Gaussian coil model may be used (derived 
by Debye, 1947), modified to include polydispersity:
P ( Q )  =
2[(1 + u v ) ~ l/v +  u -  1] 
(1 +  v)u2 (5 )
where v is a measure of the polydispersity, (A/W/Mn) — 1 and 
u = Q2R2/(1 + 2t>) where Rg is the polymer radius of gyration, 
Fig. 3(a). As may be seen, the Gaussian coil model does provides 
good fits to the data (the extremes of pH have been omitted), 
that are only slightly improved in the presence of a degree of 
polydispersity comparable to that observed by GPC.
Table 1 presents the fitted radii of gyration for a series of solu­
tions of ISA23 as a function of polymer concentration. Whilst 
the data form such solutions are rather noisy due to the weak 
contrast ((pp — pm)2) as in Eq. (1), it is clear that there is no 
significant change on polymer conformation over a wide range 
of polymer concentration.
For region (iii), and over the range 2n/L<Q<2n/Rc where 
L is the persistence length of the rod:
P ( Q )
ttMl
~Q
exp (-SS) (6)
Ml denotes the mass per unit length and Rc is the cross-sectional 
radius of the chain, Fig. 3(b). An unequivocal observation of this 
dependence requires that the persistence length is reasonably 
long. A further insight is to compare the functional form of Eq. 
(6) and that of Eqs. (3) and (5); all three functional forms scale 
as Q r2.
Finally, for region (iii), the form factor may be considered as 
that of an infinitely thin needle of length L:
which, at high Q , leads to the scaling Q~l prediction of Eq. (6), 
P(Q) ** n /Q L .  The prediction that P(Q)  «  n / Q L  should be 
easily identifiable in the scattering. Fig. 3(c) shows that over the
pH QL range studied, such a scaling law does adequately account 
for the data, including those at the limits of the pH range.
However, whilst considering these limiting behaviours, any 
appropriate model of the polymer should fit the scattering data 
over the entire Q range. It should be stated that attempts to fit 
the data to a model describing the polymer as an infinitesimally 
thin rod -  that would account for a Q~1 dependence -  were (not 
unsurprisingly) unsuccessful indicating that the polymer has an 
appreciable cross-section. The most appropriate model there­
fore, appears to be one that would incorporate both a Gaussian 
and a rod-like or elongated characteristic into the overall poly­
mer conformation. However, this is not unexpected; a polymer 
coil following Gaussian statistics will inherently demonstrate a 
rod-like structure over an appropriately short length-scale.
It is appropriate to test these data against two further models; 
a gel-type model and one that captures both the polyelectrolyte 
and Gaussian coil limiting behaviour. For the former case -  the 
“polyelectrolyte gel model” -  the P(Q) of the polymer is approx­
imately modelled as rod of length L with cross-section R^ \
Q2¥  \  
i  +  Q 2f )
(8)
where the second term accounts for the gel-type structure asso­
ciated with a correlation length or mesh size £. The latter model 
-  the Kholodenko-Dirac worm (Kholodenko, 1993a,b; Hickl et 
al., 1997) -  describes the polymer as a rod-like structure with a 
radial Guinier characteristic:
f ( l 2 )  — P w o r m ( Q ) P axial((2) (9 )
The Kholodenko-Dirac model smoothly interpolates between 
the Gaussian coil and rigid rod predictions depending on the 
persistence length Z of the polymer. The composite form factors 
are given by
/ ’w orm (G ) =  Yn  " ( '  -  f ( y ) d y
3 sinh(Ey)For Q < f ( y ) =  and E =
I E sinh(y)
r ^  3 e/ \ sinh(Fy)f o r f i> 7 , f ( y )  =  and
■ f f . r
(10)
1/2
The radial cross-section of the worm is the same as the latter 
part of Eq. (6):
AurialCfi) =  N (P P -p m)2{AL)2 exp(-jG 2/?^) (11)
where A is the cross-sectional area of the polymer worm A = 
27iR^ and L is the contour length, L = nl. Again note the simi­
larity of the functional form of Eqs. (3), (6) and (11).
Taking the first of these two models (Eq. (8)), introducing 
a finite cross-section to the rod yields a better “fit” to the data 
compared with an infinitely thin model. A typical, illustrative
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Fig. 3. (a) Normalised SANS data /poiymer(G) -  /bkgd/VV'(ppoiymcr -  psolvent)2 for ISA23 (5 wt.%) polymer in D20  as a function of pH: (□) pH 3.7; (V) pH 5.5 and 
(A) pH 7.4. (b) Cross-sectional analysis for ISA23 (5 wt.%) polymer in D20  as a function of pH: (□) pH 3.7; (V) pH 5.5 and (A) pH 7.4. (c) Normalised SANS data 
/poiymer(fi) -  fW/V^Ppoiymer — ^solvent)2 plotted as a function of reciprocal Q (Q~l) for ISA23 (5 wt.%) polymer in D20  as a function of pH: ( 0 )  pH 2.0; (□) pH 
3.7; (V) pH 5.5; (A) pH 7.4; (O ) pH 13.0.
dataset is presented in Fig. 4(a). The fit is best (but not good) 
when the cross-sectional radius is 21 A , with (too) a short length 
(11 A ) i.e. more spherical than rod-like in shape. £ is typically 
slightly longer than L for all cases. For the other pH data, the fits
were equally poor, suggesting that the dominant conformation 
of ISA23 in solution is not rod-like. The approach does invoke 
a rather distinct interface between the radial structure and the 
solvent, and in reality this interface will be rather more diffuse,
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Rg. 4. (a) Small-angle neutron scattering data for ISA23 (5 wt.%) in D2 O at 
pH 4. The lines represent the fits to the polyelectrolyte model (Eq. ( 8 ) )  with (i) 
munconstrained fit yielding flax = 21 A, L= 11 A; (ii) fits in which the radius 
is constrained; flax = 10 A (dotted line), flax = 20 A (long dashed black line), 
*n=30A (dash dotted black line), and (iii) fits in which the length is con­
strained; L=100A (long dashed black line) and L = 500A (medium dashed 
black line), (b) Small-angle neutron scattering data for ISA23 (5 wt.%) in D2 O, 
pH 4.0. The line represents the fits to the Kholodenko-Dirac wormlike chain 
rndel (Eqs. (9M 11)) with fl = 2.2 A, / = 12 A, n = 125.
which coupled to the polydispersity of the polymer, will render 
ilie fit less precise at high Q.
The second model -  the Kholodenko-Dirac worm -  (Eqs. 
(9) and (10)) represents a better treatment of the data, Fig. 4(b), 
and is as good as the Gaussian treatment (Eq. (5)) although 
'• must be stressed that for a flexible chain, the Gaussian and 
Kholodenko-Dirac worm formulations (Eq. (9)) are equivalent.
Fig. 5 summarises the characteristic parameters extracted 
horn the various analyses of the SANS data. Clearly, these all 
suggest that the polymer expands as the pH is reduced, reaching 
J maximum around pH 4.
<
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Fig. 5. Characteristic dimension extracted from the various fits to the SANS data: 
(0 ) radius of gyration from a simple spherical Guinier analysis; (A, • )  radius 
of gyration from the Gaussian coil analysis (different counterion polymers) and 
(O ) correlation length extracted from the Kholodenko-Dirac worm-like chain.
Previous studies, using light scattering and GPC, have shown 
that ISA23 tends to form aggregates (Mendichi et al., 2005a,b; 
Ferruti et al., 2000). This could be the source of the discrep­
ancy between the SANS and viscosity data as relatively few 
aggregates would be required to affect the dynamics of the sys­
tem (viscosity), but would have little effect on the scattering. 
Indeed, any scattering from such aggregates would lie beyond 
the lower boundary of the Q range accessible in these experi­
ments. The ILL data do extend to slightly lower Q values than 
the ISIS data and a weak upturn is indeed observed but this was 
discounted as an artefact as discussed previously—accordingly, 
no definitive statement may be made regarding the pres­
ence of any aggregated form of ISA23 from the SANS 
data.
To explore this facet of the system, we undertook an NMR 
analysis of the self-diffusion coefficient of ISA23 as a function of 
pH. A parallel series measurements in which the pH was varied 
was also studied at a higher ionic strength to probe separately 
the effects of pH and ionic strength. The presence of a small 
degree of aggregation would lead to significant changes in dif­
fusion coefficient. Three representative datasets -  “attenuation 
plots” -  are presented in Fig. 6 that span the pH range studied. 
Clearly, the sample at pH 4.5 decays most rapidly and therefore 
has the largest diffusion coefficient. For polymers that are iden­
tical in size (monodisperse) and/or where there is an association 
or aggregation process occurring on a timescale that is rapid 
compared with the timescale of the measurements (240 ms), 
a single exponential relationship should be observed (Eq. (2)) 
whose slope corresponds to the self-diffusion coefficient. Poly­
dispersity gives rise to upward curvature in the attenuation plot, 
the degree of which increases with increasing polydispersity. 
Aggregation that is irreversible (or “slow” on the timescale of 
the experiment) would give rise to two characteristic slopes -  
the first corresponding to the diffusion of the aggregates, the sec-
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Fig. 6. Typical PGSE-NMR dataset for ISA23 (5 wt.%) in D2 O at 25 °C; pH 4.5 
(A), pH 4 (O ) and pH 9 ( • ) .  The solid lines correspond to fits to a stretched 
exponential model that empirically accounts for small degrees of polydispersity.
ond the non-aggregated polymers -  with the balance of each term 
being determined by concentration of the polymers in each envi­
ronment. The only-slight departure from linearity indicates that 
the polymers are polydisperse but no significantly so, and that 
no irreversible aggregation is occurring. As might be expected, 
the effects of polydispersity are manifest more strongly when 
the polymer is expanded.
Fig. 7 shows the radii of hydration as a function of pH 
extracted from these NMR diffusion coefficients as a function 
of pH and the data are superimposed on the SANS results. As 
found in the viscosity data, the size clearly decreases with a 
decrease in pH attaining a minimum value around pH 43.5 i.e. 
close to the isoelectric point, before subsequently expanding at 
pH below 4.5. Interestingly, the agreement between the three 
approaches is reasonable for pH < 5. There appears to be no sig­
nificant dependence on temperature or ionic strength.
Equally clear however, is the fact that the NMR and vis­
cosity data display the opposite pH trend with respect to the 
SANS. Such a disagreement could occur if (i) the polymers 
are indeed adopting a more elongated structure such that the 
effective hydrodynamic radius scales as R2 =  +  L 2 but
this would require L to be substantial; this is not observed in 
the SANS, or (ii) the polymers are indeed aggregating, but 
the effect would have to be small so as not to contribute sig­
nificantly to the scattering. The self-association of ISA23 has 
been detected by SEC for a series of ISA23-based polymers, 
there being a small fraction of high molecular weight polymer 
present (Mendichi et al., 2005a,b). Such a component would be 
largely invisible in the SANS experiment, and provided it was
pH
Fig. 7. Hydrodynamic radii superimposed on the “scattering dimension” (□) 
(Fig. 5) as a function of pH calculated from the self-diffusion coefficients via 
the Stokes-Einstein equation; ( • )  1 wt.% ISA23 in D20  at 25 °C; (■) 1.5 wt.% 
ISA23 in 50 mM NaCl/D20  at 37 °C and (A) 1.5 wt.% ISA23 HC1 in D20  at
37 °C.
dynamic, could lead to significant discrepancies between the two 
techniques.
Interestingly pH & 5.6-6.0 coincides with the switch from an 
overall positively charged polymer at low pH to a net negatively 
charged polymer above pH 5. Coincidentally, for pH >5, the 
ability of these polymer to break the membrane of red blood cells 
-  the degree of haemolysis -  is minimal, indicating that either 
this aggregation reduces the ability of the polymers to interact 
with the membrane surface or the mechanism that drives aggre­
gation is also involved in the membrane interaction (Griffiths et 
al., 2004b).
4. Conclusions
When interpreting neutron scattering data it is essential to 
choose an appropriate mathematical model to allow accurate 
estimation of the shape and size of the polymer coil in solu­
tion. This is not always as easy task as many models predict 
a particular Q dependence that may or may not be unequivo­
cally demonstrated in the scattering depending in the size of 
the scatterer. The results presented here amply demonstrate this 
fact—a Gaussian coil model gives the best fit for IS A23 in solu­
tion (except at the limits of pH) but the “signature” of a rigid 
rod is also seen in the data due to a combination of the local 
flexibility of the polymer, its over size and the Q range. The 
Kholodenko-Dirac model captures both these facets and is also 
shown to provide an accurate treatment of the date. On balance, 
the polymers exhibit a Gaussian coil conformation -  rather than a 
rod-like conformation -  over a wide pH range and polymer con­
centrations examined (10-50 mg/ml). Irrespective of the precise 
model adopted however, these results support the proposed mode 
of action of PA As; a pH driven coil expansion/rearrangement.
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